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ABSTRACT
This study concentrates on the role of the putative phrA  gene in the DNA repair process, 
photoreactivation, in Escherichia coli K-12. It was originally proposed that there were 
two genes, phrA  and phrB, involved in the genetic control of photoreactivation. The phrB 
gene has been cloned, sequenced and extensively characterised, placing in doubt the 
relevance of the phrA  gene. In our laboratory, previous workers have cloned a restriction 
fragment thought to contain the putative phrA  gene, and shown an in vivo 
photoreactivable effect due to this restriction fragment. The work in this study is involved 
with the characterisation of the gene present on this restriction fragment.
The introduction includes a review of the literature regarding the controversy between 
phrA  and phrB.
The experimental work is divided into three sections. The first section reports the 
sequencing of the restriction fragment, suggesting it does contain a gene which codes for a 
protein of approximately 38kDa.
The second section reports attempts to over-express the putative phrA  gene product, 
including construction of two vectors designed to over-express the gene product.
In the third section, initial photoreactivation studies show the putative phrA  gene does 
produce photorecovery above that observed in controls. Temperature and dose-rate 
studies suggest that part of the photorecovery observed in phrA+ strains is produced by an 
unknown photoactive protein. A study of the near-UV sensitivity of phrA+ phrB~ and 
phrA■ phrB' strains also suggests that the putative phrA  gene increases resistance to near- 
UV killing.
These findings have been discussed with regard to the genetic control of photoreactivation 
in Escherichia coli K-12. The results of this study support the hypothesis that the putative
phrA  gene is involved in photoenzymatic repair, and offers some explanations for the 
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bp /  kbp Base pairs /  Kilo base pairs
BSA Bovine Serum Albumin
C Cytosine
C< >C Cytosine - cytosine dimer
C o T Cytosine - thymine dimer
CPD Cyclobutane pyrimidine dimer
Da Daltons










Pyr < > Pyr Pyrimidine dimer
RBS Ribosome-binding site
RNA Ribonucleic acid
SDS Sodium dodecyl sulphate
str Streptomycin
T Thymine

















































NB: Not all these amino acids are referred to in this study. The full list is included for 
completion.
TABLE OF CONTENTS
ABSTRACT ( i )
ACKNOWLEDGMENTS ( i i i )
ABBREVIATIONS ( i v )
TABLE OF CONTENTS (vi i )
PTER1 INTRODUCTION (1)
1.1 BACKGROUND (1)
1.2 UV DAMAGE TO CELLS ( 3 )
1.2.1 CYCLOBUTANE PYRIMIDINE DIMERS ( 3 )
1.2.2 PYRIMIDINE - PYRIMIDONE (6-4) PHOTOPRODUCTS ( 7 )
1.2.3 OTHER UV-INDUCED DNA PHOTOPRODUCTS ( 1 0 )
1.2.4 UV-INDUCED NON-DNA DAMAGE ( 1 0 )
1.3 PHOTOREACTIVATION (12)
1.3.1 ENZYMATIC PHOTOREACTIVATION ( 1 2 )
1.3.2 INDIRECT PHOTOREACTIVATION ( 1 8 )
1.3.3 SENSITISED PHOTOREVERSAL ( 1 9 )
1.3.4 DIRECT PHOTOREVERSAL ( 2 0 )
1.3.5 TYPE m  PHOTOREACTTVATION ( 2 0 )
1.4 OTHER DNA REPAIR PROCESSES (22)
1.4.1 EXCISION REPAIR ( 2 2 )
1.4.2 DNA DAMGE TOLERANCE AND POST-REPLICATION REPAIR ( 2 6 )
1.4.3 THE SOS REGULATORY SYSTEM OF Escherichia coli ( 2 9 )
vii
1.5 OCCURRENCE OF PHOTOREACTIVATION ( 3 1 )
ACTIVITY IN Escherichia coli
1.5.1 HISTORICAL BACKGROUND ( 31)
1.5.2 THE CONTROVERSY BETWEEN phrA AND phrB ( 33 )
1.5.3 THE EVIDENCE FOR phrA ( 35 )
1.5.4 THE PROSPECTIVE ROLE OF phrA ( 38 )
CHAPTER 2 MATERIALS AND METHODS (40 )
2.1 GENERAL METHODOLOGY ( 4 0 )
2.1.1 WATER ( 40 )
2.1.2 GLASSWARE ( 40 )
2.1.3 GROWTH OF ORGANISMS ( 40 )
2.1.4 STORAGE OF ORGANISMS ( 4 2 )
2.1.5 MATERIALS ( 4 3 )
2.2 MOLECULAR CLONING TECHNIQUES ( 4 6 )
2.2.1 SOLUTIONS, RESTRICTION AND MODIFYING ENZYMES ( 46)
AND OTHER REAGENTS
2.2.2 ISOLATION AND PURIFICATION OF PLASMID DNA (47 )
2.2.3 CALCULATION OF THE CONCENTRATION OF DNA ( 48 )
2.2.4 RESTRICTION ENZYME DIGESTION OF PLASMID DNA ( 48 )
2.2.5 ANALYSIS OF RESTRICTION FRAGMENTS BY AGAROSE GEL ( 4 9 )
ELECTROPHORESIS
2.2.6 ISOLATION AND PURIFICATION OF DNA FROM AGAROSE GELS ( 50 )
2.2.7 ALKALINE PHOSPHATASE TREATMENT OF RESTRICTED ( 52 )
PLASMID DNA
2.2.8 LIGATION OF LINEAR DNA MOLECULES ( 5 2 )
2.2.9 PREPARATION OF COMPETENT CELLS ( 5 3 )
2.2.10 TRANSFORMATION OF PLASMID DNA INTO COMPETENT CELLS (53 )
2.2.11 CONTROLS FOR LIGATION AND TRANSFORMATION ( 5 4 )
EXPERIMENTS
2.2.12 PREPARATION OF SYNTHETIC OLIGONUCLEOTIDES (55 )
viii
2.3 SEQUENCING TECHNIQUES ( 5 7 )
2.3.1 EQUIPMENT ( 5 7 )
2.3.2 PREPARATION BEFORE ASSEMBLY ( 5 8 )
2.3.3 ASSEMBLING THE GLASS PLATES ( 5 8 )
2.3.4 PREPARATION OF POLYACRYLAMIDE SOLUTIONS (59  )
2.3.5 CASTING THE GEL ( 6 0 )
2.3.6 SETTING UP FOR OPERATION ( 6 1 )
2.3.7 LOADING AND RUNNING THE GEL (61 )
2.3.8 DISASSEMBLY OF THE GEL ( 6 2 )
2.3.9 FIXING AND DYING THE GEL ( 6 2 )
2.3.10 AUTORADIOGRAPHY ( 6 3 )
2.3.11 PRODUCTION OF SYNTHETIC PRIMERS ( 6 3 )
2.4 EXPRESSION TECHNIQUES ( 6 4 )
2.4.1 GROWTH OF INDUCTION CULTURES ( 6 4 )
2.4.2 PREPARATION OF SAMPLES ( 6 4 )
2.4.3 SDS-POLYACRYLAMIDE GELS (65  )
2.4.4 PREPARATION OF POLYACRYLAMIDE SOLUTIONS ( 66)
2.4.5 CASTING THE GEL ( 6 7 )
2.4.6 SETTING UP FOR OPERATION ( 6 7 )
2.4.7 LOADING AND RUNNING THE GEL ( 6 8 )
2.4.8 DISASSEMBLY OF THE GEL ( 6 8 )
2.4.9 STAINING AND DESTAINING THE GEL ( 6 8 )
2.4.10 MOUNTING AND DRYING THE GEL ( 6 9 )
2.5 UV IRRADIATION AND PHOTOREACTIVATION ( 7 0 )
TECHNIQUES
2.5.1 GENERAL METHODOLOGY ( 7 0 )
2.5.2 IRRADIATION PROCEDURES ( 7 3 )
2.5.3 DETERMINATION OF THE FLUENCE RATE OF UV RADIATION ( 74 )
2.5.4 PHOTOREACTIVATION PROCEDURES ( 7 6 )
ix
CHAPTER 3 CLONING AND SEQUENCING
OF THE phrA GENE
( 8 1 )
3.1 INTRODUCTION ( 8 1 )
3.2 METHODS ( 8 1 )
3.3 RESULTS ( 8 2 )
3.3.1 SUBCLONING OF THE INSERT IN pASOl INTO PUC19 ( 8 2 )
3.3.2 ANALYSIS OF THE NEW PLASMIDS ( 8 5 )
3.3.3 SEQUENCING OF THE INSERT IN pNDOl ( 8 8 )
3.3.4 THE SEQUENCE OF THE INSERT IN pNDOl ( 9 2 )
3.3.5 ANALYSIS OF THE SEQUENCE ( 9 8 )
3.4 DISCUSSION ( 1 0 2 )
lPTER 4 EXPRESSION OF THE 
GENE PRODUCT
(108)
4.1 INTRODUCTION ( 1 0 8 )
4.2 METHODS ( 1 0 8 )
4.3 RESULTS ( 1 0 9 )
4.3.1 INDUCTION OF pNDOl AND pND02 (109)
4.3.2 SUB-CLONING OF THE PUTATIVE GENE INTO 
AN EXPRESSION VECTOR - PART I
(112)
4.3.3 ANALYSIS OF THE NEW PLASMIDS (116)
4.3.4 INDUCTION OF pND03 AND pND04 (119)
4.3.5 SUB-CLONING OF THE PUTATIVE GENE INTO 
AN EXPRESSION VECTOR - PART H
(121)
4.3.6 ANALYSIS OF THE NEW PLASMID (133)
4.3.7 INDUCTION OF pND05 (134)
4.3.8 INDUCTION OF pAH13 (136)
4.4 DISCUSSION ( 1 3 8 )
X
CHAPTER 5 UV .IRRADIATION AND (140)
PHOTOREACTIVATION STUDIES
5.1 INTRODUCTION ( 1 4 0 )
5.2 METHODS ( 1 4 0 )
5.3 RESULTS ( 1 4 1 )
5.3.1 TRANSFORMATION OF AS46 WITH THE PLASMIDS ( 141)
PRODUCED IN THIS STUDY
5.3.2 INITIAL PHOTOREAdTVATION STUDIES ( 142)
5.3.3 TEMPERATURE DEPENDENCE STUDIES (150)
5.3.4 DOSE-RATE DEPENDENCE STUDIES (154)
5.3.5 NEAR-UV SENSITIVITY STUDIES (161)
5.3.6 FURTHER PHOTOREACTIVATION STUDIES (164)
5.4 DISCUSSION ( 1 6 6 )
CHAPTER 6 DISCUSSION (170)
REFERENCES (181)
APPENDIX A BACTERIAL STRAINS AND PLASMIDS ( I )
APPENDIX B SOLUTIONS, MEDIA AND BUFFERS (n)
APPENDIX C SEQUENCE AUTORADIOGRAPHS (XI)
APPENDIX D U V-IRRADIATION AND ( XXH)
PHOTOREACTIVATION DATA
APPENDIX E MISCELLANEOUS DATA ( XL VII)
C H A P T E R  ON E
INTRODUCTION
1.1 BACKGROUND
In this study, the genetic control of one of the DNA repair processes, photoreactivation, in 
Escherichia coli K-12 is examined, looking at UV-induced DNA damage and its repair. 
The genetic material of a cell faces a continual challenge to its integrity from the 
environment One of the principal functions of any cell is the prevention of an 
unacceptably high mutation rate. DNA damage can conveniently be grouped into two 
major 'classes', referred to as Spontaneous and Environmental, and collectively provides 
the substrate for many DNA repair processes and other cellular responses evolved to 
combat this threat. Ultra-violet light is an environmental cause of DNA damage. 
Historically, the investigation of UV radiation damage to DNA marks the beginning of the 
study of the repair of DNA damage. It is relevant biologically as living organisms have had 
to contend with the genotoxic effects of solar UV radiation since the beginning of the 
evolution of life on this planet. The ultraviolet region of the electromagnetic spectrum can 
be divided into VACUUM- (< 190nm), Far- (190nm-290nm), MID- (290nm-320nm) and 
N e a r - (320nm-400nm), and this terminology is used throughout this study. The terms 
UVC (far-UV), UVB (mid-UV) and UVA (near-UV) are also encountered in the 
literature, being particularly popular with reference to sunlight
Photoreactivation is one of the three main types of DNA repair mechanisms. It is 
characterised by the requirement of light to initiate the repair of DNA damage. The most 
important type of repair in this group is termed Enzymatic Photoreactivation.
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Enzymatic photoreactivation is defined as a DNA repair process that requires the presence 
of a photoreactivating enzyme, DNA photolyase. DNA photolyase binds specifically to 
ultraviolet radiation-induced cyclobutane pyrimidine dimers in DNA, and upon exposure 
of the photolyase-dimer complex to wavelengths in the range of 300nm-500nm, results in 
the splitting of the dimerised pyrimidines back to their monomeric form.
In Escherichia coli, it was once proposed that their were two photolyase molecules 
produced from two separate genes, termed phrA  and phrB (Sutherland and Hausrath, 
1979). Since then, however, the role of the phrA gene has been questioned by the work of 
A. Sancar and co-workers in particular, and finally dismissed as a photolyase (Husain and 
Sancar, 1987a). However, work in our laboratory has shown a role for the phrA  gene in 
photorepair in Escherichia coli. The aim of this study was to try and confirm this role of 
the phrA  gene in light-repair in Escherichia coli K-12, and try and provide an explanation 
for the conflicting reports that exist in the literature.
2
1.2 UV DAMAGE TO CELLS
The work in this study is concerned with UV-induced DNA damage, however it is 
important to remember that DNA is not the only target for UV-induced damage. It was 
previously proposed that the cytotoxic effects of UV radiation increased with decreasing 
wavelength. However, Gates (1930) recognised that bacteria exhibited a maximum UV 
absorption at approximately 260nm which was associated with a concomitant increase in 
cell lethality. Thus interaction with a specific target molecule, later shown to be DNA, was 
suggested. Many of the biological effects of UV radiation have now been attributed to the 
formation of specific photoproducts in DNA.
Cyclobutane pyrimidine dimers and pyrimidine (6-4) pyrimidone photoproducts are the 
two main classes of cytotoxic, mutagenic and carcinogenic DNA photoproducts produced 
by ultraviolet light irradiation of cells (Friedberg, 1985; Brash, 1988; Mitchell and Naim, 
1989). These are reviewed in detail here, as well as, briefly, other DNA photoproducts and 
non-DNA damage produced by UV irradiation.
1.2.1 CYCLOBUTANE PYRIMIDINE DIMERS
When DNA is exposed to radiation at wavelengths approaching its absorption maximum 
(about 260nm), adjacent pyrimidines become covalently linked by formation of a four- 
membered ring structure resulting from the saturation of their respective 5,6 double bonds 
(Beukers and Berends, 1960). Theoretically, these dimers can exist in twelve isomeric 
forms; however, only four of them (cis-syn, cis-anti, trans-syn and trans-anti) are formed 











Figure 1.1. The four biological forms of thymine dimers formed in DNA.
In double-stranded DNA, the cis-syn isomer is the only dimer formed - see Figure 1.2. 
This preponderance of the cis-syn isomer is a consequence of steric factors, as the strain 
involved in the formation of this isomer within DNA is relatively small, in contrast to the 
other three forms (Heelis et al., 1993). Nonetheless, some distortion of the double helix is 
inevitable. A recent NMR study (Taylor et al., 1990) showed that the cis-syn T< >T dimer 
causes a minor perturbation in the helical axis of DNA, and weakens, but does not break, 







Figure 12. A  cis-syn cyclobutane pyrimidine dimer.
Dimers can form between any combination of thymine (or uracil) and cytosine. Setlow and 
Carrier (1966) found that in 265nm irradiated E. coli, which has an approximately equal 
G-C and A-T content, the percentage ratio of cytosine-cytosine (C< >C), cytosine- 
thymine (C< >T) and thymine-thymine (T< >T) dimers was 7, 34 and 59 respectively.
The formation of pyrimidine dimers during irradiation of DNA is a reversible process that 
can be represented as
uv
Py + Py Py <  >  Py
5
Since under normal conditions the equilibrium is shifted far to the right, dimer formation is 
favoured over dimer reversal (Setlow, 1968). However, if E. coli DNA radio-labelled in 
thymine is continuously irradiated with 254nm UV-light, the thymine-containing 
pyrimidine dimer content (thymine-thymine, plus thymine-cytosine dimers) of the DNA 
does not increase beyond 7% of the total thymine content (Radany et al., 1981). This 
steady state reflects a dynamic equilibrium in which the rates of dimer formation (which is 
pseudo zero order, to a good approximation) and reversal (which is first order in dimer 
content) are equal (Radany et al., 1981).
This observation was supported by Gordon and Haseltine (1982) who showed not only 
that at high doses of UV light, dimer formation reached a maximum which was unaffected 
by further irradiation; but also that the dose at which the maximum level of dimers was 
reached varied for different types of dimers. The steady-state level for C< >C dimers is 
reached at a 254nm fluence of = 500 Jnr2, while for T< >T dimers, fluences in excess of 
2000 Jm-2 are required. In addition, it was shown that the absolute level of dimerisation 
varied at individual dimer sites. The level varied ffom less than 1% at sites of potential 
C< >C dimers to as high as 10% for some T< >T sites. Flanking nucleotides in double- 
stranded DNA also influence the steady-state level of dimer formation. In general, the 
equilibrium level of dimers is greater for TT sites flanked on both sides by A, than for TT 
sites flanked on the 5' side by an A and on the 3' side by G. However, this immediate 
nucleotide flanking effect was not sufficient to account for all the variations observed.
Thus the formation of cyclobutane pyrimidine dimers in DNA is not a random 
phenomenon as was first believed. Also, pyrimidine dimer contents in a particular 
sequence of UV-irradiated DNA cannot necessarily be extrapolated to other sequences of 
DNA or other irradiation conditions. Despite this, the cyclobutane pyrimidine dimer has 
served well as the classic 'test lesion' for analysis of DNA repair.
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1.2.2 PYRIMIDINE - PYRIMIDONE (6-4) PHOTOPRODUCTS
The pyrimidine - pyrimidone (6-4) photoproduct (referred to throughout this study as the 
(6-4) photoproduct), which is observed in UV-irradiated DNA at TC, CC and TT 
sequences, is formed when the 5-6 bond of the 5' base initially forms bonds across the 
exocyclic group at the 4 position of the 3' base. The bond holding the exocyclic group to 
the 4 carbon then spontaneously breaks, transferring this group to the 5' base and leaving a 
6-4 bond (Wang, 1976) - see Figure 1.3.
Lippke et al. (1981) found that the TC (6-4) photoproduct was formed preferentially, 
followed by formation at the CC and occasionally the TT sites. In double-stranded DNA, 
(6-4) photoproduct formation was not evident at CT sequences (Franklin et al., 1982). 
Although the cyclobutane pyrimidine dimer is formed in approximately 10-fold greater 
abundance than the (6-4) photoproduct upon exposure of DNA to low fluences of 254nm 
radiation (Lippke et al., 1981), the frequency distribution of dimers did not correlate with 
the frequency of mutations observed in E. coli by Brash and Haseltine (1982). At certain 
sequences, the rate of formation of the (6-4) photoproduct exceeded that of cyclobutane 
pyrimidine dimers, even at very low fluences in the range 10 - 50 Jm2.
Chan et al. (1986) measured the action spectrum for the formation of (6-4) photoproducts 
and found it to be indistinguishable from the pyrimidine dimer-formation action spectrum. 
Below 300nm, both action spectra closely paralleled the DNA absorption spectrum. More 
cyclobutane pyrimidine dimers were formed by far-UV than (6-4) photoproducts, but the 
ratio varied according to site. Yamada and Hieda (1992) showed a similarity in 
wavelength dependence of the formation of the cyclobutane pyrimidine dimers and the (6- 









Figure 13. A  thymine-cytosine (6-4) photoproduct.
It has been proposed (Brash, 1988) that the (6-4) photoproduct is the major UV- 
mutagenic photoproduct in E. coli. The cytotoxic, mutagenic and carcinogenic properties 
of cyclobutane pyrimidine dimers and (6-4) photoproducts have been extensively reviewed 
elsewhere (Brash, 1988; Mitchell and Naim, 1989).
Johns et al. (1964) reported that the (6-4) photoproduct, known to them only as TpT4, 
could be converted quantitatively at 313nm to a new photoproduct, TpT3, and back again 
at 240nm. Such photochemical behaviour is quite similar to that observed for simpler 
pyrimidinones which have been shown to be photoisomerised to their Dewar isomers at 
wavelengths greater than 300nm.
8
Taylor and Cohrs (1987) showed that the (6-4) photoproduct is photoisomerised to its 
Dewar isomer with irradiation at X > 300nm and discovered the structure of TpT3, the 
Dewar isomer of the (6-4) photoproduct - see Figure 1.4. They showed that the Dewar 
isomer was produced by direct photolysis with biologically relevant wavelengths of light 
(k > 280nm), suggesting that (6-4) photoproducts produced during exposure of DNA to 
sunlight might be converted primarily to their Dewar isomers.
HO
Figure 1.4. Structure of the Dewar isomer of the (6-4) photoproduct.
9
1.2.3 OTHER UV-INDUCED DNA PHOTOPRODUCTS
A variety of other DNA photoproducts are formed by irradiation with ultraviolet light. 
These include noncyclobutane-type pyrimidine adducts, thymine glycols, pyrimidine 
hydrates, DNA-protein cross links (all reviewed in Friedberg, 1985), 8,8-adenine 
dehydrodimers (Gasparro and Fresco, 1986), a purine photoproduct produced at 265nm 
(Gallagher and Duker, 1986), and a photoproduct at TA sequences (Bose and Davies, 
1984). All the above mentioned UV radiation-induced damage results principally from the 
direct absorption of photons by bases in DNA. Sensitised photoreactions of DNA also 
occur (Friedberg, 1985).
1.2.4 UV-INDUCED NON-DNA DAMAGE
Whilst the action spectra for lethality in many species has been shown to closely follow the 
absorbance of DNA up to 313nm, beyond this point many of the lethal responses are 
probably due to photon absorption by other chromophores causing either DNA molecular 
alterations or other effects lethal to the cell. The targets for near-UV killing have been 
reviewed by Jagger (1985) and include DNA itself, DNA repair systems and membranes. 
Tyrrell et al. (1973) have demonstrated destruction of the E. coli photoreactivating 
enzyme by 365nm radiation. The observation that near-UV radiation survival curves 
exhibit large shoulders before dropping off steeply at higher fluences, suggests that 
damage to DNA repair systems may be an important factor in determining ultraviolet 
radiation lethality.
Kelland et al. (1983) have shown that at wavelengths above 310nm, cell membrane 
damage was induced in Escherichia coli K-12, reaching a peak at 334nm, then gradually 
decreasing. Thus, cell membrane damage may be a significant contributor to near-UV 
radiation-induced cell lethality.
10
This is supported by work by Keyse et al. (1983), who showed a marked decrease in the 
sensitivity of an excision repair deficient xeroderma pigmentosum strain compared to a 
normal human skin fibroblast strain at wavelengths longer than 313nm. This suggested 
that the importance of pyrimidine dimers as the lethal lesion decreases with increasing 
wavelength, showing that different mechanisms of inactivation operate at wavelengths 
longer than 313nm, other than damage to DNA itself.
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1.3 PHOTOREACTIVATION
In this section the basic mechanisms of photoreactivation are discussed. A more specific 
review of enzymatic photoreactivation in E. coli with relation to this study is included in 
Section 1.5. Enzymatic photoreactivation is not the only type of photorecovery reported in 
the literature.
1.3.1 ENZYMATIC PHOTOREACTIVATION
Enzymatic photoreactivation is a light-dependent process involving the enzyme catalysed 
monomerisation of cis-syn cyclobutane pyrimidine dimers - see Figure 1.5.
The enzyme, DNA photolyase, binds to the pyrimidine dimers in DNA in a light- 
independent step, forming a stable enzyme-substrate complex, which absorbs a photon, 
leading to the splitting of the cyclobutane ring and hence formation of the original 
monomers - see Figure 1.6.
The action of DNA photolyase is well described by the classic Michaelis-Menten scheme 
for enzyme catalysis with the important exception that catalysis is light-initiated.
hv
PRE + Pyr < > Pyr PRE - Pyr < > Pyr —> PRE + 2Pyr
This light dependence of the catalysis step has made it possible to study the two steps of 
DNA repair processes, Binding and Catalysis, individually both in vivo and in vitro. 
However, early studies on mechanistic aspects of DNA repair by photolyase were 
hindered for the lack of sufficient quantities of pure enzymes because the enzyme is 
present in low concentrations in all organisms possessing it
12
(1) NATIVE DNA
(2) PYRIMIDINE DIMER IN UV DNA
(3) COMPLEX OF DNA
WITH PHOTO REACTIVATING ENZYME
(4) ABSORPTION OF LIGHT ( > 300 nm)
LIGHT
(5) RELEASE OF ENZYME TO RESTORE NATIVE DNA
Figure 1.5. Schematic illustration of the photoreactivation of ultraviolet-induced 
cyclobutane pyrimidine dimers in DNA.
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In the last decade, the gene encoding photolyase has been cloned from several organisms 
and sequenced, and the enzyme overproduced permitting purification of several hundred 
milligrams of pure photolyase. This was followed by the structural identification of co­
factors involved in photoreactivation. Furthermore, recent studies using a combination of 
site-specific mutagenesis, flash photolysis, and other spectroscopic methods have 




NHO Light ( X=300 to 450nm )
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Figure 1.6. Splitting of a cis-syn thymine dimer by DNA photolyase.
So far, only a few photolyases have been characterised (Sancar, 1990). All contain two 
chromophore/co-factors. One is always flavin adenine dinucleotide (FAD) or its radical 
(FADH*) (Sancar and Sancar, 1984), the other, commonly known as the 'second
chromophore', can be either 5,10-methenyltetrahydrofolate (MTHF) (Johnson et al., 
1988) or 7,8-didemethyl-8-hydroxy-5-deazariboflavin (8-HDF) (Eker et al., 1990) - see 
Figure 1.7.
The shape and maximum wavelength of absorption or action spectrum of photolyases in 
the wavelength region 300nm - 500nm are dominated by the second chromophore (Kim 
and Sancar, 1993). Accordingly, the enzymes have been classified into two groups : the 
folate class, which has its action spectrum maximum at 360nm to 390nm, in which the 
photolyase from E. coli falls; and the deazaflavin class, which has its action spectrum 
maximum at 430nm to 460nm.
14
Comparison of the amino acid sequences (Sancar, 1990) reveals 30-40% homology in the 
photolyases of widely divergent species. In particular, the carboxy-terminal 140 amino 
acids are 50-60% identical among all photolyases, suggesting that this region might be 
involved in DNA and/or FAD binding, because enzymes from all species contain FAD and 
appear to bind DNA by the same mechanism (Kim and Sancar, 1993). In contrast, the 
amino-terminal halves of the enzymes display a much lower level of homology and appear 
to be conserved within each class of photolyases, suggesting that the amino-terminal 









Figure 1.7. The chromophores of DNA photolyases.
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In E. coli, the flavin chromophore/co-factor was identified by Joms et al. (1984) and the 
folate chromophore/co-factor by Johnson et al. (1988). The mechanism for the splitting of 
the cyclobutane ring in vitro proceeds via the photoreduction of the flavin radical 
(FADH*) to give the fully reduced form (FADH"), followed by dimer repair by the
photoexcited reduced form (Payne et al., 1987). The folate acts in a secondary capacity as 
an antenna molecule, absorbing a photon of light and transferring energy to the FADH* at 
the catalytic centre. FADH" in turn transfers an electron to the pyrimidine dimer to 
generate a radical ion pair, resulting in dimer splitting. The enzyme-bound folate in E. coli 
photolyase does not decompose or dissociate during multiple turnovers of the reaction, 
and thus the catalytic folate in photolyase provides the only known example of a catalytic 
folate among the many known enzymatic reactions that use folate co-factors (Hamm- 
Alvarez et al., 1990). The roles of the co-factors in photolyases are extensively reviewed 
by Kim and Sancar (1993).
Photolyases are extremely efficient in recognising pyrimidine dimers over nondimerised 
pyrimidines (Husain and Sancar, 1987b). In E. coli, this high level of discrimination could 
be very important because of the low number of photolyases per cell, and these should be 
able to selectively bind to a single pyrimidine dimer in 107 nucleotides and repair it 
immediately, as one dimer left unrepaired could be lethal to the cell. Photolyases are 
thought to achieve this high level of discrimination by recognising the pyrimidine dimer 
itself through random diffusion rather than through facilitated binding via unidimensional 
diffusion along the phosphodiester backbone, originally proposed as a sequential repair 
model by Davies et al. (1970).
The mode of interaction of photolyases with pyrimidine dimers is relatively well defined by 
chemical and enzymatic footprint experiments using enzymes from Escherichia coli 
(e u b a c ie r ia ) , Methanbacterium thermoautotrophicum (a r c h a e b a c ie r ia ) , and 
Saccharomyces cerevisiae (eu k a r y o ta ), and a unique 43bp double-stranded substrate 
containing a single pyrimidine dimer at the centre (Husain et al., 1987; Kiener et al., 1989;
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Baer and Sancar, 1989). These studies revealed that photolyases from the three different 
kingdoms make essentially the same contacts immediately around the pyrimidine dimer, 
and that the most important contacts on DNA were the phosphodiester bond immediately 
5' and the three phosphodiester bonds immediately 3' to the dimer on the damaged strand, 
and to a lesser extent, the phosphate opposite the dimer on the complementary strand. 
This suggested that a substrate of the structure pT< >TpNpNp would be required and 
sufficient for high affinity binding by photolyase. Of the four phosphates that appeared to 
be contacted by the chemical footprinting, only one or two are thought to be bound 
through salt bridges, consistent with the findings that the enzyme-DNA complex formation 
is relatively insensitive to the ionic strength of the reaction (Sancar et al., 1987). The other 
phosphates are presumed to make hydrogen bonds. As mentioned in Section 1.2.1, 
pyrimidine dimers are known to induce a kink or bending in DNA and local disruption of 
hydrogen bonds in the vicinity of the dimer. The fact that this localised region in DNA 
corresponds to the common contacts, pT< >TpNpNp, made by photolyases from three 
different kingdoms, suggests that the configuration of the phosphodiester backbone, as 
well as the cyclobutane ring of the dimer, are the important structural features in damaged 
DNA for rapid recognition and tight binding by photolyase. A study investigating the 
effect of sequence on the binding and repair of pyrimidine dimers by photolyase has shown 
that changes in the sequence surrounding a pyrimidine dimer has very little effect on 
binding by E. coli DNA photolyase (Svoboda et al., 1993).
The thermodynamic and kinetic properties of photolyase-DNA interactions are well 
understood. Similarly, the structures of the chromophores, their roles in photoreactivation, 
and the photochemical and the photophysical processes involving, and electron transfer to 
effect, photosplitting of the cyclobutane ring of pyrimidine dimers, have been elucidated. 
The remaining significant task, until recently, was the elucidation of the three-dimensional 
structure of the enzyme and enzyme-substrate complex. Park et al. (1993) have recendy
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reported the crystallisation and the preliminary crystallographic analysis of Escherichia 
coli DNA photolyase. Rapid developments in this area are now to be expected.
(6-4) photoproducts are not restored to normal by the E. coli photoreactivating enzyme in 
vivo and in vitro (Brash et al., 1985; Brash and Haseltine, 1985). Thus cyclobutane 
pyrimidine dimers and (6-4) photoproducts can be distinguished biologically, which is a 
useful experimental technique.
1.3.2 INDIRECT PHOTOREACTIVATION
This phenomenon became apparent when photoreactivation using near-UV light was 
observed with 254nm UV-irradiated E. coli B phr, a strain lacking photoreactivating 
enzyme. The effect did not occur with 405nm photoreactivating light and was not due to 
the splitting of the thymine dimers (Jagger et al., 1969). In contrast to enzymatic 
photoreactivation, these workers suggested that this 'indirect' photoreactivation resulted 
from enhancement o f dark repair processes. This was subsequendy proved by 
Ramabhadran and Jagger (1976) who demonstrated that near-UV irradiation induced a 
growth delay which facilitated the excision repair process. The mechanism of near-UV 
radiation-induced growth delay has been reviewed by Jagger (1985). Briefly, near-UV 
radiation induces a photoadduct between 4-thiouridine in the 8-position and a cytidine in 
the 13-position of certain rare forms of tRNA. This lowers the rate at which the tRNA 
accepts amino acids, which in turn decreases the rate of protein synthesis. This presence of 
uncharged tRNAs in the cell leads to an increase in the levels of guanosine tetraphosphate 
and guanosine pentaphosphate and a decrease in the rate of stable RNA accumulation with 
consequent growth delay.
This phenomenon also occurs if the cells are exposed to the near-UV photoreactivating 
light before far-UV irradiation, and in this case is termed Photoprotection.
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1.3.3 SENSITISED PHOTOREVERSAL
Sensitised photoreversal is a non-enzyme-dependent reaction that splits pyrimidine dimers 
in DNA. This process has been observed with tryptophan and tryptophan-containing 
oligopeptides, such as lys-trp-lys, as well as with a protein coded by gene 32 of phage T4, 
which is particularly rich in tryptophan (Helene and Charlier, 1977).
The mechanism is thought to involve an electron transfer from the excited indole ring of 
tryptophan to the dimer, possibly mediated by base-stacking interactions of the 
tryptophanyl residue with the pyrimidine dimer in DNA. This type of photoreactivation is 
not observed with wavelengths of photoreactivating light greater than 300nm (Sutherland 
and Griffin, 1980).
Tryptophan also plays a role in the photoreduction of FADH* at the active site of E. coli 
DNA photolyase (Li et al.t 1991). All 15 tryptophan residues in E. coli DNA photolyase 
were replaced with phenylalanine, individually, by site-directed mutagenesis. It was found 
that the W306F mutation abolished photoreduction of FADH* without affecting the
substrate binding of the enzyme. Unpublished work referred to by Kim and Sancar (1993) 
claims unambiguous evidence that W306 is indeed involved in the reduction of the flavin 
radical.
It has been shown that the wavelengths effective in photoreactivation extend into the far- 
UV range where, in addition to the two co-factors, the aromatic residues of the enzyme 
absorb significantly (Payne and Sancar, 1990; Kim et al., 1992). Photolyase is active only 
when the flavin is in the fully reduced form (Enz - FADH'). Using the W306F mutant 
enzyme to evaluate the catalytic role of tryptophan(s) in E. coli DNA photolyase, Kim et 
al. (1992) showed that photolysis of T< >T with the mutant enzyme occurred at 280nm, 
but not at 366nm. It was shown that the repair was caused by a single tryptophan residue, 
identified as W277 in E. coli DNA photolyase.
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As well as direct repair of pyrimidine dimers, W277 in E. coli DNA photolyase is also 
involved in specific binding to the dimers (Li and Sancar, 1990), suggesting that W277 is 
in the DNA binding site of the photolyase.
1.3.4 DIRECT PHOTOREVERSAL
As has been discussed already in Section 1.2.1, irradiation of DNA containing pyrimidine 
dimers at wavelengths between 200nm and 300nm results in the direct reversal of some 
fraction of the dimers until a new equilibrium between monomerisation and dimerisation is 
attained (Setlow, 1968). This phenomenon is referred to as Direct Photoreversal, but is 
not believed to be a biologically important process.
1.3.5 TYPE m  PHOTOREACTIVATION
Jagger et al. (1970) defined three distinct molecular phenomena that result in 
photoreactivation. One is enzymatic photoreactivation, which was termed Type I 
Photoreactivation. The second phenomenon is indirect photoreactivation, termed Type II 
Photoreactivation, while the third phenomenon, termed Type III Photoreactivation, was 
first described in Streptomyces griseus and is characterised by a X max of 313nm with a 
narrow wavelength range (300nm to 360nm) and the absence of dose-rate and 
temperature effects. This suggested a direct photochemical reaction without the mediation 
of an enzyme. It has since been shown that 313nm light photoreverses (not to the original 
bases) mostly (6-4) photoproducts and, to a much lesser extent, pyrimidine dimers 
(Ikenaga et a l., 1971). Taylor and Cohrs (1987) demonstrated that the (6-4) photoproduct 
is photoisomerised to its Dewar isomer with irradiation at X > 300nm.
The terminology of Type I, Type II and Type III Photoreactivation is used widely in the 
literature.
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The statement that Type III Photoreactivation is characterised by an absence of dose-rate 
and temperature effects is quoted regularly in the literature (e.g. Husain et a l 1988). 
Reference to the original work by Jagger et al. (1970) shows that they found the dose-rate 
dependence of photoreactivation in Streptomyces griseus was strong at 436nm, moderate 
at 366nm and only slight at 313nm over a range of fluence-rates of 10-1000 erg mnr2sec_1 
(1-100 Wm~2); and that temperature dependence was considerable at 436nm and only 
slight at 313nm over a range of temperatures between 2°C and 37 °C. Therefore, the 
statement that Type III Photoreactivation is characterised by an absence of dose-rate and 
temperature effects is not literally true, but a good approximation.
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1.4 OTHER DNA REPAIR PROCESSES
The cellular responses to DNA damage can be divided into three categories
1) Reversal of the damage.
2) Excision of the damage.
3) Tolerance of the damage.
The first two responses involve recognition and repair o f the damage prior to replication, 
while the third response facilitates tolerance of persisting damage during and after 
replication.
The nature of this study concentrates solely on the reversal of UV-induced damage by 
photoreactivation repair processes. A summary of the other two responses is included for 
completeness, as it is important to remember that in wild-type strains, these responses 
work side-by-side.
1.4.1 EXCISION REPAIR
The forms of DNA damage that can be repaired by direct reversal are apparently limited in 
number. An important DNA repair mechanism observed in nature is one in which damaged 
or inappropriate bases are excised from the genome and replaced by the normal nucleotide 
sequence and chemistry. This cellular response to DNA damage is appropriately referred 
to as Excision Repair. For a comprehensive review on excision repair in general, see 
Friedberg (1985).
One of these repair processes is the nucleotide excision repair pathway. This system deals 
with a strikingly diverse array of structurally unrelated lesions, including various UV- 
induced photoproducts, such as cyclobutane pyrimidine dimers and (6-4) photoproducts.
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The nucleotide excision repair pathway consists of five steps : damage recognition, 
incision of the damaged strand on both sides of the lesion and at some distance from it, 
excision of the lesion-containing oligonucleotide, synthesis of new DNA using the 
undamaged strand as a template, and ligation. The reaction is, in principle, error-free.
The key proteins involved in the nucleotide excision repair pathway are Uvr A-D (for a 
review, see Hoeijmakers, 1993; Sancar and Tang, 1993). The nucleotide excision repair 
process is thought to start when two molecules of Uvr A dimerise in the presence of ATP 
and complex with one molecule of Uvr B (Lin and Sancar, 1992). The heterotrimer binds 
to DNA; its weak 5'-3' DNA helicase activity may then allow it to translocate along one of 
the strands of the helix, scanning it for distorting lesions (Grossman and Yeung, 1990). If 
such a lesion is encountered, translocation stops and Uvr B is hooked onto the DNA, 
inducing a specific DNA conformation that includes a kink and a locally denatured region. 
The Uvr A molecules dissociate, allowing Uvr C to bind (Lin and Sancar, 1992). The Uvr 
BC complex then makes two incisions in the damaged strand. One, located eight 
phosphodiester bonds 5' of the lesion, is probably catalysed by Uvr C. The other incision, 
five or four bonds 3' of the lesion, is presumably made by Uvr B (Sancar and Rupp, 1983). 
The concerted action of Uvr D (which is also a helicase) and DNA polymerase I 
accomplishes the release of the 12-13-mer containing the damaged site, turnover of the 
bound Uvr B and Uvr C, and synthesis of an undamaged copy of the sequence that has 
been removed (Lin and Sancar, 1992). Finally, DNA ligase seals the nicks in the repaired 
strand. See Figure 1.8 for a diagrammatic representation of this repair process.
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Figure 1.8. Diagrammatic representation of the nucleotide excision repair pathway
in Escherichia coli.
A, B, C, and D, molecules of Uvr A, B, C, and D respectively.
Pol I, DNA polymerase I; ligase, DNA ligase;
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This system can not only detect an impressive spectrum of damaged structures, ranging 
from thymine glycols to bulky chemical adducts and inter- and intra-strand crosslinks; it 
can also differentiate between two strands of a gene and assign a higher priority to 
eliminating DNA damage in the transcribed strand than in the non-transcribed (coding) 
strand. In E. coli it has been shown that the mfd (mutation frequency decline) gene is 
necessary for strand-specific repair (Selby et al., 1991). The Mfd protein appears to target 
the transcribed strand for repair by recognising a stalled RNA polymerase molecule, 
blocked by a lesion in the transcribed strand, and actively recruiting the repair enzyme to 
the transcription blocking lesion as it dissociates the stalled RNA polymerase (Selby and 
Sancar, 1993). The Mfd protein has previously been termed a transcription-repair coupling 
factor (TRCF).
The E. coli photoreactivating enzyme also interacts with the nucleotide excision repair 
pathway. As well as monomerising cyclobutane pyrimidine dimers in its own right, during 
light-repair, in addition it facilitates the repair of these lesions by the nucleotide excision 
repair pathway during dark-repair (Yamamoto et al., 1983a; Yamamoto et al., 1983b; 
Hays et al., 1985; Sancar and Smith, 1989). Therefore, DNA photolyase is not only a 
DNA repair enzyme in its own right but also an auxiliary protein in the nucleotide excision 
repair pathway.
Another excision repair enzyme of interest regarding this study, is the T4 endonuclease V, 
which is involved in the direct excision repair of cyclobutane pyrimidine dimers. In E. coli 
cells infected with bacteriophage T4, T4 endonuclease V, encoded by the deriV gene of 
the bacteriophage, is responsible for the first step in the excision repair pathway of UV- 
damaged DNA. The T4 endonuclease V catalyses two distinct reaction steps (Macmillan 
et al., 1981; Dodson and Lloyd, 1989); the incision of the N-glycosyl bond at the 5-side 
of the pyrimidine dimer and the cleavage of the apyrimidinic phosphodiester bond. It has 
been suggested that T4 endonuclease V can bind non-specifically to DNA via electrostatic
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interactions and can thus scan along the DNA duplex before binding to a pyrimidine 
dimer.
Interestingly, this enzymatic activity had never been found in any other organisms, either 
prokaryotes or eukaryotes, with the exception of Micrococcus luteus (Friedberg, 1985; 
Sancar and Sancar, 1988). However, Hamiliton et al. (1992) have reported that an enzyme 
functionally similar to the above activity exists in Saccharomyces cerevisiae. Whether 
there is T4 endonuclease V-like activity in E. coli has yet to be shown.
Both cyclobutane pyrimidine dimers and (6-4) photoproducts are excised from UV- 
induced damaged DNA by the E. coli uvr ABC repair system (Franklin and Haseltine, 
1984).
1.4.2 DNA DAMAGE TOLERANCE AND POST-REPLICATION 
REPAIR
The cellular responses involved in DNA damage tolerance have important biological 
consequences. With respect to individual dividing cells, these responses provide potential 
mechanisms for survival in the face of replicative arrest, possibly allowing for DNA repair 
to occur once template DNA containing base damage has been replicated. Also some 
damage tolerance mechanisms are associated with a significant increase in mutation 
frequency, thus providing the potential for genetic diversification within a population. For 
a comprehensive review on DNA damage tolerance in general, see Friedberg (1985).
There are at least two mechanisms whereby cells can resume DNA synthesis on templates 
containing replicative blocks and in so doing, enhance their potential for survival. One is 
by reinitiating DNA synthesis some distance downstream from the blocks (essentially 
circumnavigating them), thereby creating gaps of discontinuities in the daughter DNA 
strands, which subsequently become filled in by some mechanism. The second is by
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continuing DNA synthesis past the template lesion in a continuous mode after an initial 
arrest.
One of the best understood processes is termed Post-Replication Repair. Post-replication 
repair is best explained with the aid of a diagram - see Figure 1.9. Briefly, post-replication 
repair deals with, for example, a pyrimidine dimer that interferes with replication, during 
which the parental DNA strands unwind at the replication fork and two daughter strands 
are synthesised (1). The pyrimidine dimer prevents base pairing along a stretch of one 
parental strand, producing a post-replication gap opposite a stretch of single-strand DNA 
(2). RecA protein, the product of the reck  gene, binds to the single-strand region (3) and 
aligns it with a homologous region of the sister duplex. The interaction of RecA with 
single-stranded DNA is stabilised by the ssb gene product, DNA single-stranded binding 
protein. When homologous pairing is achieved, an enzyme nicks the duplex (4). RecA 
switches the free-end of the duplexes parental strand into the gap, producing a crossed- 
strand exchange (5). The upper heteroduplex can now be repaired by DNA polymerase. 
With the correct sequence in place opposite the pyrimidine dimer, RecA is released (6). 
Finally, two cuts are made by an enzyme at the site of the crossed-strand exchange (7). 
The pyrimidine dimer is still present in one of the daughter strands (8). For a review, see 
Howard-Flanders (1981).
Based on cell survival studies, two independent pathways for post-replication repair in E. 
coli have been proposed. One is dependent on the recF gene (Rothman et al., 1975) and 
the other is dependent on the recB, uvrD and lexA genes (Wang and Smith, 1981). The 
recF-dependent pathway promotes the repair of daughter-strand gaps, whereas the recB- 
dependent pathway repairs DNA double-strand breaks arising from unrepaired daughter- 
strand gaps (Wang and Smith, 1983; Wang and Smith, 1986).
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Figure 1.9. Diagrammatic representation of the post-replication repair pathway
in Escherichia coli.
28
1.4.3 THE SOS REGULATORY SYSTEM OF Escherichia coli.
E. coli exhibits a complex and diverse response to many conditions which damage DNA 
or inhibit DNA replication. The SOS regulatory network of E. coli is triggered by 
treatments that damage DNA or block the normal replication of the chromosome. The 
origin of the term 'SOS' to describe this phenomenon was a conference on mutagenesis 
held in Rochester, New York, in 1973. Miroslav Radman coined the phrase SOS primarily 
to emphasise the dramatic nature of this cellular response to a distress signal, i.e., DNA 
damage (Friedberg, 1985). It is often misinterpreted to imply a last-ditch attempt by the 
cell to survive the lethal effects of DNA damage after other cellular responses have failed. 
Biochemical and genetic data have demonstrated that the SOS response is under the 
control of the reck  and lex A genes (Little and Mount, 1982; Walker, 1984). The RecA 
protein is required for the induction of the SOS genes, and also for the process of 
homologus recombination (Witkin, 1976). The LexA protein is the common repressor of 
at least 18 genes, including reck  and lexk. The RecA protein is reversibly converted to a 
protease by an inducing signal after DNA damage. It is thought that at least part of this 
activating signal in vivo is the single-stranded DNA that is generated after inhibition of 
DNA replication (Walker, 1984), although the exact nature of the signal is not yet known. 
Once activated, the RecA protease can cleave or promote the self-cleavage of the LexA 
repressor, resulting in the expression of the SOS genes (Little et al., 1980; Little, 1984). 
Under these conditions, several cellular activities such as enhanced DNA repair ability, 
enhanced mutagenesis, and inhibition of cell division (filamentation) among others are 
displayed. SOS induction also leads to increases in both RecA and LexA protein synthesis. 
When DNA lesions are repaired, the inducing signal is no longer produced, and RecA 
protein becomes inactive. Thus, balance between LexA and the activated form of RecA 
protein is destroyed, LexA repressor accumulates, and the SOS genes are newly
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repressed. In cells containing temperate phages such as X and <J>80, activated RecA protein 
also promotes the cleavage of the phage repressors leading to prophage induction. 
Fernandez de Henestra et al. (1991) introduced a broad host range plasmid containing an 
operon fusion between the reck  and lacZ genes of E. coli into various aerobic and 
facultative gram-negative bacteria to study the expression of the reck  gene after DNA 
damage. Ail the bacteria tested, except Xanthomonas campestris and those of the genus 
Rhodobacter, were able to repress and induce the reck  gene of E. coli in the absence and 
in the presence of DNA damage respectively. This indicates that the SOS system is present 
in bacterial species of several families and that the LexA-binding site must be highly 
conserved in them. This supported work by Sedgwick and Goodwin (1985) who 
introduced a plasmid carrying the E. coli lexk gene into six Enterobacteria species. The 
results suggested that the SOS regulatory mechanism is widespread in Enterobacteria and 
functionally conserved.
There is evidence to suggest that the cis-syn cyclobutane pyrimidine dimer is the 
significant SOS-inducing lesion in UV-induced DNA damage in E. coli. Removal of the 
pyrimidine dimers by photoreactivation blocks induction of the SOS response (Brash and 
Haseltine, 1985).
30
1.5 OCCURRENCE OF PHOTOREACTIVATION 
ACTIVITY IN Escherichia coli
The subject of this study centres on the genetic control of photoreactivation in 
Escherichia coli. Therefore this section concentrates on the occurrence of 
photoreactivation and the photoreactivating enzymes in Escherichia coli.
1.5.1 HISTORICAL BACKGROUND
Although Albert Kelner is generally credited with the discovery of photoreactivation in 
1949, a photoreactivation type of process was reported in 1933 by Hausser and von 
Oehmcke (see Jagger, 1960). These workers observed that UV radiation-induced 
darkening of banana skin could be prevented by post-UV irradiation exposure to near UV 
light (366nm) and visible light.
The systematic study of enzymatic photoreactivation did not begin until the late 1940's 
with the nearly simultaneous publications by Kelner and Renato Dulbecco. Whilst 
investigating the effect of post-irradiation temperature on the UV-survival of certain 
strains of Streptomyces griseus, Kelner (1949) reported that exposure of UV-irradiated 
suspensions to visible light resulted in an increase in survival rate of 100,000 to 400,000- 
fold, whereas controls kept in the dark did not. Dulbecco (1949) reported a similar 
observation with T-bacteriophages in E. coli and coined the term Photoreactivation.
It was not until the late 1950's, however, that studies with extracts of E. coli and baker's 
yeast demonstrated that photoreactivation is an enzyme-mediated phenomenon. Rupert et 
al. (1958) used crude cell extracts and the Haemophilus influenzae transformation assay 
to measure photoreactivating enzyme activity in vitro. This suggested that the 
photorepairable lesion was situated in the DNA and that the agent was enzymatic in 
nature.
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At this point, the nature of the substrate was not known. Beukers and Berends (1960) and 
Wang (1960) found that UV-irradiation of a frozen thymine solution yielded a dimeric 
thymine photoproduct which was identical to the main photoproduct in UV-irradiated 
DNA. Subsequent irradiation of the thawed solution led to the reappearance of the 
characteristic thymine absorption spectrum. Beukers and Berends (1960) suggested that 
this reversible alteration of DNA by UV-irradiation might be related to biological 
photoreactivation. However, Wang (1960) showed that irradiation of thymine dimers in 
solution with 370nm photoreactivating light did not lead to the reappearance of thymine 
monomers. Wulff and Rupert (1962) were able to show loss of thymine dimers from 3H- 
thymine labelled DNA by the combined action of the cell-free extract of baker's yeast and 
photoreactivating light This suggested that enzymatic photoreactivation involved the 
splitting of pyrimidine dimers into their constituent monomers, and was proven by the 
work of Setlow and Setlow (1962).
Photoreactivating enzyme, or DNA photolyase, has been detected in many organisms. 
Considering the role of UV irradiation as a source of genetic damage in biological 
evolution, it is not surprising that organisms have developed specific methods for the 
repair of pyrimidine dimers. Studies on the enzymes found in different organisms have 
revealed a remarkable functional and structural conservation (reviewed by Sancar, 1990).
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1.5.2 THE CONTROVERSY BETWEEN phr A  AND phrB
Although E. coli was the first organism in which DNA photolyase activity was 
demonstrated in vitro (Rupert et al., 1958), the combination of high cellular nuclease 
activities and the low copy number of the enzyme per cell made purification of the enzyme 
difficult. Thus much of the early characterisation was of the in vivo process using the flash 
photolysis method (reviewed by Harm et al., 1971).
Sutherland et al. (1972) studied photoenzymatic repair in mutants with deletions 
extending from chlA to either attX or through to gal, and concluded that the phr locus 
was between gal and attX - see Figure 1.10. An E. coli strain lysogenic for a X specialised 
transducing phage canying the gal-attX region was constructed, and a 2000-fold increase 
in photoreactivating enzyme activity was obtained upon induction. An enzyme with 
apparent photoreactivating enzyme activity was isolated and characterised (Sutherland et 
al., 1973).
However, Youngs and Smith (1978) and Sancar and Rupert (1978) presented data which 
conclusively placed the phr gene counter-clockwise of gal between kdp and git A, 
contradicting the findings of Sutherland et al. (1972).
hemF pgl attt.
kdp phrB gltA gal chi esp bio uvrB chlA
_i | i______ i_____________ | 1 i I i I i i i _
16min 17min 18min
Figure 1.10. The genetic map of the E. coli chromosome between 16 and 18 mins, 
showing the genes relevant to this section.
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Sutherland and Hausrath (1979) investigated photoreactivation in deletion mutants lacking 
the gal-attX region and found them to be photoreactivable, although at a reduced rate, in 
contrast to the findings of Sutherland et al. (1972). They proposed that the gene in the 
gal-attX region at 17min should be termed phr A, and the gene mapped by Youngs and 
Smith (1978) and Sancar and Rupert (1978) at 15.9min should be termed phrB. The 
recalibrated E. coli linkage map (Bachmann, 1983) placed phr A  at 17.3min and phrB at 
16.2min.
Sancar et al. (1983) have cloned and amplified the phrB gene product, and have isolated, 
purified and sequenced the photolyase gene and protein (Sancar et al., 1984a; Sancar et 
al., 1984b). Husain and Sancar (1987a) investigated the genetics of photoreactivation in 
E. coli in detail. They found that deletion of the gal-attX region increased the sensitivity of 
E. coli to near-UV radiation, but had no effect on the rate or extent of photoreactivation. 
However, point mutations in, or deletion of, the phrB gene drastically reduced both the 
rate and extent of photoreactivation but did not totally eliminate it. They concluded that 
extensive illumination of cells deleted in the phrB gene results in an increase in cell 
survival, suggesting that another mechanism exists in E. coli to photoreverse (inefficiently) 
the effect of far-UV irradiation by subsequent exposure to near-UV or visible light 
Further studies (Husain et al., 1988) showed that the residual photoreactivation in phrB 
mutants is not associated with reversal of pyrimidine dimers. It was suggested the residual 
photoreactivation was attributable to the direct photoconversion of the (6-4) 
photoproducts to their Dewar isomers by Type HI photoreactivation.
Thus Husain and Sancar (1987a) proposed that the gene in the gal-attX region termed 
phr A  should not be described as such, since their findings showed deletion of this gene 
had no effect on the rate or the extent of photoreactivation; and that the gene product 
should not be called a photolyase because the protein did not play any physiologically 
significant role in photoreactivation in vivo, according to their results. With this, phr A  was 
effectively dismissed from the literature.
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1.5.3 THE EVIDENCE FOR phrA
Sutherland et al. (1973) purified a DNA photoreactivating enzyme from induced cells of 
an E. coli strain having a lysogenic ^-bacteriophage carrying the gal-attX chromosomal 
region (Sutherland et al., 1972). The purified enzyme tended to form aggregates, but 
Snapka and Sutherland (1980) developed a purification procedure to minimise 
aggregation. The purified enzyme had a molecular weight of approximately 40kDa and 
was associated with RNA (10 -15  nucleotides per enzyme molecule).
Sutherland et al. (1986) characterised the substrate range of the 40kDa PRE isolated by 
Snapka and Sutherland (1980). The enzyme was at least as active on cis-syn cyclobutane 
pyrimidine dimers in supercoiled DNA as in linear DNA, but inactive on dimers in RNA. 
Both the phosphodiester bond internal to the deoxyriboses of the pyrimidines of the dimer 
and the N-glycosyl bond joining the pyrimidine to deoxyribose must be intact for enzyme 
action. The enzyme was shown to have no activity towards (6-4) photoproducts in DNA. 
Sutherland et al. (1986) also studied extracts from wild-type E. coli and found they 
contained PRE activity corresponding to a 40kDa species and a 50kDa species, which 
they suggested were the gene products of phr A  and phrB.
Sutherland and Hausrath (1979) investigated the photoreactivation kinetics of wild-type 
and A (gal-attX) strains and reported that whereas the A(gal-attX) strains could indeed be 
photoreactivated, the rate of photoreactivation was much slower in strains with this 
deletion. Husain and Sancar (1987a) attempted to reproduce these results, but were 
unable to do so. They found, however, that deletions of the gal-attX region increased the 
sensitivity of the strains to near-UV light killing. They suggested that this may be due to 
the accumulation of coproporphyrin in the cell, due to deletion of the hemF gene which is 
located in the gal-attX interval (Bachmann, 1983), which in turn photosensitises to near- 
UV killing.
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Hejmadi and Verma (1987) were also able to isolate a 40kDa PRE using the method 
developed by Snapka and Sutherland (1980), and showed that in the absence of the RNA 
cofactor, the 40kDa PRE binds with DNA regardless of the presence of pyrimidine 
dimers. This suggested that the RNA cofactor is somehow involved in the site-selection 
for the 40kDa PRE on DNA containing pyrimidine dimers. Verma et al. (1990) showed 
that binding of the 40kDa PRE with UV-irradiated DNA protects the RNA cofactor 
against subsequent digestion with RNase, and suggested a qualitative model for the 
structure of the photolyase:UV-irradiated DNA complex, based on the stacking 
interactions between a base of the RNA cofactor and the destacked purines on the 
complementary strand opposite to the pyrimidine dimer.
Smith et al. (1987) studied photoreactivation after 254nm UV irradiation in a dark-repair- 
deficient phrB mutant (DY326) and in a strain deleted at the proposed phr A  locus 
(AS44). They showed apparent enzymatic repair in the phrB mutant, which was abolished 
when the mutation was transduced into the phr A  mutant. They also showed an apparent 
decrease in the production of active PRE molecules in the phr A  mutant compared to a 
non-isogenic phr + strain (AB2480), and that photoreactivation proceeds at a rate 30% of 
that o f the phr + strain. They concluded that the phrB gene is the major structural gene for 
PRE molecules, but that a gene in the region of the putative phr A  locus also had an effect 
on photoenzymatic repair in E. coli, and indeed could code for a second photolyase 
molecule.
Smith and Moss (1987) studied the efficiency of photoreactivation with respect to the 
wavelength of photoreactivating light in the same dark-repair-deficient phr +, phr A  and 
phrB mutants, and showed a structureless peak over the range 360nm to 400nm for all 
three strains. This data suggested that the light dependent repair observed in the phrB 
mutant was similar to enzymatic photoreactivation and may be mediated by an unknown 
photoactive protein.
36
Smith and Moss (1988) cloned a SphI restriction fragment from Xgal transducing 'phage 
DNA specifically carrying the gal-attA, region and demonstrated the appearance of a 
photoreactivable response in a photoreactivation-deficient phrA phrB mutant (AS46), and 
an increase in the rate of photoreactivation when the plasmid carrying the restriction 
fragment (pASOl) was transformed into the phrA  mutant (AS44). When the plasmid 
pASOl was transformed into the phrB mutant (DY326) no increase in the rate or extent of 
photoreactivation was observed. They concluded that although a gene present on the 
plasmid fulfilled the role of the phrA  gene, and confirmed the hypothesis that a gene in the 
gal-attX region does affect the rate of photoenzymatic repair in E. coli; the evidence to 
date did not permit the conclusion that this gene codes for a protein having photolyase­
like activity. A similar conclusion was drawn by Smith (1987).
Thus, the evidence for phrA  is rather confusing. Some of the more speculative claims 
made by Sutherland and Hausrath (1979) were that phrA~ phrB+ mutants photoreactivate 
ultraviolet-induced killing at a rate 20% of normal and they contained approximately 20% 
of the normal photoreactivating enzyme level. Statements such as these have gone a long 
way to discredit phrA  research. It would be easy to dismiss the work of B.M. Sutherland 
and co-workers as A. Sancar and co-workers have done in both E. coli (Husain and 
Sancar, 1987a) and human cells (Li et al., 1993). However, as far as E. coli is concerned, 
the work by Hejmadi and Verma (1987) and Verma et al. (1990) using the same 
photoreactivating enzyme as purified by Snapka and Sutherland (1980) must not be 
overlooked.
It is hoped that the work performed during this study will help to clarify the role of phrA  
in photoreactivation in Escherichia coli.
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1.5.4 THE PROSPECTIVE ROLE OF THE phrA  GENE
Following the reports by Husain and Sancar (1987a) and Husain et al. (1988), which 
effectively dismissed phrA  from a role in photorepair in E. coli, the role of phrA  with 
respect to the results obtained in our laboratory needs to be reviewed.
The reports by the above authors could be correct as stated, and the phrA  gene does not 
play any significant role in photoreactivation in vivo. However, the report by Husain et al. 
(1988) used a strain deleted in both phrB and phrA as the phr~ mutant. Therefore, even if 
the phrA  gene product is not involved in the repair of pyrimidine dimers, that statement 
can not be concluded from this work. Interestingly, it is not mentioned whether the phrA+ 
phrB~ mutant used by Husain and Sancar (1987a) was assayed for removal of pyrimidine 
dimers. It would seem logical to have assayed this strain to finally confirm that phrA  is not 
involved with the repair of pyrimidine dimers.
Another explanation could be that the photoreactivation conditions used by Husain and 
Sancar (1987a) were not conducive to activate the phrA  gene product. The fluence-rate 
used by Sutherland and Hausrath (1979) was quoted as 192.5 Wnr2, however Husain and 
Sancar (1987a) found this fluence-rate to be quite lethal over a 20 minute period of 
photoreactivation, and used a fluence-rate of 5 Wnr2 It should be noted that fluence-rates 
of polychromatic light are inherently unreliable, and in particular may be distorted by the 
presence of infra-red radiation. Smith et al. (1987) found that saturating irradiance 
conditions were reached at approximately 7-8 Wnr2. Was the fluence-rate of the 
photoreactivating light used by Husain and Sancar (1987a) too low for the activity of 
phrA  to be seen?
It has been reported that a new photoreactivating enzyme has been discovered in 
Drosphilia melanogaster which specifically repairs (6-4) photoproducts (Todo et al., 
1993). Studies by these workers showed that E. coli possesses a protein that specifically 
binds (6-4) photoproducts, but an initial assay for its photoreactivation-mediating activity
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was negative. The biological function of this (6-4) photoproduct-binding factor remains to 
be determined. The phrA  gene product could be this (6-4) photoproduct-binding factor, 
and is possibly a photoreactivating enzyme specific for (6-4) photoproducts. The level of 
repair seen in the phrA+ phrB' strain studied in our laboratory is consistent with the 
amount of (6-4) photoproducts likely to be induced by the UV-irradiation conditions. As 
stated in Section 1.2, cyclobutane pyrimidine dimers and (6-4) photoproducts are the most 
abundant of the total UV-induced photoproducts, constituting 70-80% and 20-30% of the 
total photoproducts respectively (Svoboda et al., 1993).
Therefore, three major possibilities exist for the role of phrA  in Escherichia coli
i) No significant role in photoreactivation.
ii) Photoreactivation by repair of pyrimidine dimers at higher fluence-rates of 
photoreactivating light.
iii) Photoreactivation by repair of (6-4) photoproducts.
The aim of this study was to characterise the probable gene on the insert in pASOl (Smith 






All water used for preparative work throughout this study was freshly double glass 
distilled by a bi-distillation Fistreem still (fiso ns  ltd) fitted with a Fistreem pre-deioniser 
(h s o n s  l td ). It is referred to throughout this study as deionised double-distilled water 
(DDDW).
2.1.2 GLASSWARE
Glassware was decontaminated where necessary by autoclaving at 121 °C for 30 minutes 
(d r a y t o n  ca st l e  labo r ato ry  steriliser). All glassware was washed in DDDW and then 
rinsed three times before drying overnight in a drying oven (g a llen k a m p). Glassware was 
then sealed with aluminium foil and sterilised by dry heat at 160°C for 4 hours
(GALLENKAMP STERILISING OVEN).
2.1.3 GROWTH OF ORGANISMS
The organisms used in this study were all Escherichia coli K-12 strains. A list describing 
the genotypes and sources of all the organisms used is included in APPENDIX A. A
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similar list detailing the plasmids used in this study is also included in APPENDIX A. The 
organisms used were routinely grown up from stock LB agar plates - see Section 2.1.4.
MEDIA USED FOR THE GROWTH
LB broth was routinely used as the growth medium for all experiments, except for the 
studies on UV-survival and photoreactivation experiments where Oxoid CM1 nutrient 
broth was used. A full list of media used in this study is included in APPENDIX B2.
The media was made up in DDDW and allowed to stand for 15 minutes. 100ml volumes 
were dispensed into 150ml medical screw-cap flat bottles (b e a t so n -clark e) and sterilised 
by autoclaving at 121°C for 15 minutes. These were stored in the dark at room 
temperature prior to use.
INCUBATION
Cultures were incubated in either an Immersion Water Bath (g a l l e n k a m p  BKS350) or a 
Hot Air Incubator (g allenkam p illum inated  co o led  o rbital  in c u ba to r ). Unless 
otherwise stated, the temperature was set at 37°C ± 0.5°C and shaking at 100 cycles per 
minute, with the safety "cut off' set at 45 °C. Both the temperature and the number of 
cycles per minute were monitored routinely.
AERATION APPARATUS
A forced aeration system used to standardise the amount of air to each culture vessel was 
used for all UV-survival and photoreactivation studies. Compressed air was passed 
through a course cotton wool pre-filter connected to a Rotameter flow meter (r o t a m e r , 
c r o y d o n ) which regulated the flow-rate to 10ml per minute to each culture vessel. The air 
was sterilised by passage through a 25mm diameter, 0.45|im pore-size Sartorius 
membrane filter (sarto rius g m b h , Ge r m a n y ) positioned immediately before the entrance 
port to the culture vessel. This apparatus has been described previously (Hodges, 1979).
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METHODOLOGY
A loopful of surface-grown culture was inoculated into an appropriate vessel containing 
an appropriate amount of pre-warmed growth medium. For small culture volumes, a 30ml 
sterile Universal Container (st e r iu n , feltham ) containing 10ml of pre-warmed growth 
medium was used. For larger culture volumes, a 250ml pyrex, screw-cap, conical flask 
containing 40ml - 100ml of pre-warmed growth medium was used. For strains carrying 
antibiotic resistance plasmids, the appropriate antibiotic was added to the growth medium. 
The vessel was incubated in either a shaking water bath or in the hot air shaking incubator 
for a length of time appropriate to the experiment For the UV-irradiation and 
photoreactivation studies, the flask was connected to the aeration apparatus and incubated 
in a shaking water bath for 24 hours. A secondary liquid culture was prepared by 
inoculating 99ml of pre-warmed growth medium with 1ml of primary culture, and 
incubated as described above for 24 hours. These culture conditions were adhered to 
strictly to minimise the variation in photoreactivability measured by Tyrrell et al. (1972).
2.1.4 STORAGE OF ORGANISMS.
Stock cultures of all strains were sealed in sterile plastic tubes, packed in plastic vials and 
stored in the vapour phase of a liquid nitrogen refrigerator (u n io n  c a r b id e  ltd) at a 
temperature of approximately -161 °C.
Stocks for routine use were also prepared, by adding 0.15ml sterile glycerol to 0.85ml of 
bacterial culture, vortexing the culture to ensure the glycerol was evenly dispersed, then 
transferring the culture to a sterile, labelled, storage tube, equipped with a screw-cap and 
an air-tight gasket (in ter -m e d , Denm ar k ). The culture was stored at —161°C, as described 
above. The sterile glycerol was prepared by dispensing 20ml aliquots into 30ml straight­
sided glass containers, sealed and sterilised at 121 °C for 15 minutes.
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For routine use, a sterile inoculating needle was used to scrape the surface of the above 
frozen culture and immediately streaked onto a LB agar plate containing the appropriate 
antibiotic(s). The agar for these plates was prepared as described in APPENDIX B2 and 
20ml volumes of molten agar were poured into 9cm sterile petri dishes (s t e r iu n  l td , 
felth a m ). After inoculation, the plates were incubated at 37°C for 48 hours in a LEEC 
PCF2 incubator (leec , Notting h am ). The plates were sealed with parafilm (n e sc o h l m ) 
and stored in an inverted position at 4°C. These plates were discarded after two weeks. 
The phenotype of each strain was routinely verified by assessing growth on the 
appropriate defined media plates.
2.1.5 MATERIALS
PIPETTES
Four Gilson pipettes (gblson m ed ic a l  electronics, Fr a n c e) with volume ranges 1.0ml - 
5.0ml (MODEL P5000), 0.1ml - 1.0ml (MODEL P1000), lOpl - 2000|il (MODEL P200) and 
0.5pl - 20fil (MODEL P20) were used, in conjunction with the appropriate plastic tips. 
After use the tips were washed and boiled in glass distilled water, dried and packed into 
BS6257 specification autoclave bags (d r g  hospital  supplies) or plastic tip boxes (g ilson  
m e d ic a l  electronics, Fr a n c e ) before sterilisation by autoclaving at 121 °C for 15 minutes.
ANTIBIOTIC SOLUTIONS
Stock solutions of all the antibiotics used in this study were prepared to a concentration as 
described in Table 2.1. Solutions made up in DDDW were sterilised through a 25mm 
diameter 0.22|im pore-size Sartorius membrane filter, while solutions made up in ethanol 
required no sterilisation (Sambrook et al.y 1989). Solutions were stored in light resistant, 
sterile containers in the dark at -20°C.
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ANTIBIOTIC STOCK SOLUTIONS WORKING
CONCENTRATIONS
CONCENTRATION STORAGE TEMPERATURE
AMPICELLIN 50mg/ml in H20 -20°C 50 - lOOjig/ml
STREPTOMYCIN lOmg/ml in H20 -20°C 50|ig/ml
TETRACYCLINE 5mg/ml in ethanol -20°C 15|ig/ml
Table 2.1. Summary of antibiotics used with working and stock concentrations. 
DILUTION TUBES
All serial dilution’s were performed in 15cm x 1.9cm rimless, thick-walled, pyrex glass 
tubes, fitted with Oxoid aluminium caps. The tubes were prepared as described under 
’’Glassware", dried and sterilised by dry heat at 160°C for 4 hours.
SPREADERS
These were prepared from glass quill, sealed at each end and having a 60° bend 
approximately two-thirds along its length. They were prepared as described under 
"Glassware", dried, packed into autoclave bags and sterilised by autoclaving at 121°C for 
15 minutes.
DILUTION MEDIUM
M9 salts solution (Anderson, 1946) was used as the dilution fluid. M9 salts solution was 
prepared from two stock concentrates, M9A and M9B (see APPENDIX B l). M9 salts 
solution (’M9') was prepared by aseptically mixing 100ml of M9A concentrate and 400ml 
of M9B concentrate and making up to 5 litres with DDDW. Approximately 100ml
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volumes of this solution were transferred to 150ml medical, screw-cap, flat bottles and 
sterilised by autoclaving at 121°C for 15 minutes. The pH of this solution was 6.9 at 20°C.
SOLUTIONS AMD OTHER REAGENTS
All other solutions and other reagents used in this study are described in APPENDIX B. 
PLATING MEDIA
LB agar was used as plating media throughout this study, unless otherwise stated. Oxoid 
CM3 nutrient agar was used for the UV-irradiation and photoreactivation studies. The 
formulae are given in APPENDIX B2 and the method of preparation is described in 
Section 2.1.4.
All plates were stored at 4°C in the dark for up to 4 days. Immediately before use they 
were 'overdried' by placing in an inverted position at 37 °C for 60 minutes under ventilated 
conditions.
MANIPULATIONS
All manipulations requiring aseptic technique were performed in a horizontal laminar flow 
cabinet (m icro flo w , in ter -m e d ). Experimental protocols not requiring sterile conditions 
were performed at the bench.
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2.2 MOLECULAR CLONING TECHNIQUES
The majority of the molecular cloning techniques used in this study are from, or have been 
adapted from Sambrook et al. (1989).
2.2.1 SOLUTIONS, RESTRICTION AND MODIFYING ENZYMES,
AND OTHER REAGENTS
SOLUTIONS
Details of all the solutions used for molecular cloning are included in APPENDIX B 1. 
RESTRICTION ENZYMES
Unless otherwise stated, restriction enzymes were purchased from PHARMACIA, stored at 
-20°C in lOjil aliquots, and used in accordance with the manufacturers instructions.
MODIFYING ENZYMES
All modifying enzymes were purchased from PHARMACIA, stored at -20°C in 10}il 
aliquots, and used in accordance with the manufacturers instructions.
REACTION BUFFER
U nless otherwise stated, the reaction buffer used was ONE-PHOR-ALL PLUS (PHARMACIA), 
supplied as a lOx concentrate.
OTHER REAGENTS
Details of all the other reagents used in this study are included in APPENDIX B.
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2.2.2 ISOLATION AND PURIFICATION OF PLASMID DNA
For the requirements of this study, the quantity and quality of plasmid DNA obtained by 
the alkaline lysis 'mini-prep* method described below was sufficient 
1.3ml of an overnight culture of the bacterial strain containing the plasmid was transferred 
to a 1.5ml microcentrifuge tube (elk ay  pro du cts in c) and centrifuged at full speed for 1 
minute in a microcentrifuge (m se  m icrocentuar) to pellet the cells. The media was 
removed using a sterile glass pipette. lOOpl of ice-cold SOLUTION I was added to the 
cells, and the pellet resuspended by vigorous vortexing, then incubated on ice for 5 
minutes. 200|il of SOLUTION II was added, and the microcentrifuge inverted five times 
to gently mix the contents, then incubated on ice for 5 minutes. 150jil of SOLUTION III 
was added, and the contents vortexed for 10 seconds to disperse SOLUTION III through 
the viscous bacterial lysate, then incubated on ice for 5 minutes, then centrifuged at full 
speed for 5 minutes. The supernatant was transferred to a new microcentrifuge tube and 
450|il o f phenol:chloroform:iso-amyl alcohol (25:24:1) added. The contents were 
vortexed for 20 seconds and then centrifuged at full speed for 2 minutes. The upper 
aqueous layer was carefully transferred to a new microcentrifuge tube and 1ml of 96% 
ethanol (-20°C) added to precipitate the plasmid DNA. The contents were vortexed for 20 
seconds and incubated at -20°C for 60 minutes. The DNA was pelleted by centrifugation 
at full speed for 5 minutes, then the supernatant carefully discarded. The pellet was 
carefully rinsed with 70% ethanol (room temperature), briefly spun on the centrifuge for 1 
minute and the supernatant carefully removed. The DNA pellet was dried by placing in a 
vacuum desiccator for 2 minutes and air drying at room temperature for 5 minutes. The 
DNA was redissolved in 50jil of TE (pH 8.0 containing DNA-ase free RNA-ase 20|Xg/ml), 
unless otherwise stated elsewhere. The contents were briefly vortexed, spun down and 
stored at -20°C.
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2.2.3 CALCULATION OF THE CONCENTRATION OF DNA IN 
SOLUTION
This was calculated by the spectrophotometric measurement of the amount of ultra-violet 
irradiation absorbed by the bases in solution. 10|il of DNA solution was diluted to 1.0ml 
with TE (pH 8.0) and using TE (pH 8,0) as a blank, readings for the OD260 and OD280 
were made using a spectrophotometer (m ilto n  r o y  spectronic  60i). The reading at 
260nm allows calculation of the concentration of nucleic acid in the sample. An OD260 of 
1.0 corresponds to approximately 50jig/ml for double-stranded DNA. The ratio OD260 /  
OD280 provides an estimate of the purity of the nucleic acid. Pure preparations of DNA 
have an OD260 /  OD280 of 1.8. If there is contamination with protein or phenol, the OD260 
/  OD280 will be significandy less (Sambrook et al., 1989).
2.2.4 RESTRICTION ENZYME DIGESTION OF PLASMID DNA
Plasmid DNA can be analysed by cleavage with restriction enzymes. Restriction enzyme 
digestion reactions were set up as follows :-
DNA SOLUTION = 10|ig
Re s t r ic t io n  e n z y m e  = 10 units
Re s t r ic t io n  b u f f e r  (lOx c o n c e n t r a t e ) 2pi
S t e r il e  DDDW to 20|il
The reaction mixture was briefly vortexed, spun down and incubated at 37°C for 1 hour in 
a water bath. 1 unit of restriction enzyme will digest lfig o f ADNA in 50|il Assay Buffer in 
1 hour at 37°C, according to the manufacturers data sheet. After incubation, 3|il o f gel-
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loading buffer was added, briefly vortexed, spun down and stored at -20°C until ready to 
load onto an agarose gel.
2.2.5 ANALYSIS OF RESTRICTION FRAGMENTS BY AGAROSE GEL 
ELECTROPHORESIS
Electrophoresis through agarose or polyacrylamide gels is the standard method used to 
separate, identify and purify DNA fragments. Routinely, a 0.8% agarose gel was used, 
which separates linear DNA molecules in the range 0.6 - 9 kbp (Sambrook et al, 1989).
PREPARATION OF A GEL
240mg of electrophoresis grade agarose (b d h , poole) was added to 30ml TAE buffer and 
dissolved by heating in a boiling water bath for 5 minutes with constant swirling, until all 
the agarose lenses' had dissolved. The solution was cooled to about 60°C, then ethidium 
bromide solution was added to a final concentration of 0.5jig/ml. The ends of a clean, dry, 
plastic electrophoresis tray (b io -r a d ) were sealed with autoclave tape and either an 8- or 
15-tong plastic comb positioned 1.0mm above the plate surface at one end of the tray. The 
molten gel was poured carefully into the tray and allowed to cool and set for 30 - 45 
minutes at room temperature.
LOADING AND RUNNING A GEL
The comb and sealing tape were carefully removed, and the gel mounted in an 
electrophoresis tank (b io -r a d  m in i-su b  d n a  cell) with a nominal capacity of 250ml. The 
gel was covered with TAE buffer to a depth of just over 1mm, making sure that all the 
'wells' were filled. 12|il (8 wells) or 7pi (15 wells) of sample was loaded into each well as 
required, using 3jil o f ADNA/HindM as a marker in one of the outside lanes. When all the 
wells were loaded, the lid of the tank was closed and a voltage of 60V applied using a
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250/2.5 Power Supply (bio -r a d ). The gels were run for between 60 - 120 minutes. The 
TAE buffer was recirculated around the tank by a flow-inducer (w a t so n -m a r lo w . 
fa lm o uth ), so it flowed from the cathode to the anode.
VISUALISATION AND PHOTOGRAPHY OF A GEL
The fluorescent dye, ethidium bromide (Sharp et al, 1973), which is present in the agarose 
gel contains a planar group that intercalates between the stacked bases of DNA. 
Ultraviolet radiation at 254nm is absorbed by the DNA and transmitted to the dye, the 
energy re-emitted at 590nm in the red-orange region of the visible spectrum. The fixed 
position of this planar group and its close proximity to the bases causes ethidium bromide 
bound to DNA to display an increased fluorescent yield compared to free dye. Thus small 
amounts of DNA can be detected in the presence of free ethidium bromide in the gel.
At anytime during electrophoresis, the gel tray could be removed from the tank, and the 
DNA fragments viewed on a UV Products Transilluminator. When the DNA fragments 
had migrated as far as was required, the gel was photographed with a CU-5 Fotodyne 
camera and Type 55 Polaroid Film.
2.2.6 ISOLATION AND PURIFICATION OF DNA FROM AGAROSE 
GELS
The isolation and purification of DNA, usually a restriction fragment from a restriction 
enzyme digest of plasmid DNA, was performed using the Sephaglas Band Prep Kit 
(Pharm acia). This kit provides a simple and rapid method for extracting individual DNA 
bands from agarose gels following electrophoresis. The method utilises a novel matrix, 
Sephaglas BP. Sephaglas BP is well suited to DNA purification for two reasons; a) DNA 
can be bound to it selectively, then eluted into a buffer of low ionic strength for direct use 
in a variety of common laboratory procedures; and b) the chaotropic salt required for
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binding (sodium iodide), denatures proteins and dissolves agarose. The kit is able to 
isolate from an agarose gel plug DNA of sufficient purity for subsequent ligation, 
according to the manufacturers data sheet.
The DNA was loaded onto an agarose gel and run for 6 0 - 120 minutes until the fragment 
required had separated from the other bands. The gel was viewed using 366nm UV light 
(d e sa g a  u v is  254nm /  366nm light so u r c e) to minimise damage to the DNA. A piece of the 
gel containing the required fragment was cut out of the gel with a scalpel, chopped into 
small pieces and transferred to a pre-weighed clean 1.5ml microcentrifuge tube, then 
weighed to calculate the weight of the agarose slice. 250|il of Gel Solubiliser (250|il 
minimum, or ljul for each mg of agarose) was added, vortexed vigorously, and incubated 
at 60°C for 10 minutes until the agarose slice had dissolved. 5|il of Sephaglas BP (5pl for 
each estimated pg of DNA) was added to the dissolved agarose slice, vortexed gently, 
then incubated at room temperature for 5 minutes, vortexing gently every minute to 
resuspend the Sephaglas. The contents were centrifuged at full speed in a microcentrifuge 
for 1 minute, and the supernatant carefully discarded. 40pl of Wash Buffer (or 8x the 
volume of Sephaglas added previously) was added to the Sephaglas pellet, vortexed gently 
to resuspend the pellet, then centrifuged for 1 minute. The supernatant was carefully 
removed. This wash-step was repeated twice. The tube was inverted, and the pellet 
allowed to air-dry for 10 minutes. lOpl of Elution Buffer (lOfil minimum, or 0.5x the 
volume of Sephaglas added previously), vortexed gently to resuspend the Sephaglas pellet, 
incubated for 5 minutes at room temperature, with periodic agitation, then centrifuged for 
1 minute. The supernatant was carefully transferred to a clean microcentrifuge tube, taking 
care not to disturb the Sephaglas pellet. This elution step was repeated to obtain a better 
yield of DNA. The concentration of the DNA was calculated using the spectrophotmetric 
assay described in Section 2.2.3. The DNA was now pure enough to proceed directly to 
the next stage, without further purification.
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2.2.7 ALKALINE PHOSPHATASE TREATMENT OF RESTRICTED 
PLASMID DNA
Treatment of linear DNA molecules produced by restriction enzyme cleavage with calf- 
intestinal alkaline phosphatase (Ph arm ac ia ) results in the removal of the 5-terminal 
phosphate residues and prevents self-ligation. This is a useful technique when cloning 
restriction fragments into vectors.
Restricted DNA (l-20|ig) in a reaction volume of 50|il is dephosphorylated by the 
addition of = 0.1 units of alkaline phosphatase and incubation at 37 °C for 30 minutes. 
Afterwards, the alkaline phosphatase can be inactivated by incubating at 85°C for 15 
minutes, then allowing the reaction mixture to cool at room temperature for 30 minutes. 
Using this protocol, less than 1% of the input DNA should retain its terminal phosphate 
groups, according to the manufacturers data sheet.
2.2.8 LIGATION OF LINEAR DNA MOLECULES
Ligation of a segment of foreign DNA to a linearised plasmid vector involves the 
formation of new bonds between phosphate residues located at the 5-termini of double­
stranded DNA and adjacent 3'-hydroxyl moieties. Four new phosphodiester bonds are 
formed if all of the four 'ends' carry 5'-phosphate residues, however if the plasmid DNA 
has been dephosphorylated, only two new phosphodiester bonds can be formed. The 
resulting hybrid molecules carry two single-stranded nicks that are repaired after the 
hybrids have been introduced into competent bacteria.
For all cloning purposes in this study, bacteriophage T4 DNA ligase (Ph a r m a c ia ) was 
used to catalyse in vitro the formation of phosphodiester bonds between adjacent 5'- 
phosphate and 3'-hydroxyl residues in the presence of ATP. The advantage of 
bacteriophage T4 DNA ligase was that it will join blunt-ended termini efficiently under
52
normal reaction conditions as well as cohesive termini. The constituents of the ligation 
mixtures used are given in the relevant RESULTS section.
2.2.9 PREPARATION OF COMPETENT CELLS
5ml of LB broth was inoculated with a single colony of the chosen bacteria from a LB 
agar plate. This was incubated at 37°C overnight. 40ml of pre-warmed LB broth was 
inoculated with 0.4ml of overnight culture and incubated at 37°C until the OD550 = 0.5 
(mid-log phase), usually 3 - 4  hours. The cells were transferred in 20ml aliquots to ice- 
cold sterile Universal Containers, and the cultures cooled on ice for 10 minutes. The 
cultures were then centrifuged at 4000rpm at 4°C for 10 minutes in a centrifuge (m s e  
chilsptn, h s o n s ). The media was removed with a sterile glass pipette, and the containers 
inverted to drain off the last traces of media. The cells were resuspended in 5ml ice-cold 
sterile 0.1M CaCl2 and incubated on ice for 30 minutes, then centrifuged at 4000rpm at 
4°C for 10 minutes. The supernatant was removed with a sterile glass pipette, and the 
containers inverted to drain off the last traces of supernatant. The cells were resuspended 
in 1ml of ice-cold sterile 0.1M CaCl2 and stored at 4°C for 16 hours, then used for 
transformation. The above procedures were carried out under aseptic conditions. Dagert 
and Ehrlich (1979) have shown that competent cells may be stored at 4°C for 24 - 48 
hours in CaCl2 solution. The efficiency of transformation increases four- to six-fold during 
the first 12 - 24 hours of storage, then decreases to the original level.
2.2.10 TRANSFORMATION OF PLASMID DNA INTO COMPETENT 
CELLS
It has been shown that bacteria treated with ice-cold CaCl2 and then briefly heated can be 
transfected with bacteriophage X DNA, plasmid DNA and E.coli chromosomal DNA.
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Apparently, the treatment induces a transient state of "competence" in the recipient 
bacteria, during which they are able to take up DNAs derived from a variety of sources. 
Many methods have been devised with the aim of increasing the transformation efficiency. 
The method used in this study has been derived from Sambrook et al. (1989).
A sterile thin-walled glass tube (h o sl a b , ilford , ESSEX) was chilled on ice for 5 minutes, 
then 300{il of competent cells and 5|il of plasmid DNA (either purified plasmid DNA or a 
ligation mixture - = 0.05|ig DNA) were added and mixed by gentle swirling, then 
incubated on ice for 30 minutes. The cells were heat-shocked by placing the tube in a 
water bath at 50°C for 45 seconds, then incubated on ice for 1 - 2 minutes. 1ml of pre- 
warmed LB broth was added to the tube, mixed gently, then the contents transferred to a 
sterile Universal Container and incubated at 37°C for 1 hour with shaking. 8.7ml of pre- 
warmed LB broth was added along with the appropriate antibiotic depending on the 
resistance conferred by the plasmid. The contents were mixed by gentle swirling and then 
incubated at 37°C for 12 hours with shaking. The resulting culture was streaked out onto 
LB agar plates supplemented with the appropriate antibiotic and incubated at 37°C for 48 
hours. The resulting individual colonies were then screened by isolating the plasmid DNA 
and restriction enzyme analysis as described previously.
2.2.11 CONTROLS FOR LIGATION AND TRANSFORMATION 
EXPERIMENTS
Various controls were performed alongside the ligation and transformation experiments to 
verify the validity of the final result. These are described in the appropriate RESULTS 
section later on.
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2.2.12 PRODUCTION OF SYNTHETIC OLIGONUCLEOTIDES
Synthetic oligonucleotides were required for a variety of purposes in this study, from 
primers for DNA sequencing to synthetic linkers for sub-cloning.
The synthetic oligonucleotides were prepared using a DNA Synthesiser Model 381A 
( applied  b io sy st e m s) in pre-packed disposable Synthesis Columns (Se v e r n  biotech  ltd ) 
by Dr Paul Towner in the Department of Biochemistry, University of Bath. The synthetic 
oligonucleotide was bound to a resin in the column. The synthetic oligonucleotide was 
extracted and isolated as follows
A 1ml syringe was filled with 1ml of concentrated ammonia solution and fixed to one end 
of the column. A 5ml syringe was fixed to the other end of the column, and used to draw 
0.3ml of concentrated ammonia solution into the column. This was left for 60 minutes at 
room temperature, then a further 0.2ml of concentrated ammonia solution was drawn into 
the column. This was repeated until all of the concentrated ammonia solution had passed 
through the column. The concentrated ammonia solution containing the oligonucleotide 
was transferred to a 1.5ml screw-capped microcentrifuge tube, which was placed into a 
7.5ml Universal Container (s t e r iu n , felth am ) containing 0.5ml of concentrated ammonia 
solution. This was placed into a water bath at 55°C overnight (a minimum of 6 hours), to 
remove the amino-protecting groups. The solution was transferred to an ice-cold 30ml 
Universal Container and 5ml of 96% ethanol (-20°C) added, followed by 3ml of glacial 
acetic acid, added slowly down the side of the tube. The contents were mixed and 
incubated at -20°C for 60 minutes. The oligonucleotide was collected by centrifugation at 
2000rpm for 10 minutes in a MSE Chilspin. The supernatant was carefully removed, and 
the oligonucleotide rinsed carefully with 5ml of 70% ethanol at room temperature. This 
was carefully removed, and the oligonucleotide pellet dried under vacuum for 3 minutes, 
then air-dried at room temperature for 10 minutes. The oligonucleotide was redissolved in 
200fil of sterile DDDW. The concentration of the oligonucleotide was calculated as
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described in Section 2.2.3, however an OD26o of 1.0 corresponds to = 37jig/ml of 




Details of the preparation of DNA for sequencing are included in Section 3.3.3.
2.3.1 EQUIPMENT
A Sequi - Gen Nucleic Acid Sequencing Cell (bio -r a d ) was used for the sequencing 
experiments. This was a modular, high resolution, vertical slab gel electrophoresis 
instrument designed for DNA /  RNA sequencing. The dimensions of the cell plate were 
21cm (width) by 50cm (height). The actual gel area was 17cm by 50cm.
The Sequi - Gen Cell used a new type of upper buffer chamber called an Integral Plate /  
Chamber (IPC). The IPC was the inner glass plate and buffer chamber bonded together 
with a permanent adhesive at the sides and bottom edges of the plate. This formed a thin, 
0.5cm buffer chamber that extended over the entire area of the gel plate. A platinum 
electrode wire, strung across the bottom of the IPC, functioned as the cathode.
The IPC assembly consisted of the IPC, an outer glass plate and a pair of clamps. A gel 
mould was formed when 0.4mm plastic spacers were clamped between the glass plates of 
the IPC assembly. After a gel had been cast, the IPC assembly was placed in an upright 
position in the lower buffer chamber (Universal Base), and locked into place with a 
stabiliser bar. Buffer was poured into the upper buffer chamber (minimum volume 575ml) 
and lower buffer chamber (minimum volume 350ml) until it contacted the top and bottom 
of the gel. Two safety covers were used to cover the upper and lower buffer chambers. 
The upper safety cover was attached to the 'plugs' at the top of each clamp, and the lower 
safety cover was attached to the 'plugs' on the lower buffer chamber. The anode was a 
platinum electrode wire strung across the bottom of the lower buffer chamber, between 
the two 'plug attachments'. The upper buffer carried the current from the cathode up to the
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top of the plates where the gel was exposed. The lower buffer contacted the gel at the 
bottom edge of the plates.
2.3.2 PREPARATION BEFORE ASSEMBLY OF THE GEL
The glass plates were thoroughly cleaned with detergent and rinsed with warm tap water. 
The plates were dried with paper towels, making sure that all traces of detergent were 
removed from the edges of the plates. Both plates were rinsed with DDDW and then 95% 
ethanol just prior to assembly, wiping off any dust with a lint-free paper tissue moistened 
with 95% ethanol at the point o f assembly.
The IPC glass plate was siliconised before use, and this was repeated after five gels had 
been run. This allowed easy removal of the IPC plate from the outer plate, as the gel 
would stick preferentially to the unsiliconised outer plate. The plate was cleaned and 
rinsed as described above, placed horizontally glass face up in a fume cupboard, and a 
solution of Sigamacote® (sig m a ) rubbed onto the glass plate using lint-free paper tissue, 
ensuring that the whole of the glass surface was treated. The plate was then cleaned and 
rinsed again before assembly.
All plastic parts (buffer chambers, stabiliser bar, combs, spacers and casting tray) were 
rinsed with detergent in lukewarm tap water, rinsed well with warm tap water, rinsed with 
DDDW, and allowed to drip dry on clean paper towels. The spacers were wiped with lint- 
free paper tissue moistened with 95% ethanol prior to assembly.
Clean plates and spacers were the key to pouring gels without bubbles or leaks.
2.3.3 ASSEMBLING THE GLASS PLATES
The IPC was placed on the bench, horizontally glass face up. The spacers were placed on 
the long edges of the IPC plate, and the outer glass plate was placed on top of the spacers,
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with the cleaned side face down. The outer plate and spacers were aligned with the bottom 
edge of the inner glass plate, so that the two glass plates were flush at the bottom. The 
clamps were slid over the gel plate assembly, one clamp at a time. Each clamp was 
attached at one end first, then slid onto the gel plate assembly until it snapped into place 
along the entire length. The spacers and outer glass plate were checked to be flush at the 
bottom with the inner glass plate.
2.3.4 PREPARATION OF POLYACRYLAMIDE SOLUTIONS
All polyaciylamide solutions used in this work were prepared from purchased Stock 
Solutions (SEQUAGEL). A gel concentration of 6% v/v was used and prepared as 
follows
Seq u a g e l  Co n c  14ml
Seq u a g e l  D il 40ml
Seq u a g e l  B u ffer  6ml
For Sealing Gels, the following solution was prepared
6% G el  So lutio n  10ml
Seq u a g e l  Co n c  1ml
TEMED 50p,l
A m m o n iu m  Per sulph a te  (25% w /v) 70pl
This was mixed by swirling and used immediately as described later.
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For sequencing gels, the following solution was prepared
6% G e l  S o l u t io n  50ml
TEMED 50|il
A m m o n iu m  P e r s u l p h a t e  (25% w/v) 67 pi
This was mixed by swirling and used as described later.
2.3.5 CASTING THE GEL
The bottom edge of the gel was sealed as follows. A foam cushion and filter paper sealing 
strip were placed into the clean, dry casting tray with the paper on top. The sealing gel 
was prepared, mixed immediately and poured over the entire length of the paper sealing 
strip, so it became completely saturated. The IPC assembly was placed on top of the 
sealing strip (bottom of the glass plates in contact with the strip), and the screws on the 
casting tray tightened to bind the casting tray tightly to the clamps of the IPC assembly. 
The movement of the sealing gel into the space between the gel plates by capillary action 
was checked along the full width of the gel. The sealing strip was allowed to set for 60 
minutes
Once the sealing gel had polymerised, the IPC assembly was laid on the bench at an angle 
of approximately 15°, and the casting gel prepared. The gel solution was drawn into a 
50ml plastic syringe, and the IPC assembly tilted so that the gel solution entered the glass
plates near one spacer. This reduced the formation of bubbles during filling, any bubbles
that formed were removed by gently tapping the glass plate.
After pouring, the IPC assembly was laid nearly flat at an angle of approximately 5°. The 
flat end of a 'sharkstooth' comb (bethesda research laboratories) was inserted between
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the gel plates before the gel had polymerised. This was clamped at both sides to ensure
that the plates held firmly against the comb, using two 'bulldog' clips.
Once the gel had polymerised, a paper towel was laid across the top of the gel and
saturated with DDDW. The gel was left overnight to 'age'.
2.3.6 SETTING UP FOR OPERATION
The casting tray was detached and the sealing strip pulled away from the bottom of the 
gel. The 'sharkstooth' comb was removed, and the well formed immediately rinsed with 
DDDW to remove any unpolymerised acrylamide.
The IPC assembly was placed into the lower buffer chamber and the stabiliser bar inserted. 
The upper buffer chamber was filled with 0.5x TBE buffer to about 1cm from the top of 
the chamber. The lower buffer chamber was filled with 350ml - 500ml of the same buffer. 
A Gel Temperature Indicator (bio -r a d ) was attached to the outer glass plate near the 
centre of the gel to monitor the temperature during electrophoresis. The 'sharkstooth' 
comb was replaced into the well at the top of the gel, 'teeth' down to form the loading 
wells. The 'teeth' penetrated the gel by about 1mm. The safety covers were attached and 
the gel pre-run for 45 minutes at 1800V using a Model 3000xi Computer Controlled 
Electrophoresis power supply (bio -r a d ). This was to warm the gel up to operating 
temperature ( s  50°C). The level of the buffer in the upper buffer chamber was monitored 
regularly, and topped up when required so that it always covered the top of the gel.
2.3.7 LOADING AND RUNNING THE GEL
The power supply was turned off, the upper safety cover removed, and the samples loaded 
onto the gel, via the 'sharkstooth' wells, as described in Section 3.3.3. Prior to loading, the 
wells were rinsed with buffer using a pasteur pipette to remove any dissolved urea. The
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samples were always loaded onto a 'hot' (45° - 50°C) gel using a P20 Gilson pipette. Once 
the samples were loaded, the upper safety cover was replaced.
The gel was run at a constant power of 45W. It was found that this power produced a 
constant gel temperature of = 50°C. Running at constant power also resulted in more 
reproducible runs.
2.3.8 DISASSEMBLY OF THE GEL
The power supply was switched off and both safety covers removed. The stabiliser bar 
was detached and the IPC assembly removed. The buffer was poured out of the EPC 
assembly, and the inside and outside rinsed. The clamps were removed from the IPC, and 
the inner glass plate carefully removed by prying gently at the top of the gel.
2.3.9 FIXING AND DRYING THE GEL
The gel on the outer glass plate was fixed in 2 litres of Fixing Solution (Acetic Acid : 
Methanol: DDDW /  1 : 1 : 8) solution for 15 minutes. This process removed hygroscopic 
urea, which would inhibit drying. The gel was then transferred to a fresh sheet of 
Whatman 3mm filter paper. This was achieved by laying the filter paper on top of the gel, 
gendy rubbing it flat with a test tube, and then peeling back the filter paper from one end. 
The gel was covered with Saran Wrap ™, and the edges trimmed to fit the slab gel dryer 
(bio -r a d  m o d e l  583 g el  d r y e r ). The gel was dried at 80°C under vacuum for 90 minutes. 
The Saran Wrap ™ was removed and the gel trimmed again to fit the film exposure 
Cassette (SIGMA, 14in x 17in).
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2.3.10 AUTORADIOGRAPHY
The gel was placed in the film exposure cassette, gel face up and secured using masking 
tape, and the edges of the gel marked with a black marker pen. One piece of High 
Performance Autoradiography Film (hyperfilm  ™ - p m a x  - a m er sh a m ) was removed from 
its box under red light conditions and placed over the gel surface, shiny side up, using the 
edge markers as a guide. The cassette was closed and clamped shut, and the film left for 
48 hours exposure. After this time, the film was removed under red light and placed in a 
Developing solution (k o d a k  l x -24 X-r a y  developer) until the sequence bands appeared. 
The film was then transferred to a Rinsing solution (1% v/v acetic acid in water) and then 
transferred to a Fixing solution (k o d a k  f x -40 X-r a y  liquid  fixer) until the hazy appearance 
of the film had disappeared. The film was rinsed again and then hung up to dry.
2.3.11 PRODUCTION OF SYNTHETIC PRIMERS
The start point for sequencing the forward section of the insert was the M l3 Universal 
Primer, and for the reverse section the M l3 Reverse Primer. These were purchased from 
USB, OHIO, USA. Approximately 300bps from the primer could be read accurately on the 
autoradiographs. A clear section was taken of between 17 and 20 base pairs and a new 
synthetic primer produced as described in Section 2.2.12. The primers were diluted with 
sterile DDDW to a final concentration of 0.5pmol/pl
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2.4 EXPRESSION TECHNIQUES
Intact native proteins can be produced in E.coli by providing a strong, regulated promoter 
and an efficient ribosome-binding site - see Section 4.3. Levels of expression may vary 
from less than 1% to more than 30% of the total cell proteins.
2.4.1 GROWTH OF INDUCED CULTURES
An overnight culture of the plasmid of interest, present in a suitable host, was prepared in 
LB broth supplemented with the appropriate antibiotic(s). The induction culture was 
prepared by inoculating 50ml of pre-warmed LB broth supplemented with the appropriate 
antibiotic(s) with 0.5ml of overnight culture. This culture was incubated at 37°C for 2 
hours with shaking until the culture had reached approximately mid-log phase - for the 
two host strains used (JM83 and JM105) this was equivalent to an OD550 of about 0.5. 
IPTG was aseptically added to the culture to a final concentration of 1.0 mM. A 1ml 
sample was aseptically removed and transferred to a 1.5ml microcentrifuge tube. The 
culture was returned to the incubator, taking this point as T = 0. The culture was 
incubated for to 24 hours, with 1ml samples taken at T = 2 ,4 ,6 ,1 2 ,  and 24.
2.4.2 PREPARATION OF SAMPLES
The bacteria were recovered from the 1ml of culture by centrifugation at full speed for 1 
minute. The medium was carefully removed using a sterile glass pipette, leaving the 
bacterial pellet as dry as possible.
The pellet was resuspended by vortexing in 50pl of sterile H20, then 50pl of 2 x SDS gel- 
loading buffer was added, and the contents vortexed for 20 seconds. The sample was 
placed in a boiling water bath for 5 minutes. The sample was centrifuged for 10 minutes,
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then 50|il o f the supernatant transferred to a fresh microcentrifuge tube. The samples were 
stored at -20°C until ready to load onto a SDS-polyacrylamide gel for analysis.
2.4.3 SDS-POLYACRYLAMIDE GELS
Almost all analytical electrophoresis of proteins is carried out in polyacrylamide gels under 
conditions that ensure dissociation of the proteins into their individual polypeptide 
subunits and that minimise aggregation. Most commonly, the strongly anionic detergent 
SDS is used in combination with a reducing agent and heat to dissociate the proteins 
before they are loaded onto the gel - see Section 2.4.2. Because the amount of SDS is 
almost always proportional to the molecular weight of the polypeptide and is independent 
of the sequence, SDS-polypeptide complexes migrate through polyacrylamide gels in 
accordance with the size of the polypeptide. By using markers of a known molecular 
weight, it is therefore possible to estimate the molecular weight of the polypeptide 
chain(s), and to see if over-expression of a certain protein is occurring over a set of 
samples taken at different time intervals from the same culture.
EQUIPMENT
A Mini-PROTEAN II (bio rad ) dual slab cell was used to prepare and run the SDS- 
polyacrylamide gels in conjunction with a Model 200/2.0 Power Supply (b io r a d ). The 
glass plates and the plastic components were cleaned and prepared in a similar fashion to 
that described in Sections 2.3.2 and 2.3.3. The kit was assembled and used in accordance 
with the manufacturers instructions.
2.4.4 PREPARATION OF POLYACRYLAMIDE SOLUTIONS
All polyacrylamide solutions used in this work were prepared from purchased Stock 
Solutions (PROTOGEL). Gel concentrations of 12% for the stacking gels and 4% for the 
resolving gels were used.
For resolving gels, the following solution was prepared
Sterile DDDW 3.35ml
P rotogel 4.0ml
1.5M T ris (pH 8.8) 2.5ml
SDS (20% w /v) 50JJ.1
A m m o n iu m  Persulph ate  (25 % w /v) 100p.l
T em ed  5pl
This was mixed by swirling and used as described later.
For stacking gels, the following solution was prepared
Sterile DDDW 6 .1 ml
P rotogel 1.3ml
0.5M T ris  (pH 6.8) 2.5ml
SDS (20% w /v ) 50fil
A m m o n iu m  Per sulph a te  (25% w /v) IOOjllI
T em ed  IOjxI
This was mixed by swirling and used as described later.
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2.4.5 CASTING THE GEL
A comb was placed completely into the assembled glass plate sandwich, and a mark made 
lcm below the teeth of the comb with a marker pen. A freshly prepared resolving gel 
solution was added slowly down the gap present at the top of the glass plates, up to the 
level of mark. This was covered with a layer of 50% v/v methanol and left to polymerise 
for 60 minutes. The methanol was removed by shaking, the top of the gel rinsed with 
DDDW, then covered with a layer of 0.375M Tris (pH8.8), wrapped tightly in Saran 
Wrap ™ and left overnight at room temperature to 'age'.
The top of the gel was rinsed with DDDW and shaken dry. A freshly prepared stacking gel 
solution was then added on top of the resolving gel until it had filled the rest of the space 
between the two glass plates. A comb was inserted into the stacking gel, making sure that 
no air bubbles formed, then left to polymerise for 45 minutes.
2.4.6 SETTING UP FOR OPERATION
The comb was carefully removed from the stacking gel, the 'wells' rinsed with DDDW and 
shaken dry. The gel apparatus was assembled according to the manufactures instructions, 
and placed into the lower buffer chamber. The buffer used was Tris-glycine-SDS 
electrophoresis buffer. A lOx stock solution (b io r a d ) was purchased and diluted to a 
working concentration as required. 300ml of buffer was prepared, and added to the upper 
buffer chamber until the buffer covered the smaller, but not the larger, glass plate. The 
remaining buffer was poured into the lower buffer chamber.
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2.4.7 LOADING AND RUNNING THE GEL
The samples were loaded onto the gel in 5}il volumes. A molecular weight marker was 
loaded into the first lane. The marker used was SDS-PAGE Molecular Weight Standard - 
Low Range (bio r a d ), which contains six molecular weight markers ranging between 
14,400 Da and 97,400 Da. The full list of the molecular weights of the markers is given in 
Section 4.3.1. The marker was prepared for use by diluting ljxl in 19p.l of SDS-gel loading 
buffer, placed in a boiling water bath for 5 minutes, and centrifuged for 10 minutes at full 
speed. The supernatant transferred to a fresh microcentrifuge tube. The marker was stored 
at -20°C until ready to load onto a SDS-polyacrylamide gel. The lid of the lower buffer 
chamber was connected and attached to the power supply. The gel was run at a constant 
voltage of 180V for about 45 minutes, until the blue marker present in the SDS-gel 
loading buffer had reached the bottom of the gel.
2.4.8 DISASSEMBLY OF THE GEL
The power supply was switched off, the lid removed, and the gel plates snapped out of the 
holding apparatus. The top plate was carefully removed, then the stacking gel and the 
spacers removed also. The resolving gel was carefully lifted of the bottom plate using one 
of the spacers.
2.4.9 STAINING AND DESTAINING THE GEL
The gel was stained in Coomassie Brilliant Blue Stain (see APPENDIX B l) on a gently 
rocking platform for 60 minutes. The gel was then destained by immersion in a Destaining 
/  Fixing Solution (Methanol : Acetic Acid : DDDW /  4 : 1 : 5) on a gently rocking
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platform. The destaining / fixing solution was changed four to five times over a 2 to 3 
hour period.
2.4.10 MOUNTING AND DRYING THE GEL
The gel was mounted onto a clean piece of Whatman 3mm filter paper and dried in a 
similar fashion to that described in Section 2.3.9 for 30 minutes.
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2.5 UV IRRADIATION AND PHOTOREACTIVATION 
TECHNIQUES
2.5.1 GENERAL METHODOLOGY 
WASHING /  DILUTION FLUID
M9 salts solution was used to wash and resuspend cells, and also as the dilution fluid Its 
preparation has been described in Section 2.1.5.
HARVESTING CELLS
A 24 hour liquid secondary culture was prepared as described in Section 2.1.4. 1ml was 
pipetted into a sterile 1.5ml microcentrifuge tube, and centrifuged at full speed in a 
microcentrifuge for 1 minute, to pellet the cells. The media was removed using a sterile 
glass pipette, and the cells resuspended in 0.5ml of ice-cold sterile M9. The cells were 
pelleted by centrifuging at full speed for 1 minute. This step was repeated twice, to rinse 
the cells three times. The cells were resuspended in 1.0ml of ice-cold sterile M9 and 
transferred to a sterile dilution tube containing 9.0ml of ice-cold sterile M9.
After harvesting, an estimate of the viability of the cell suspension was provided by 
measurement of the absorbance of the suspension at 470nm, and referring to a previously 
determined calibration curve for the particular organism - see APPENDIX E for an 
example. The OD470 of 1ml of cell suspension was measured against a blank of 1ml of M9 
in plastic cuvettes (e lk a y  pro ducts in c ). The Beer-Lambert relationship does not apply to 
optical densities greater than 0.35, so cell suspensions exceeding this value were diluted 
accordingly. The cell suspension was diluted with ice-cold sterile M9 to a final volume of 
15.0ml in a sterile 15cm x 2.5cm rimless, pyrex glass boiling tube to give an approximate 
cell count of 1 x 107 colony forming units per ml.
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METHOD OF ASSESSMENT OF VIABILITY
The viable count of the bacterial cell suspension was determined by an initial 20-fold 
dilution, produced by transferring 0.2ml of the test suspension into 3.8ml of M9 in a 
dilution tube. When survival was low after UV-irradiation, a 2-fold dilution was prepared 
by adding 0.4ml of the test suspension to 0.4ml of M9. A subsequent series of 10-fold 
dilution's were performed as necessary by transferring 0.5ml of the diluted test suspension 
to 4.5ml of M9. Each dilution was thoroughly mixed using a Whirlimix (fiso n s  l td ). A 
0.2ml aliquot of the required dilution was pipetted onto the surface of each of three 
nutrient agar plates, and spread uniformly with a sterile glass spreader. A range of 
dilution's were plated to yield colony counts in the 20 -200 range. The plates were allowed 
to stand for 30 minutes, then incubated in an inverted position in the dark at 37°C for 48 
hours. The number of visible colonies (without magnification) on each plate were counted. 
The mean value of the three plates, together with the dilution factor, was used to 
determine the number of viable bacteria in the test suspension.
INVESTIGATION OF THE ERRORS INVOLVED IN VIABLE COUNT 
ASSESSMENT BY THIS TECHNIQUE
The two principle sources of error which may be introduced arise from a) the pipettes may 
not deliver accurate or precise volumes, and b) the mixing of the bacterial test suspension 
after each dilution stage may be insufficient for the count to truly reflect the viability of the 
test suspension.
The error arising from the pipettes was assessed every 3 months by weighing out six 
individual volumes of DDDW delivered under experimental conditions - see Table 2.2. 
The conditions used simulated 'in-use' conditions, the pipettes were reset on each occasion 
and a fresh tip fitted. The DDDW was equilibrated to room temperature for 15 minutes 
before testing. The results are very similar to the errors calculated by Smith (1987).
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The efficiency of the mixing of the bacterial test suspension was assessed by performing 
six individual serial dilution's of the same test suspension and determining the viability by 
plating 0.2ml aliquots onto the surface of four nutrient agar plates per dilution series. The 
experimental results are given in Table 2.3. Again, the results are very similar to the errors 





0.2 P1000 0.1961 ±0.0012
0.5 PI 000 0.4932 ±0.0031
3.8 P5000 3.7819 ±0.0016
4.5 P5000 4.4903 ±0.0021
Table 2.2. Investigation of the errors introduced in viable count assessment
by the use of Gilson pipettes.
Sample Plate Counts D ilution Factor V iable Count
1 50,58 ,61 ,55 105 5.58 ±0.43 xlO 6
2 52 ,63 ,49 ,58 105 5.55 ± 0.62 xlO 6
3 44,48, 60, 54, 105 5.15 ±0.70 x 106
4 55 ,54 ,59 ,56 105 5.60 ± 0.22 x 106
5 47, 56,51,63 105 5.43 ± 0.69 xlO 6
6 49, 61, 54, 62 105 5.65 ±0.61 xlO6
Table 2.3. Investigation of the errors introduced during serial dilution and plating o f the
bacterial suspension.
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Therefore, the calculated errors introduced by the experimental protocol were in the same 
order as previously calculated by Smith (1987) for the same protocol.
2.5.2 IRRADIATION PROCEDURES
All ultra-violet light experiments were carried out in a 'dark-room' under illumination from 
red fluorescent tubes (a tlas l t d , sow) which do not emit at wavelengths below 540nm. 
This did not cause concurrent photoreactivation of damage to DNA and was further 
confirmed by action spectra studies for photoreactivation (Smith, 1987)
FAR UV-RADIATION (254nm)
The source used was a 5cm Penray lamp (ultraviolet  pro duc ts  in c , s a n  Ga br iel , c .a . JnC 
sc-i) fitted with a G-275 filter, which results in 95% of the emission at 254nm. Mains 
electricity to the lamp was supplied through a voltage stabiliser (a d v a n c e d  electro nics , 
cv iooa). The lamp was used in a horizontal position in the apparatus shown in Figure 2.1. 
The irradiation vessel was positioned 20cm directly beneath the UV source, with a shutter 
regulating exposure, positioned between. This was an iris camera shutter (G.B. k er sh a w  
630) with a 2cm aperture and fitted with a cable release. The shutter was electronically 
tripped using a relay switch and the exact exposure time recorded on a millisecond timer 
(m ar co ni in st r u m e n t s  ltd). The irradiation vessel was a jacketed, straight-sided glass 
bowl, with an internal diameter of 5.2cm. Adequate stirring was ensured by passing a 
stream of filtered, humidified air onto the surface of the test suspension through a side jet 
9ml of bacterial test suspension was irradiated. The fractional increase in the distance 
between the source and the surface of the suspension after removal of each 0.2ml aliquot 
was considered to be insignificant. A flow of compressed air was directed over the source 
filter to prevent any build up of ozone. The bacterial suspension was equilibrated at 25°C 
prior to irradiation, which was subsequently carried out at room temperature.
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This apparatus has been described previously (Smith, 1987).
METHODOLOGY
After the appropriate growth period, the bacterial cells were harvested and resuspended in 
ice-cold sterile M9 to give a final viable count of approximately 1 x 107 colony forming 
units per ml. The period of time between harvesting and irradiation of the bacterial 
suspension was standardised at 20 minutes. The Penray lamp was switched on at least 20 
minutes before use. The bacterial suspension was equilibrated to 25°C in a water bath for 
the last 5 minutes of the 20 minute period. 9ml of the bacterial cell suspension was 
transferred to the irradiation vessel which had been sterilised by 254nm UV radiation from 
the Penray light source for 20 minutes. A 0.2ml aliquot was removed for an initial viable 
count assessment and after each subsequent fluence to determine the surviving fraction.
2.5.3 DETERMINATION OF THE FLUENCE RATE OF ULTRAVIOLET 
RADIATION
254nm SOURCE
The fluence rate was determined by routine chemical actinometry (Hatchard and Parker, 
1956). The method uses potassium ferroxalate as the actinometer and relies on the light- 
catalysed production of Fe2+ ions in a solution of K3Fe(C204)3. The solution absorbs light 
completely in the UV region, the yield is independent of the fluence rate and the quantum 
yield of the reaction is constant.
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v u j / j n  r u n
Figure 2.1. Diagram of the apparatus for 254nm UV-irradiation.
UV Source (1) Irradiation Vessel (3)
Shutter (2) Air Inlet (4)
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Actinometry was performed under red light according to the method of Jagger (1967), by 
irradiation of 8.8ml of actinometer solution in the irradiation vessel. It was intended that 
this method would take into account any internal reflection arising from the use o f the 
glass irradiation vessel. A calibration curve of optical density at 510nm against amount of 
ferrous ions (shown in APPENDIX E) was constructed and used to determine the amount 
of ferrous ions formed by the radiation. The fluence rate was calculated from this, using 
the constant pertaining to 254nm as described by Jagger (1967).
CALIBRATION OF A THERMOPILE
Conversion of incident energy from microvolts to fluence rate was made by reference to 
the calibration for a thermopile determined by potassium ferroxalate actinometry. A 
number of fluence rates obtained at different distances from the UV source were 
determined by chemical actinometry and plotted against the thermopile reading for a Oriel 
7101 detector. This graph is shown in Figure 2.2. From the slope of this graph a 
conversion factor for millivolts to Wnr2 of 0.03597 was calculated.
2.5.4 PHOTOREACTIVATION PROCEDURES
APPARATUS
The apparatus is shown diagrammatically in Figure 2.3. All fittings were mounted on an 
optical bench. This apparatus has been described previously (Smith, 1987).
LIGHT SOURCE
Continuous broad-band light was produced by a Tutor 2 Projector (r a n k  a l d is , po w er
300W - MAX LAMP 24V 250W).
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Figure 2 2 .  Calibration curve for the Oriel 7101 thermopile, plotting fluence rate 
determined by actinometry against the thermopile reading in microvolts.
FILTERS
The continuous broad-band light was filtered through a 2cm pathlength solution 
containing 1.2% copper sulphate and 1.4% cobaltous sulphate and a purple glass filter 
(ealing  26-3384). The resulting transmission spectrum is shown in Figure 2.4. The 
transmitted light was a continuous band of wavelengths between 350nm and 420nm, 
which is the biologically effective region for photoreactivation (Smith, 1987; Jagger et al., 
1969). No measurable transmission was recorded in the infra-red range.
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ILLUMINATION VESSEL
The bacterial suspension for photoreactivation was placed in a 1cm pathlength glass 
cuvette (u n ic a m ) fitted with a plastic lid. These were stored in 70% ethanol, dried by a 
stream of compressed air and sterilised by 254nm radiation from a Penray lamp for 15 
minutes.
TEMPERATURE CONTROL UNIT
This consisted of a rectangular glass vessel 10cm x 10cm x 2.5cm with two optically flat 
surfaces (e a u n g  l td ) and an aluminium lid assembly, incorporating an insert to hold the 
illumination vessel in the light path. A continuous flow of water was supplied to the vessel 
through one tube from a water bath (g r a n t  se  m o d e l ) at 25°C by means of a flow-inducer 
(w a t so n -m a r l o w , fa lm o u th ), and removed by a constant level syphon tube. The rate of 
flow was set so that the flow of water into the illumination vessel was approximately the 
same as the flow out via the syphon tube. Temperature equilibration was achieved in 
approximately 4 minutes and maintained throughout within ± 0.1 °C.
For experiments requiring the temperature to be above 25°C, water was supplied from a 
different water bath (g r a n t  jb m o d el ) set at the required temperature to give the 
necessary temperature in the temperature control unit
For experiments requiring the temperature to be below 25 °C, water was supplied from a 
different water bath (g r a n t  jb m o d el) cooled using a Bath Cooler (u -c o o l , n e sl a b ) set at 
the required temperature to give the necessary temperature in the temperature control 
unit















Figure 2.3. Diagram of the apparatus used for photoreactivation. 
Projector (1) Temperature Control Unit and
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Figure 2.4. Transmission properties of the filters used 
in the photoreactivating experiments.
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METHODOLOGY
After UV-irradiation, the bacterial suspension to be photoreactivated was held in a 25°C 
water bath for 20 minutes to allow formation of any photoreactivating enzyme - substrate 
complexes. 3.0ml of the bacterial suspension was transferred to an illumination vessel. 
3.0ml of unirradiated bacterial suspension was also transferred to an illumination vessel, 
to act as a control. The cuvettes were then placed in the temperature control unit. A piece 
of opaque material (the 'Shutter') was placed between the projector assembly and the 
irradiation vessel, after which the lamp was switched on. This screen was removed at the 
same instant that the stop watch was started to time the photoreactivation period.
Separate UY-irradiated samples were used for each photoreactivating exposure, since it 
has been shown that fractionated doses have an increased effect (Tyrrell, 1971).
A comparative estimate of the fluence rate was made using another calibrated thermopile, 
an Oriel 7102 detector, which was positioned such that its window corresponded to the 
front face of the glass cuvette. A conversion factor of 0.025 was calculated as described in 
Section 2.5.3 and used to convert millivolts to Wm-2.
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CHAPTER THREE
CLONING AND SEQUENCING OF THE
phrA GENE
3.1 INTRODUCTION
The first objective of this study was to sequence the insert from pASOl, which is thought 
to contain the phrA  gene (Smith and Moss, 1988). In order to achieve this aim, the insert 
was subcloned into plasmid pUC19. The reasoning for this was pUC19 has the M13 
Universal Primer and M13 Reverse Primer sites (Messing et al. 1981) either side of the 
polycloning site, into which the Sphl-SphI restriction fragment in pASOl could be cloned 
and then easily sequenced. The sequencing was performed using the chain termination 
method of Sanger et al. (1977). The resulting sequence was analysed using the Staden and 
GCG programmes on the SERC Daresbury Seqnet computer system.
3.2 METHODS
The majority of the cloning and sequencing techniques have already been described in 
Chapter 2.
The preparation of plasmid DNA prior to sequencing and other relevant methods are 
described in detail in the following section.
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3.3 RESULTS
3.3.1 SUB-CLONING OF THE INSERT IN pASOl INTO pUC19
PREPARATION OF THE Sphl-SphI RESTRICTION FRAGMENT FROM pASOl 
Plasmid pASOl was isolated and purified as described in Section 2.2.2. The concentration 
of the purified plasmid DNA was calculated as described in Section 2.2.3. 20}ig of pASOl 
plasmid DNA was digested with an excess of restriction enzyme SphI for 2 hours at 37 °C 
to ensure complete digestion. The resulting Sphl-SphI restriction fragment was isolated 
and purified as described in Section 2.2.6. The concentration of the purified fragment 
DNA was calculated as described in Section 2.2.3.
PREPARATION OF VECTOR DNA
Plasmid pUC19 (see Figure 3.1) was isolated and purified as described in Section 2.2.2. 
The concentration o f the purified plasmid DNA was calculated as described in Section 
2.2.3. The plasmid DNA was digested with an excess of restriction enzyme SphI for 2 
hours at 37°C to ensure complete digestion. A small sample was run on an agarose gel to 
confirm that digestion had taken place. The restriction enzyme was inactivated by 
incubating at 85°C for 30 minutes, then allowing the reaction mixture to cool at room 
temperature for 30 minutes.
The pUC19 /  SphI restricted DNA was treated with Alkaline Phosphatase to 
dephosphorylate the sticky ends of the linear DNA, to prevent self-ligation, as described in 
Section 2.2.7. The Alkaline Phosphatase was inactivated by incubating at 85°C for 15 
minutes, then allowing the reaction mixture to cool at room temperature for 30 minutes.
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Figure 3.1. Diagram of pUC19, showing the important features.
LIGATION OF INSERT AND VECTOR DNA
The insert DNA was ligated to the vector DNA in the following ligation mixture
pUC19 /  SphI = 0.1|lg
SphI - SphI R e s t r ic t io n  f r a g m e n t  = 0 .15pg
S t e r il e  DDDW to 7pl
This reaction mixture was incubated at 45 °C for 5 minutes to melt any cohesive bonds that 
had formed, then cooled on ice for 5 minutes. Then the following were added
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BUFFER (1 OX CONCENTRATE) 
ATP (lOmM)




This was mixed by vortexing, spun down and incubated at 15°C for 10 hours.
Two separate ligation mixtures were set up, termed LIGATION A and LIGATION B.
PRODUCTION OF COMPETENT JM83 CELLS
Fresh competent cells of JM83 were prepared as described in Section 2.2.9. These were 
stored at 4°C for 16 hours and then used for transformation.
TRANSFORMATION OF LIGATION MIXTURE INTO JM83
Transformation of the competent JM83 cells with the ligation mixtures were performed as 
described in Section 2.2.10. The 12 hour liquid cultures were streaked out onto LB /  amp 
plates and incubated at 37°C for 48 hours. Growth was seen on plates from both 
LIGATION A and LIGATION B.
CONTROLS
The following controls were performed alongside the ligation mixture described above
a) LIGATION M IX -N O  ENZYME
The T4 DNA ligase was omitted from the ligation mixture. No growth was seen after 
incubation in the LB /  amp broth after 12 hours at 37°C or after streaking onto LB /  amp 
plates after incubation for 48 hours at 37°C.
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b) LIGATION M IX -N O  INSERT DNA
The insert DNA was omitted from the ligation mixture. Growth was seen after incubation 
in the LB /  amp broth after 12 hours at 37 °C and after streaking onto LB /  amp plates 
after incubation for 48 hours at 37°C. Restriction analysis showed the plasmid present to 
be indistinguishable from pUC19.
c) TRANSFORMATION MIX - NO LIGATION MIX
No ligation mixture was added to the competent cells of JM83, which then underwent the 
transformation procedure. No growth was seen after incubation in the LB /  amp broth 
after 12 hours at 37°C or after streaking onto LB /  amp plates after incubation for 48 
hours at 37 °C.
d) COMPETENT CELLS - VIABILITY TEST
The competent cells of JM83 were streaked out on LB, LB /  amp and LB /  str plates and 
incubated at 37°C for 48 hours. No growth was seen on LB /  amp plates, while growth 
occurred on the LB and LB /  str plates.
3.3.2 ANALYSIS OF THE NEW PLASMIDS
Plasmid DNA was isolated from individual colonies in batches o f twelve as described in 
Section 2.2.2. The plasmids were restricted with restriction enzyme EcoRI and then 
loaded onto an agarose gel and run for 90 minutes, using pUC19 /  EcoRI as a control. 
Plasmids which showed up on the gel to be heavier than pUC19 were then restricted with 
restriction enzyme SphI to see if the insert DNA could be cut out of the plasmids. This 
proved to be the case for all plasmids tested. These plasmids were then restricted with 
restriction enzymes HindHI and EcoRV (a restriction enzyme known to have one site
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within the SphI - SphI restriction fragment from pASOl). The results showed two 
different plasmids had been produced, depending on the orientation of the SphI - SphI 
restriction fragment in pUC19 - see Agarose Gel 3.1. These were termed pNDOl and 
pND02 - see Figures 3.2 and 3.3.
Agarose Gel 3.1. Restriction digests of plasmids pASOl, pNDOl, pND02 and pUC19. 
Lane 1, ^DNA /  Hindlll; Lane 2, pASOl /  SphI; Lane 3, pNDOl /  SphI;
Lane 4; pND02 /  SphI; Lane 5, pUC19 /  SphI; Lane 6, pND02 /  Hindm + EcoRV; 































Figure 3.3. Diagram of pND02, showing the important features.
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3.3.3 SEQUENCING OF THE INSERT IN pNDOl
The Sphl - Sphl restriction fragment inserted into pUC19 to form pNDOl was sequenced 
using the chain termination method of Sanger et al (1977). Sequencing was performed 
using the Sequenase® Version 2.0 kit (USB, OHIO, u s a ). The preparation of polyacrylamide 
gels for sequencing, materials used and the treatment of the gel after electrophoresis have 
been described previously in Section 2.3.
DENATURING PLASMID DNA
Plasmid pNDOl was isolated and purified as described in Section 2.2.2, and resuspended 
in TE (pH 7.5). The concentration of the plasmid DNA was calculated as described in 
Section 2.2.3, and diluted to = 0.5p.g/|il with TE (pH 7.5). The plasmid DNA was 
prepared for sequencing by denaturing with NaOH and then removing the NaOH and 
other impurities by spun-column chromatography. The following reaction mixture was set
This was vortexed briefly, spun down and incubated at room temperature for 30 minutes.
A Sephacryl S-400 column (Ph arm ac ia ) was prepared in accordance with the 
manufacturers instructions. The denaturing reaction mixture was slowly pipetted onto the 
flat upper surface of the compacted bed of Sephacryl S-400, and the column centrifuged 
for 2 minutes at 1500 rpm. The eluted solution contained purified denatured plasmid DNA 
in approximately 25fil of TE (pH 7.5).
up:-
pNDOl P l a s m id  DNA
D e n a t u r in g  S o l u t io n  (1M NaOH, ImM EDTA)




The following annealing reaction mixture was set up
Pu r ifie d  D e n a t u r e d  Pl a sm id  DNA 7 pi
Pr im e r  (0 .5p m ol/p l) lp l
Re a c t io n  B u ffe r  (5 x  c o n c en tr a te) 2 p l
This was mixed by vortexing briefly, spun down and incubated at 65°C for 2 minutes, then 
allowed to cool slowly from 65°C to room temperature over 30 minutes. The annealed 
mixture was stored on ice until ready for labelling (no longer than 4 hours).
LABELLING
The following labelling reaction mixture was set up
ANNEALED MIXTURE (TEMPLATE /  PRIMER) lOpl
DTT(O.IM) lp l
[a  - 35S] dATP lp l
LABELLING MIX 2pl
SEQUENASE ® VERSION 2.0 (1.5units/pl) 2pl
This was mixed by vortexing briefly, spun down and incubated at room temperature for 5 
minutes.
TERMINATION
Prior to the labelling reaction, 2.5pl of ddGTP /  ddATP /  ddTTP /  ddCTP were placed in 
four separate microcentrifuge tubes. The tubes were pre-warmed at 37°C for at least 1 
minute. 3.5pl of labelling mix was added to each tube, vortexed briefly, spun down, and
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incubated at 37°C for 5 minutes. 4jxl of ’STOP' solution was added to each tube, vortexed 
briefly, spun down, and stored on ice until ready to load onto a polyacrylamide sequencing 
gel, prepared as described previously in Section 2.3.
LOADING
A sample of each tube G - A - T- C (approximately 2.5 - 3.0|il) was incubated at 75 80°C 
for 2 minutes, then chilled briefly on ice. This was to prevent most nucleic acid secondary 
structures from re-annealing. The samples were then immediately loaded onto a 
polyacrylamide sequencing gel in the order G - A - T- C. This order was strictly adhered 
to - see Section 2.3.7.
RUNNING A GEL
Samples were loaded onto a polyacrylamide sequencing gel at different time intervals to 
run between 9 hours and 1 hour, depending on the part of the sequence to be read. The 
gels were run, disassembled, soaked in methanol:acetic acid:water, dried and exposed to 
autoradiography film, as described in Section 2.3.
READING THE SEQUENCE
The film was developed and dried as described in Section 2.3.10. As soon as it was dry, 
the left and right sides of the gel were identified, and the film labelled with the date, primer 
details and the times run.
The sequence was read over a light box (c o pejte , halgo  s u n b u r y  co  ltd ) and was 
recorded twice by myself and Dr A.H. Ahmed. The autoradiographs are shown in 
Appendix C.
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SEQUENCING CLOSE TO THE PRIMER
It has been shown (Tabor and Richardson, 1989) that di-deoxy-nucleotide triphosphates 
are incorporated by Sequenase ® Version 2.0 more efficiently relative to deoxy-nucleotide 
triphosphates in the presence of Mn2+. Thus the addition of Mn2+ to normal sequencing 
reactions (with fixed di-deoxy to deoxy ratios) reduces the average length of DNA 
synthesised, intensifying bands corresponding to sequences close to the primer.
Using the reaction conditions described previously, it was possible to read about 100 bases 
away from the primer. By reducing the amount of template DNA in the ANNEALING' 
reaction to about ljig, adding lp l of Mn2+ buffer to the LABELLING' reaction, and 
reducing the LABELLING' and TERMINATION' reaction times to 2 minutes, it was 
possible to read up to 20 bases away from the primer.
BUILDING UP THE SEQUENCE
The entire length of the Sphl - Sphl restriction fragment was sequenced for both strands 
using the M l3 Universal and M l3 Reverse Primers as starting points. Thus points of 
compression within the sequence on one strand could be "ironed out" by sequencing the 
complementary strand. This method also reduced the possibility of errors when reading the 
sequence, as any discrepancy was highlighted immediately.
PRIMERS
Using the above sequencing method, it was possible to read accurately up to about 300bps 
from the primer. The forward and reverse strands of the insert DNA were sequenced using 
the primers indicated in Table 3.1. Problems were initially encountered using the M l3 
Reverse Primer. This was due to the strain of pUC19 used been one of a series of rogue 
strains of pUC19, which have a 'C' base missing at position 33, between the T  and 'A' - 
see Figure 3.5. This disrupts the annealing of the M13 Reverse Primer (Dr P. Towner,
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Personal Communication). This was overcome by synthesising a new 1st Reverse Primer 
as indicated in Table 3.1.
FORWAR]D PRIMERS REVERS E PRIMERS
NAME SEQUENCE NAME SEQUENCE
M 13 U niversal P rim er S -g t a a a a c g a c g g o c a g t -S' 1st  Rev erse Prim er 5*- a c o c c a a o c t t o c a t g c -3'
2 n d  F orward Prim er 5-CCTGTAGTGGTTCATCG-3’ 2n d  Reverse  Prim er S'-AGTTTGTCCAGTTTGCT-3'
3 rd  Forward  P rim er y-OCTGTAAOCTTGCGGAT-3' 3rd Rev erse  Prim er 5’-c a t o c g c a a g g t t a c a g -3'
4 t h  F orward  P rim er y-AGCAAACTGGACAAACT-3' 4th  Reverse  Prim er S'-CG ATGAACCACTACAOO-3'
Table 3.1. Primers used in the sequencing of the insert
3.3.4 THE SEQUENCE OF THE INSERT IN pNDOl 
NUCLEOTIDE SEQUENCE
The resulting sequence was 1188bp in length, flanked by Sphl restriction sites at both 
ends, as expected, and with the sequences expected for plasmid pUC19 either side of the 
Sphl site within the polycloning site on that plasmid - see Figure 3.5. The sequence was 
analysed using the Staden and GCG programmes on the Daresbury Seqnet computer 
system.
No significant open reading frame was found on the forward strand of the sequence, using 
the GCG program F r a m e s '. Upon reversing and complementing the sequence, an open 
reading frame starting from an ATG start codon was discovered which covered 1020 
bases - see Figure 3.4.
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FRAMES o f :  a a q .r a v  Ck: 5 (45 , 1 t o :  1 ,2 (8  Ju n e  10, 1093 22:08
RE VERSE-COMPLEMENT o f :  a a q .q c q  check : 9297 from : 1 t o :  12(8
- t = i  h - t t -
4= 5'
-U± 4-------- f±4=t
Figure 3.4. Open Reading Frames on the Forward and Reverse Strand of the Insert.
Preceding the ATG start codon, areas were identified which bore similarity to the 
consensus sequences for E.coli transcriptional and translational signals. These are 




























AACAATTTCA CACAGGAAAC AGCTATGACC ATATTACGCC AAGCTTGCAT
| —* Sphl - Sphl Restriction Fragment
GCAACTGGCG CAGCAGTTCG GTATTACCGG CCCTCCTGGA CCGACGCITr
|->  RBS
AAATACCTTT CCACTGGCGA GACGCGAAAA ACCCTGCTGT GTCAGGCGCT
  => Gene
GATGTCGGAG CCTGACTTGT TGATTCTTGA TGAGCCGTTC GATGGCCTGG
ATGTTGCCTC ACGTGAGCAG CTGGCTGAGC GACTCGCCTC GTTACATCAG
TCCGGTATTA CTCTGGTACT GGTGCTCAAT CGCTTCGATG AGATCCCGGA
GTTTGTCCAG TTTGCTGGCG TGCTGGCGGA TTGCACGTTA GCGGAAACTG
GCGCTAAAGA GGAACTGCTC CAACAAGCAC TCGTCGCGCA ACTGGCGCAT
AGTGAACAGC TTGAAGGTGT GCAACTGCCG GAGCCGGATG AACCTTCAGC
ACGTCACGCC TTACCCGCCA ACGAACCGCG CATTGTGCTG AACAATGGCG
TGGTTTCTTA TAACGATCGC CCCATTCTTA ATAACCTTAG CTGGCAGGTG
AATCCAGGCG AACACTGGCA AATTGTCGGG CCAAATGGTG CAGGAAAATC
GACGTTATTA AGCCTGGTTA CTGGCGATCA TCCGCAAGGT TACAGCAACG
ATTTGACGGC TTTTCGACGA CGTGCCGGCA GCGGCGAAAC CATCTGGGAT
ATCAAAAAGC ATATCGGTTA CGTCAGCAGT AGTTTGCATC TGGATTACCG
GGTCAGCACT ACCGTGCGTA ATGTGATTCT TTCTGGCTAT TTTGATTCGA
TTGGCATTTA TCAGGCCGTT TCGGATCGCC AGCAAAAACT GGTGCAGCAG
TGGCTGGATA TTCTCGGCAT TGATAAACGC ACGGCTGACG CTCCGTTCCA
TAGTCTTTCC TGGGGACAGC AGCGTCTGGC GCTGATTGTC CGCGCACTGG
TGAAACATCC GACGTTGCTT ATTCTCGATG AACCACTACA GGGGCTTGAT
CCGCTGAATC GCCAGCTTAT CCGCCGTTTT GTTGATGTGC TGATTAGCGA
AGGTGAAACG CAATTGTTGT TTGTTTCGCA CCACGCTGAA GATGCGCCTG
CCTGTATTAC CCATCGTCTT GAGTTCGTGC CGGACGGTGG ACTCTATCGC
 .........................  Termination Sequence.........
TATGTGCTGA CAAAAATATA TTGAGTCGGT AGTGCTGACC TTCGCGGAGG
  | -> pUC19
CGGCCTTAGC ACCCTCTCCG GCCAACGGTT CGACGCATGC CTGCAGGTCG
I ->
ACTCTAGAGG ATCCCCGG
Figure 3.5. The sequence of the insert from pNDOl.
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AMINO ACID SEQUENCE
The coding region of the open reading frame codes for a protein of 340 amino acids, with 
a calculated molecular weight of 37,894 Da. This is a very similar size to the protein 
isolated by Snapka and Sutherland (1980), however the amino acid composition is very 
different to the one presented by these workers. This is discussed in Section 3.4. The 
amino acid sequence is presented in Figure 3.6.
116 GGC GAG ACG CGA AAA ACC CTG CTG TGT CAG GCG CTG
Met Ser Glu Pro Asp Leu Leu He Leu Asp Glu Pro
152 ATG TCG GAG CCT GAC TTG TTG ATT CTT GAT GAG CCG
Phe Asp Gly Leu Asp Val Ala Ser Arg Gin Gin Leu
188 TTC GAT GGC CTG GAT GTT GCC TCA CGT CAG CAG CTG
Ala Glu Arg Leu Ala Ser Leu His Gin Ser Gly He
224 GCT GAG CGA CTC GCC TCG TTA CAT CAG TCC GGT ATT
Thr Leu Val Leu Val Leu Asn Arg Phe Asp Glu He
260 ACT CTG GTA CTG GTG CTC AAT CGC TTC GAT GAG ATC
Pro Glu Phe Val Gin Phe Ala Gly Val Leu Ala Asp
296 CCG GAG ITT GTC CAG n r GCT GGC GTG CTG GCG GAT
Cys Thr Leu Ala Glu Thr Gly Ala Lys Glu Glu Leu
332 TGC ACG TTA GCG GAA ACT GGC GCT AAA GAG GAA CTG
Leu Gin Gin Ala Leu Val Ala Gin Leu Ala His Ser
368 CTC CAA CAA GCA CTC GTC GCG CAA CTG GCG CAT AGT
Glu Gin Leu Glu Gly Val Gin Leu Pro Glu Pro Asp
404 GAA CAG CTT GAA GGT GTG CAA CTG CCG GAG CCG GAT
Glu Pro Ser Ala Arg His Ala Leu Pro Ala Asn Glu
440 GAA CCT TCA GCA CGT CAC GCC TTA CCC GCC AAC GAA
Pro Arg lie Val Leu Asn Asn Gly Val Val Ser Tyr
476 CCG CGC ATT GTG CTG AAC AAT GGC GTG GTT TCT TAT
Asn Asp Arg Pro He Leu Asn Asn Leu Ser Trp Gin
512 AAC GAT CGC CCC ATT CTT AAT AAC CTT AGC TGG CAG
Val Asn Pro Gly Glu His Trp Gin He Val Gly Pro
548 GTG AAT CCA GGC GAA CAC TGG CAA ATT GTC GGG CCA
Asn Gly Ala Gly Lys Ser Thr Leu Leu Ser Leu Val
584 AAT GGT GCA GGA AAA TCG ACG TTA TTA AGC CTG GTT
Thr Gly Asp His Pro Gin Gly Tyr Ser Asn Asp Leu
620 ACT GGC GAT CAT CCG CAA GGT TAC AGC AAC GAT TTG
Thr Ala Phe Arg Arg Arg Ala Gly Ser Gly Glu Thr
656 ACG GCT TTT CGA CGA CGT GCC GGC AGC GGC GAA ACC
lie Trp Asp He Lys Lys His He Gly Tyr Val Ser
692 ATC TGG GAT ATC AAA AAG CAT ATC GGT TAC GTC AGC
Ser Ser Leu His Leu Asp Tyr Arg Val Ser Thr Thr
728 AGT AGT TTG CAT CTG GAT TAC CGG GTC AGC ACT ACC
Val Arg Asn Val He Leu Ser Gly Tyr Phe Asp Ser
764 GTG CGT AAT GTG ATT CTT TCT GGC TAT TTT GAT TCG
lie Gly ne Tyr Gin Ala Val Ser Asp Arg Gin Gin
800 ATT GGC ATT TAT CAG GCC GTT TCG GAT CGC CAG CAA
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Lys Leu Val Gin Gin Trp Leu Asp He Leu Gly He
836 AAA CTG GTG CAG CAG TGG CTG GAT ATT CTC GGC ATT
Asp Lys Arg Thr Ala Asp Ala Pro Phe His Ser Leu
872 GAT AAA CGC ACG GCT GAC GCT CCG TTC CAT AGT CTT
Ser Trp Gly Glu Glu Arg Leu Ala Leu He Val Arg
908 TCC TGG GGA CAG CAG CGT CTG GCG CTG ATT GTC CGC
Ala Leu Val Lys His Pro Thr Leu Leu He Leu Asp
944 GCA CTG GTG AAA CAT CCG ACG TTG CTT ATT CTC GAT
Glu Pro Leu Gin Gly Leu Asp Pro Leu Asn Arg Gin
980 GAA CCA CTA CAG GGG CTT GAT CCG CTG AAT CGC CAG
Leu lie Arg Arg Phe Val Asp Val Leu He Ser Glu
1016 CTT ATC CGC CGT TTT GTT GAT GTG CTG ATT AGC GAA
Gly Glu Thr Gin Leu Leu Phe Val Ser His His Ala
1052 GGT GAA ACG CAA TTG TTG TTT GTT TCG CAC CAC GCT
Glu Asp Ala Pro Ala Cys lie Thr His Arg Leu Glu
1088 GAA GAT GCG CCT GCC TGT ATT ACC CAT CGT CTT GAG
Phe Val Pro Asp Gly Gly Leu Tyr Arg Tyr Val Leu
1124 TTC GTG CCG GAC GGT GGA CTC TAT CGC TAT GTG CTG
Thr Lys lie Tyr Stop . • • • . . .




153 lslv tg d h pq g y sn d lta fr r r a g sg etiw d ik k h ig y v ssslh ld y r v st
204 TVRNVILSGYFDSIGIYQAVSDRQQKLVQQWLDILGIDKRTADAPFHSLSW 
255 GQQRLALIVRALVKHPTLLILDEPLQGLDPLNRQLIRRFVDVLISEGETQLL 
307 FV SHH AED APACITHRLEF VPDGGL YR Y VLTKIY
Figure 3.6. The amino acid sequence of the major open reading frame on the insert 
sequenced from pNDOl, showing the three letter codes for the amino acids against 
the nucleotide sequence (above) and the numbered single letter codes for the
amino acids (below).
REGISTRATION OF THE SEQUENCE
Upon searching on the EMBL and GenBank databases for similar nucleotide and protein 
sequences using the GCG programs F a s T a ' and T F a s T a ', no significant matches were 
found. The open reading frame was thus termed the putative phrA  gene.
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A search was also performed on a DAP parallel computer for the amino acid sequence 
against the Owl Database Release 19.0 (February 1993) by Dr S.M. Keyse. In general, 
these searches are faster and more sensitive than equivalent searches performed on a 
conventional computer. No significant matches were found, however, a lot of matches 
were made to transport /  membrane pump-type proteins. The significance of this is not yet 
known.
The sequence was registered with the European Molecular Biology Laboratory in 
Hiedleberg, Germany, in April 1993. The Accession Number is X69182. The gene was 
registered as the putative phrA  gene, coding for a photolyase enzyme.
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3.3.5 ANALYSIS OF THE SEQUENCE
With the variety of different computer programs available for analysing sequences, it 
would have been very easy to over analyse the sequence. The computer analysis of the 
putative phrA  gene was initially kept to a minimum, concentrating rather on experimental 
work.
CODON PREFERENCE ANALYSIS
One of the most useful pieces of sequence data is codon preference analysis. The program 
used was the GCG program 'Co d o n  P r e f e r e n c e '. This program is a frame-specific gene 
finder that tries to recognise protein coding sequences by virtue of the similarity of their 
codon usage to a codon frequency table, or by the bias of their composition (usually GC) 
in the third position of each codon.
The three reading frames of the sequence were analysed. The average codon preference 
for the frame with the open reading frame was 0.7327 (Frame 2), compared with 0.5470 
(Frame 1) and 0.5698 (Frame 3) for the other two frames - see Figure 3.7. This is 
comparable with the codon preference analysis of phrB, for example, where the average 
codon preference for the frame encoding the gene is 0.6124, compared to 0.5345 and 
0.5555 for the other two frames.
PROTEIN ANALYSIS
Using the GCG program 'Mo t if s1, the peptide sequence for the putative phrA  gene was 
analysed for sequence motifs. The program works by searching through protein sequences 
for the patterns defined in the PROSITE Dictionary o f Protein Sites and Patterns.
The one match found was for an ATP /  GTP-binding site motif A (P-loop). It has been 
shown (Saraste et al.y 1990) that an appreciable proportion of proteins that bind ATP or 
GTP share a number of more or less conserved sequence motifs. The best conserved of
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these motifs is a glycine-rich region, which probably forms a flexible loop between a beta- 
strand and an alpha-helix. This loop interacts with one of the phosphate groups of the 
nucleotide. This sequence motif is generally referred to as the 'A' consensus sequence or 
the 'P-loop'. The consensus pattern and the matching area on the putative phrA  gene 
product are shown in Figure 3.8.
CODONPREFERENCE o f:  em b l.seq  Ck: 6510, 1 to  1188 June 10, 1993 22:09
Codon T able: gen ru n d a ta :eco h ig h .co d  PrefWindow: 25 Rare Codon T h resh old : 0 .1 0  
BiasWindow: 25 D en sity : 39 .0















0 soo 1 , 0 0 0
-  0 .0  T J
Figure 3.7. Codon preference analysis of the three reading frames.
The matching area on the protein sequence is found between positions 542 to 564 - see 
Figure 3.6. The significance of this ATP /  GTP binding site is as yet unknown. It is hoped 
that maybe either the expression studies on the putative phrA  gene product (Chapter 4) or 
the in vivo photoreactivation studies (Chapter 5) could cast further light on this matter.
No match was found to the DNA Photolyase motif, which was found when the peptide 
sequence from phrB was analysed using the 'M otifs' program.
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[ AG ] - x (4) - G - K - [ ST ]
142 G - P - N - G - A - G - K - S 149
Figure 3.8. The consensus sequence of the P-loop (above) and the match with 
the putative phrA  gene product (below).
RESTRICTION ENZYME ANALYSIS
Using the Staden program 'NIP*, the theoretical restriction enzyme sites for the sequenced 
insert and plasmid vector pUC19 were obtained - see Figures 3.9 and 3.10. The term 'Cut 
Position' is used to indicate the number of the base immediately 5' to the cut produced by 
digestion with the relevant restriction enzyme. This confirmed previous work which had 
showed that there was an EcoRV site within the insert from pASOl. Restriction digests of 
plasmids pASOl, pNDOl, pND02 and pUC19 were performed to confirm this theoretical 
data in practice.
N a m e S e q u e n c e C u t  P o s it io n F r a g m ent
Hindlll A'AGCTT 42 41
Sphl GCATG'C 52 10
Dral TTT AAA 101 49
PvuII CAG'CTG 221 120
EcoRV GATATC 701 480
Sphl GCATG’C 1240 539
PstI CTGCA’G 1246 6
BamHI G'GATCC 1260 14
9
Figure 3.9. Important restriction enzyme sites in the 1268bp sequence obtained from the
reverse-strand sequencing of pNDOl.
NB: The insert from pASOl is between the two Sphl sites at 48 and 1236.
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N a m e Se q u e n c e  C u t  P o s it io n F r a g m e n t  l e n g t h s
PvuII CAG'CTG 309 718
EcoRI G'AATTC 397 88
Bam HI G'GATCC 418 21
PstI CTGCA'G 440 22
Sphl GCATG’C 446 6
Hindlll A’AGCTT 448 2
PvuII CAG’CTG 631 183
Dral TTT AAA 1566 935
Dral TTTAAA 1585 19
Dral TTTAAA 2277 692
Figure 3.10. Important restriction enzyme sites in the 2698bp plasmid vector pUC19. 
Plasmid pUC19 is numbered by the standard numbering system for the 
pUC plasmids (Sambrook et a l 1989).
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3.4 DISCUSSION
Sequencing of the insert from pASOl showed that there was an open reading frame 
present which could code for a protein of 37, 894Da. This is similar in size to the phrA  
gene product studied by Snapka and Sutherland (1986). Having found an open reading 
frame beginning with an ATG start codon, other features associated with E.coli genes 
were investigated. Areas were identified which bore similarity to the consensus sequences 
for E.coli transcriptional and translational signals.
TRANSCRIPTION SIGNALS
Transcriptional promoters in E.coli generally exhibit common features (Rosenburg and 
Court, 1979, Siebenlist et al, 1980, Aoyama et al, 1983): a) centred approximately 10 
base pairs 51 to the mRNA start, site a heptameric sequence TATAATG, called a Pribnow 
box, is found; b) centred about 35 base pairs upstream from the mRNA start site, the 
sequence TTGACA occurs; c) the distance between the Pribnow box and the -35 
sequence is 17+2 base pairs.
Within the region 5' to the translational start site of the gene, two areas exhibit varying 
degrees of homology to the consensus promoter - see Figure 3.11. Of these two, the one 
with the Pribnow box at position 110-116 and a -35 sequence at 87-92 has the best match 
to a consensus promoter, however the one with the Pribnow box at position 135-141 and 
a -35 sequence at either 109-114 or 114-119 is much closer to the mRNA start site - see 
Figure 3.5.
Certain common features have also been noted near or at sites of transcription 
termination in E.coli (Rosenberg and Court, 1979): a) preceding the termination site is a 
region of hyphenated dyad symmetry; b) termination occurs at a site 20 ±  4 nucleotides 
from the centre of symmetry and usually within a region containing several consecutive
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T residues; and c) a G /  C - rich sequence variable in length (3 -1 1  contiguous G /  C base 
pairs) are found preceding the stop-site.
Using the GCG program TERMINATOR1, an area 3' to the translational termination point 
of the gene (between 1168 and 1218 - see Figure 3.5) was identified as a possible 
termination sequence for the gene. This contains a G /  C - region of dyad symmetry, and 
the presence of a T rich region 22 base pairs 3' to the centre of dyad symmetry suggests 
that this region constitutes the transcriptional termination site of the gene - see Figure 
3.12.
CONSENSUS SEQUENCE:
•35 S e q u e n c e  
TTGACA
P r ib n o w  b o x
TATAATG
OPTION 1 87 TGGACC 110 TCCACTG
OPTION 2 109 TTCCAC 135 TGCTGTG
OPTION 3 114 CTGGCG 135 TGCTGTG
Figure 3.11. Transcriptional promoters of the putative phrA  gene.
Stop
1168 A TAT TGA GTC 
TATA ACT CAG
1223 CGG TTC GA 
GCC AAG CT
—>
1193 CGC GGA GGC GGC CT«T AGC ACC CTCTCC 
GCG CCT CCG CCG GA«A TCG TGG GAG AGG
Figure 3.12. Termination Sequence for the putative phrA  gene.
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TRANSLATIONAL SIGNALS
Translational signals also have consensus sequences, originally proposed by Shine and 
Dalgamo (1974) for the ribosome-binding site. This consists of a consensus sequence 3- 
9bp in length and 3-1 lbp 5' from the mRNA start site (Sambrook et al, 1989). At 
position 144-146, the sequence AGG is found. This is the same ribosome-binding site as 
found in the trpA gene (Platt and Yanotsky, 1975). This ribosome-binding site is found 5 
nucleotides prior to the initiator methionine of the gene. Translation of the gene 
terminates at a UGA corresponding to the TGA at nucleotides 1172-1174 in the DNA 
sequence - see Figure 3.5.
CODON USAGE
Use of synonymous codons in structural genes is non-random. In E.coli the frequency of 
use of different synonymous codons is directly related to the abundance of cognate 
tRNAs (Ikemura, 1981). The significance of this observation is not known; however it 
has been noted that rarely used codons appear less frequently in highly expressed genes 
than in genes which are expressed at a low level (Ikemura, 1981, Konigsberg and 
Godson, 1983). It has been proposed that codon usage affects the efficiency of translation 
and therefore the level of gene expression. Using the same analysis technique used by 
Sancar et al (1984b) comparing the codon usage in phrB to that in 25 non-regulatory 
proteins from E.coli (Konigsberg and Godson, 1983), it can be seen that there is a 
definite bias in favour of the use of rare and infrequent codons in the putative phrA  gene. 
The frequency of synonym usage is actually reversed (i.e. an infrequently used synonym 
in E.coli non-regulatory proteins becomes the most frequently used) for Phe, Gly, His, 
lie, Asn, Arg, Ser, Thr, Val, and Tyr. Also the usage of the rare codons AUA (lie), UCG 
(Ser), CCU and CCC (Pro), ACG (Thr), CAA (Gin), AAU (Asn), and AGG (Arg) is 
increased, to a level o f 9.7% of the total codon usage, in comparison to that in phrB of 
7.8% and 4% in the 25 non-regulatory proteins. See Table 3.2.
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ALA (A) GCU 7 29 28 ASN (N) aaur 7 58 24
GCC 7 29 19 AAC 5 42 76
GCA 4 17 23 PRO (P) CCUR 3 17 9
GCG 25 30 COCR 10 6
CYS (C) UGU 1 SO 42 CCA 3 17 20
UGC I SO 58 CCG 10 56 65
ASP(D) GAU 19 86 51 GLN(Q) ca a r 8 36 27
GAC 3 14 49 CAG 14 64 73
GLU(E) GAA 12 60 73 ARO(R) CGU 7 35 58
GAG 8 40 27 CGC 9 45 35
PHE (F) u uu 6 60 44 CGA 3 IS 2
u u c 4 40 56 CGO 1 5 3
GLY (G) GGU 7 30 47 J AGA 0 0 1
GGC 11 48 40.3 aggr 0 0 0.25
GGA 3 13 5 SER(S) UCU 2 9 27
GGG 9 7 UCC 2 9 26
HIS (H) CAU 8 67 39 UCA 2 9 8
CAC 4 33 61 u c g r 6 26 11
ILE(D AUU 14 70 37 AGU 4 17 6
AUC 5 25 62 AGC 7 30 22
auar 1 3 1 THR(T) ACU 4 29 24
LYS(K) AAA 7 88 77 ACC 3 21 51
AAG 1 12 23 ACA 1 7 6
LEU(L) UUA 5 10 6.1 acg r 6 43 20
UUG 7 14 8 VAL (V) GUU 6 23 38
CUU 10 20 9 GUC 6 23 13
cue 7 14 7 GUA 1 4 23
CUA 1 2 2 GUG 13 50 27
CUG 19 40 69 TRP(W) UGG 5 100 100
MET CM) AUG 1 100 100 TYR(Y) UAU 6 67 41
UAC 3 33 59
Table 3.2. Codon usage in the putative phrA  gene compared with that 
in 25 Escherichia coli non-regulatory genes.
R indicates rare codons in Escherichia coli.
It has been shown (Sancar et al., 1984b) that under inducing conditions, this bias in 
favour of infrequently used or rare codons results in reduced amounts of protein being 
produced, in comparison with a gene that utilises more commonly used codons. It is
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therefore predicted that the level of the putative phrA gene product in E.coli in its natural 
state is very low. The occurrence of the phrB gene product in the natural state is only 
about 10 molecules of photolyase per cell (Harm et al., 1968). If this is regulated by the 
degree of rare codon usage, predicted as 7.8%, then the occurrence of the putative phrA  
gene product, with a predicted rare codon usage of 9.7%, is likely to be in the order of 
one to two molecules per cell. This could help to explain the relatively small effect that 
the putative phrA  gene contributes to the rate and extent of photoreactivation.
It is also predicted that engineering the over-expression of the putative phrA  gene 
product is likely to be difficult. If the rate of production of the protein is limited in the 
natural state by the intracellular levels of the tRNAs corresponding to the rare or 
infrequently used codons, then even by cloning the gene into an efficient expression 
vector with a strong promoter and ribosome-binding site, the level of protein may still be 
small. This was the next step in the study, and is discussed in Chapter 4.
COMPARISON WITH SUTHERLANDS phrA  ENZYME
Snapka and Sutherland (1980) reported the purification and properties of a PRE from 
E.coli with a molecular weight of 36,800Da, later revised to slightly less than 40kDa 
(Sutherland et al., 1986). This was claimed to be the phrA  gene product. The reported 
amino acid composition of this enzyme is very different from the theoretical amino acid 
composition of our putative phrA  gene product, predicted from the sequence obtained in 
this study.
The photoreactivating enzyme isolated by Snapka and Sutherland (1980) consists o f 298 
amino acids, with the absence of any tryptophan residues. The protein predicted from the 
putative phrA  gene would consist of 340 amino acids, with 5 tryptophan residues. The 
molecular weights of the two proteins are very similar, though this is unlikely to be of 
any significance.
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This would suggest that the enzyme studied by Sutherland and co-workers, and later by 
Hejmadi and Verma (1987) and Verma et al. (1990), is a different enzyme from that 
responsible for the activity studied in our laboratory at Bath.
There is a possibility that if the putative phrA. gene product does bind to pyrimidine 
dimers in vivo then repair could proceed via a tryptophan-mediated photolysis of the 
dimers - see Section 1.3.3. However, this is an unlikely explanation for the 
photorecovery seen with AS46 /  pASOl (Smith and Moss, 1988) as this type of 
photoreactivation is not observed with wavelengths of photoreactivating light greater 
than 300nm (Sutherland and Griffin, 1980). The photoreactivating light used in our 
laboratory has no significant transmission properties below 340nm - see Figure 2.4.
It was hoped that the work on both the expression of the gene product of the putative 
phrA  gene (Chapter 4) and the in vivo photoreactivation experiments would shed more 
light on the above points.
In conclusion, sequencing the insert from pASOl shows there is an open reading frame 
present which codes for a protein of approximately 40kDa. These were termed the 
putative phrA  gene and the putative phrA  gene product respectively. This work would 
suggest that the photorecovery seen when pASOl is transformed into the repair-deficient 
strain AS46 (Smith and Moss, 1988), is due to the protein produced from the gene 
present on the insert present on that plasmid.
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CHAPTER FOUR
EXPRESSION OF THE GENE PRODUCT
4.1 INTRODUCTION
Having sequenced the insert from pASOl, and identified a potential open reading frame 
coding for a protein of approximately 40kDa, the next step was to try and over-express 
this protein. Work in our laboratory with the maleate dehydrogenase gene (mdh) cloned 
into plasmid vector pUC19, termed plasmid pAH13, had showed over-production of the 
enzyme when cultures of JM83 /  pAH13 had been induced with ImM IPTG (A.H. Ahmed 
- unpublished results). Thus the starting point for this part of the work was attempting to 
try and induce over-production of the gene product from plasmid pNDOl to a level that 
could be detected using SDS - PAGE techniques.
4.2 METHODS
The induction and expression techniques and the use of SDS - PAGE to analyse the 
results have already been described in Chapter 2.
Other relevant methods are described in detail in the following section.
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4.3 RESULTS
In all of the induction /  expression experiments, cultures of JM83 /  pAH13 induced with 
ImM IPTG were used as a positive control - see Section 4.3.8. This was to show that the 
experimental conditions were conducive to induction of a gene product using IPTG, as it 
was predicted that it would be difficult to express the putative phrA  gene product - see 
Section 3.4.
4.3.1 INDUCTION OF pNDOl AND pND02
Overnight cultures of JM83 /  pNDOl and JM83 /  pND02, with JM83 /  pUC19 and JM83 
used as controls, were grown up in LB broth supplemented with 100|ig/ml ampicillin and 
50|ig/ml streptomycin. Induction cultures were prepared as described in Section 2.4.1. 
The cultures were grown over a 24 hour period and sampled at different time intervals as 
described in Section 2.4.1. The samples were treated as described in Section 2.4.2. A SDS 
polyacrylamide gel was prepared as described in Section 2.4.3 and 5pl of marker loaded 
onto the first lane of each gel. 5|il of each sample was then loaded onto the remaining 
lanes of the gels, and the gel run for approximately 60 minutes, until the blue marker in the 
loading buffer had reached the bottom of the gel. The gel assembly was disassembled, the 
gel stained and destained as described in Section 2.4.4. The results are shown in SDS-PA 
Gels 4 .1 to 4.4. The sizes of the molecular weight markers are, in decreasing size, 97,400 
Da, 66,200 Da, 45,000 Da, 31,000 Da, 21,500 Da and 14,400 Da.
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SDS-PA Gel 4.1. JM83 / pNDOl induced with ImM IPTG over 24hrs.
Lane 1, Markers; Lane 2, 2hrs; Lane 3, 4hrs; Lane 4, 6hrs; Lane 5, 12hrs; Lane 6, 24hrs








SDS-PA Gel 4.2. JM83 /  pND02 induced with ImM IPTG over 24hrs.
Lane 1, Markers; Lane 2, 2hrs; Lane 3 ,4hrs; Lane 4, 6hrs; Lane 5, 12hrs; Lane 6, 24hrs
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SDS-PA Gel 4.3. JM83 /  pUC19 induced with ImM IPTG over 24hrs.
Lane 1, Markers; Lane 2, 2hrs; Lane 3, 4hrs; Lane 4, 6hrs; Lane 5 , 12hrs; Lane 6, 24hrs
: • ! « « !
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SDS-PA Gel 4.4. JM83 induced with ImM IPTG over 24hrs.
Lane 1, Markers; Lane 2, 2hrs; Lane 3, 4hrs; Lane 4, 6hrs; Lane 5, 12hrs; Lane 6, 24hrs
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4.3.2 SUB-CLONING OF THE PUTATIVE GENE INTO AN 
EXPRESSION VECTOR - PART I
Due to the failure to show any expression of the gene product from pNDOl, the next step 
was to sub-clone the insert containing the putative phrA  gene into a specialist expression 
vector. The chosen expression vector was pKK223-3 (Brosius and Holy, 1984) which was 
purchased from Pharmacia - see Figure 4.1. pKK223-3 contains the strong tac promoter 
which, in an appropriate host such as JM105 (Yanisch-Perron et al, 1985), is regulated by 
the lac repressor and induced by the addition of IPTG to the medium. Immediately 
downstream of the tac promoter is the pUC8 multiple cloning site and the strong rrriB 
ribosomal terminator, which stabilises this vector-host system by inhibiting read-through 
transcription initiated from the tac promoter in the parent plasmid. Genes containing a 
ribosome-binding site and an ATG start codon may be expressed by insertion into the PstI 
or Hindm sites. The ribosome-binding site on the plasmid can be utilised to express inserts 
cloned into the EcoRI site if the start codon is within 10-15 base pairs from the ribosome- 
binding site. Plasmid pKK223-3 was transformed into competent cells of JM105 as 
described in Section 2.2.10.
The initial approach was to utilise the tac promoter on the expression vector and the 
ribosome-binding site located in front of the putative gene. This approach was chosen 
because :- a) it was a much simpler and quicker cloning procedure than trying to insert 
the ORF of the putative gene in position to utilise the ribosome-binding site on the 
expression vector, and b) it would test the 'efficiency1 of the proposed ribosome-binding 
site 'AGG'.
By taking a PstI - HindHI restriction fragment from pND02 and inserting it into the 
expression vector pKK223-3 digested with PstI and Hindin, the putative gene would be 
inserted in the correct orientation with the tac promoter.
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Figure 4.1 Plasmid expression vector pKK223-3, showing the important features.
PREPARATION OF THE Pstl-HindEI RESTRICTION FRAGMENT FROM pND02 
Plasmid pND02 was isolated and purified as described in Section 2.2.2. 20|ig of pND02 
plasmid DNA was digested with an excess of restriction enzymes PstI and Hincffll for 2 
hours at 37°C to ensure complete digestion. The resulting Pstl-Hindlll restriction 
fragment was isolated and purified as described in Section 2.2.6. The concentration of the 
purified fragment DNA was calculated as described in Section 2.2.3.
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PREPARATION OF VECTOR DNA
Plasmid pKK223-3 was isolated and purified as described in Section 2.2.2. The 
concentration of the purified plasmid DNA was calculated as described in Section 2.2.3. 
10|ig of pKK223-3 plasmid DNA was digested with an excess of restriction enzymes PstI 
and Hindlll for 2 hours at 37°C to ensure complete digestion. Half the sample was run on 
an agarose gel to confirm that digestion had taken place. The restriction enzymes were 
inactivated by incubating at 85°C for 30 minutes, then allowing the reaction mixture to 
cool at room temperature for 30 minutes.
The pKK223-3 /  PstI /  Hindlll restricted DNA was treated with Alkaline Phosphatase to 
dephosphorylate the sticky ends of the linear DNA, to prevent self-ligation, as described in 
Section 2.2.7. The Alkaline Phosphatase was inactivated by incubating at 85°C for 15 
minutes, then allowing the reaction mixture to cool at room temperature for 30 minutes.
LIGATION OF INSERT AND VECTOR DNA
The insert DNA was ligated to the vector DNA in the following ligation mixture
This reaction mixture was incubated at 45°C for 5 minutes to melt any cohesive bonds that 
had formed, then cooled on ice for 5 minutes. Then the following were added
pKK223-3 /  PstI /  Hindlll sO .ljig  
= 0.15|ig 
to l \ i \
PstI - H in d lll  Restr ic tio n  fr a g m en t
Sterile DDDW
BUFFER (10x CONCENTRATE) 
ATP (lOmM)





This was mixed by vortexing, spun down and incubated at 15°C overnight (a minimum of 
6  hours).
Two separate ligation mixtures were set up, termed LIGATION A and LIGATION B. 
PRODUCTION OF COMPETENT JM105 CELLS
Fresh competent cells of JM105 were prepared as described in Section 2.2.9. These were 
stored at 4°C for 16 hours and then used for transformation.
TRANSFORMATION OF LIGATION MIXTURE INTO JM105 
Transformation of the competent JM105 cells with the ligation mixture was performed as 
described in Section 2.2.10. The 12 hour liquid culture was streaked out onto LB /  amp 
plates and incubated at 37°C for 48 hours. Growth was seen on plates from LIGATION A 
and LIGATION B.
CONTROLS
The following controls were performed alongside the proper ligation mixture
a) LIGATION M IX-NO ENZYME
The T4  DNA ligase was omitted from the ligation mixture. No growth was seen after 
incubation in the LB /  amp broth after 12 hours at 37°C or after streaking onto LB /  amp 
plates after incubation for 48 hours at 37°C.
b) LIGATION MIX - NO INSERT DNA
The Pstl-Hindlll restriction fragment was omitted from the ligation mixture. Growth was 
seen after incubation in the LB /  amp broth after 12 hours at 37°C and after streaking onto 
LB /  amp plates after incubation for 48 hours at 37°C. Restriction analysis showed the 
plasmid present to be indistinguishable from pKK223-3.
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c) TRANSFORMATION MIX - NO LIGATION MIX
No ligation mixture was added to the competent cells of JM105, which then underwent 
the transformation procedure. No growth was seen after incubation in the LB /  amp broth 
after 12 hours at 37°C or after streaking onto LB /  amp plates after incubation for 48 
hours at 37°C.
d) COMPETENT CELLS - VIABILITY TEST
The competent cells of JM105 were streaked out on LB, LB /  amp and LB /  str plates and 
incubated at 37°C for 48 hours. No growth was seen on LB /  amp plates, while growth 
occurred on the LB and LB /  str plates.
4.3.3 ANALYSIS OF THE NEW PLASMIDS
Plasmid DNA was isolated from individual colonies in batches of twelve as described in 
Section 2.2.2. The plasmids were restricted with restriction enzyme EcoRI and then 
loaded onto an agarose gel and run for 90 minutes, using pKK223-3 /  EcoRI as a control. 
Plasmids which showed up on the gel to be heavier than pKK223-3 were then restricted 
with restriction enzymes PstI and Hindlll to see if the insert DNA could be cut out of the 
plasmids. This proved to be the case for all plasmids tested. These plasmids were then 
restricted with restriction enzymes SphI and Hindlll + EcoRV to test for the same insert 
as in pASOl. This test was positive for all plasmids tested - see Agarose Gel 4.1. This new 
plasmid was termed pND03 - see Figure 4.2.
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*Agarose Gel 4.1. Restriction digests of plasmids pND03, pND04 and pKK223-3.
Lane 1, >X>NA /  Hindlll; Lane 2, pND03 /  PstI + Hindlll;
Lane 3, pND04 /  PstI + Hindlll; Lane 4; pKK223-3 /  PstI + Hindlll;
Lane 5, pND03 /  HindlH + EcoRV; Lane 6, pND04 /  Hindlll + EcoRV;
Lane 7, pND03 /  SphI; Lane 8, pND04 /  Sphl.
The above protocol was also used to produce the control plasmid with the insert 
containing the gene in the reverse orientation. The only difference was that the PstI - 
Hindlll restriction fragment used was isolated from pNDOl instead of pND02. The 
restriction analysis used on the resulting transformant plasmids was the same as above, but 
different sized fragments were produced upon restriction analysis with restriction enzymes 
Hindlll and EcoRV - see Agarose Gel 4.1. This new plasmid was termed pND04 - see 
Figure 4.3. The purpose of the control plasmid pND04 was to check that no protein was 















Figure 4 3 . Plasmid pND04, showing the important features.
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4.3.4 INDUCTION OF pND03 AND pND04
Overnight cultures of JM105 /  pND03 and JM105 /  pND04, with JM105 /  pKK223-3 and 
JM105 used as controls, were grown up in LB broth supplemented with lOOpg/ml 
ampicillin and 50}ig/ml streptomycin. Induction cultures were prepared as described in 
Section 2.4.1. The cultures were grown over a 24 hour period and sampled at different 
time intervals as described in Section 2.4.1. The samples were treated as described in 
Section 2.4.2. A SDS polyacrylamide gel was prepared as described in Section 2.4.3 and 5 
pi of marker loaded onto the first lane of each gel. 5pl of each sample was then loaded 
onto the remaining lanes of the gels, and the gel run for approximately 60 minutes, until 
the blue marker in the loading buffer had reached the bottom of the gel. The gel assembly 
was disassembled, the gel stained and destained as described in Section 2.4.4. The results 
are shown in SDS-PA Gels 4.5 to 4.8.








SDS-PA Gel 4.5. JM105 / pND03 induced with ImM IPTG over 24hrs.
Lane 1, Markers; Lane 2, 2hrs; Lane 3 ,4hrs; Lane 4, 6hrs; Lane 5, 12hrs; Lane 6, 24hrs
- f i i i f
1 2 3 4 5 6
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SDS-PA Gel 4.6. JM105 /  pND04 induced with ImM IPTG over 24hrs.
Lane 1, Markers; Lane 2, 2hrs; Lane 3, 4hrs; Lane 4, 6hrs; Lane 5, 12hrs; Lane 6, 24hrs
f l l H
5 * a 1 1
1 2 3 4 5 6







i i * • I
LANE NUMBERS 1 2 3 4 5 6
SDS-PA Gel 4.7. JM105 / pKK223-3 induced with ImM IPTG over 24hrs.
Lane 1, Markers; Lane 2, 2hrs; Lane 3, 4hrs; Lane 4, 6hrs; Lane 5, 12hrs; Lane 6, 24hrs
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SDS-PA Gel 4.8. JM105 induced with ImM IPTG over 24hrs.
Lane 1, Markers; Lane 2, 2hrs; Lane 3, 4hrs; Lane 4, 6hrs; Lane 5, 12hrs; Lane 6, 24hrs
4 .3 .5  SUB-CLO NING  OF THE PUTATIVE GENE INTO A N  
EXPRESSIO N VECTOR - PART B
Due to the failure to show any major expression of the gene product from pND03, the 
next step was to place the open reading frame of the putative phrA  gene in frame with the 
promoter and the ribosome-binding site of the expression vector, pKK223-3. This 
involved inserting the gene in the EcoRI site on pKK223-3 so that the initiation codon 
ATG was between 10 to 15 base pairs downstream (3') to the ribosome-binding site on 
pKK223-3 - see Figure 4.4.
^ i a i i
1 2 3 4 5 6
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RIBOSOME 




AACA CCGG GTCGAC CC
4586 4554
Figure 4.4. The ribosome-binding site and polycloning site of pKK223-3.
There is no EcoRI site in the insert DNA from pASOl, and no obvious restriction site to 
achieve easy cloning. The plan decided upon involved producing a large quantity of the 
insert DNA from plasmid pND02, plus parts of the polycloning site from pUC19 at either 
end, by the Polymerase Chain Reaction (PCR) method so a partial digest of this fragment 
DNA with NlaTV (which cuts the insert twice, once just downstream of the ATG start 
codon and once in the middle of the putative phrA  gene) could be achieved, then isolating 
the fragment with the cut just downstream of the ATG start codon. This fragment DNA 
was ligated to a synthetic oligonucleotide specially prepared to match the portion of the 
gene, including the ATG start codon, which had been removed by the restriction enzyme, 
NlaTV, and also including an engineered EcoRI site at the 5' end. This fragment was then 
reduced by restriction cleavage with restriction enzymes EcoRI and Hindlll and inserted 
into the expression vector, pKK223-3, previously restricted with the same two restriction 
enzymes - see Figure 4.5.
PCR PRODUCTION OF A DNA FRAGMENT CORRESPONDING TO THE INSERT 
FROM PLASMID pND02
Two synthetic primers from both ends of the insert from plasmid pND02, one forward (51 
end) and one reversed and complemented (3' end), were prepared and purified as 
described in Section 2.2.12.
122
Forward primer 20-mer TCT AGA GTC GAC CTG CAG GC
Reverse primer 20-mer ACG CCA AGC TTG CAT GCG TC
The concentration of the purified primers were calculated as described in Section 2.2.3, 
and diluted to approximately O.lp.g/p.1 with sterile DDDW. Plasmid pND02 was isolated 
and purified as described in Section 2.2.2, the concentration of the purified plasmid DNA 
calculated as described in Section 2.2.3, and diluted to approximately l.Ong/fil with sterile 
TE (pH8.0). The following reaction mixture was then set up :-
P lasm id  pND02 DNA (lng/jil) lOjal
F o r w a rd  P rim er (0. lp.g/p.1) 10|xl
R everse  Prim er (0. l|ig/|il) 10^1
dNTPs (5mM) 5fil
Buffer (IOx concentrate) 10|il
S te r i le  DDDW 55|il
A couple of drops of PCR oil (sigma) were added on top of the reaction mixture to reduce 
evaporation, then 0.5|il Taq DNA Polymerase was added, mixed by vortexing briefly, and 
spun down. The tube containing the reaction mixture was placed in the heating block of a 
DNA Thermal Cycler (perkin elm er cetu s). The PCR reaction was initiated using the 
following heat and time settings pre-programmed in the memory of the DNA Thermal 
Cycler :-
D e n a tu r in g  Step  94°C for 60 seconds, then,
A n n ea lin g  S tep  50°C for 90 seconds, then,
P o ly m e r isa t io n  Step  72°C for 120 seconds, then repeat.
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Figure 45 . Diagram showing the steps involved in the production of pND05.
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The PCR reaction was programmed for 30 cycles, then the DNA Thermal Cycler cooled 
the reaction mixture to 4°C. The reaction mixture was extracted with an equal volume of 
chloroform : iso-amyl alcohol (24:1) to remove the PCR oil. The upper aqueous layer was 
carefully transferred to a new microcentrifuge tube and 1ml of 96% ethanol (-20°C) added 
to precipitate the DNA. The contents were vortexed for 20 seconds, then incubated for 60 
minutes at -20°C. The DNA was pelleted by centrifugation at full speed for 5 minutes, 
then the supernatant carefully discarded. The pellet was carefully rinsed with 70% ethanol 
(room temperature), briefly spun on the centrifuge for 1 minute and the supernatant 
carefully removed. The DNA pellet was dried by placing in a vacuum desiccator for 2 
minutes and air drying at room temperature for 5 minutes. The DNA was redissolved in 30 
[il o f TE (pH 8.0 containing DN-ase free RN-ase 20|ig/ml). The contents were briefly 
vortexed, spun down and stored at -20°C. The concentration of the PCR fragments was 
calculated as described in Section 2.2.3. The size of the PCR fragments was identified by 
running a sample on a 0 .8% agarose gel, which confirmed the major fragment to be 
approximately 1200bps. The nature of this major fragment was checked by restriction 
analysis with restriction enzyme EcoRV.
PARTIAL DIGESTION OF THE PCR FRAGMENT WITH NlalV
The theoretical nature of the 1223bp major PCR fragment is shown in Figure 4.6.
NdvanE
/flSTCGCA/OCCTG
13 19 124 129 402 670 1207 1213
PstI Sphl ATG NlalV NlalV EcoRV Sphl HlndU
J I___________________________ I_____ l_________________l_______________I_________________ I___L
Primer Primer
1-20 1204-1223
Figure 4.6. Diagram of the major PCR fragment, showing the important features.
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The next step was to perform a partial digest of the 1223bp DNA fragment with 
restriction enzyme NlaTV at position 129, but not at position 402. NlaTV cuts DNA 
leaving blunt-ended fragments. Restriction enzyme NlalV, BSA (lOOx concentrate) and 
N4 Buffer (lOx concentrate) were purchased from n ew  En g l a n d  b io l a b s .
The following reaction mixture was set up
PCR F r a g m e n t  (1.5p.g/jil) 10 |il
B u ffe r  (lOx c o n c en tr a te) 2jxl
BSA (100X  CONCENTRATE) 0 .2 fil
N la lV  (lunit/jxl) lp,l
S terile DDDW 6.8fxl
This was incubated on ice for 10 minutes, then 3jil of Gel-Loading Buffer added and 
mixed. A sample was run on a 1.5% agarose gel - see Agarose Gel 4.2, which showed 
three major fragments one = 1200bp, one = llOObp, and one = 800bp; which 
corresponded to undigested DNA, digested DNA at site 129, and digested DNA at site 
402 respectively - see Figure 4.6. The fragment of = llOObp was the desired piece of 
DNA.
This fragment was isolated and purified as described in Section 2.2.6. The concentration 
of the purified DNA was calculated as described in Section 2.2.3.
PREPARATION OF THE SYNTHETIC OLIGONUCLEOTIDE LINKER 
The linker was designed to be a mirror-image from the middle of the EcoRI site, so that 
whichever end ligated to the blunt-end of the partial NlalV-digested PCR fragment, it 
would leave the ATG start codon 3' of the EcoRI site - see Figure 4.7.
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Agarose Gel 42 . Restriction digests of plasmid pND02 and the PCR fragment 
Lane 2, ADNA / Hindlll; Lane 3, pND02 / BamHI + Hindlll;
Lane 4; PCR fragment /  NlaTV; Lane 5, PCR fragment /  NlalV;
Lane 6, ADNA / Hindlll.
Two synthetic oligonucleotides (20-mers) were prepared and purified as described in 
Section 2.2.12. The concentration of the purified oligonucleotides were calculated as 
described in Section 2.2.3, and diluted with sterile DDDW to approximately 2}ig/}il. 50p.l 
of each oligonucleotide were combined in a fresh microcentrifuge tube, so that the 
oligonucleotides would hybridise to form a double-stranded piece of DNA. The 
concentration of the linker was calculated as described in Section 2.2.3.
127
START CODON
TC CGA CAT GAA TTC ATG TCG GA
AG GCT GTA CTT AAG TAC AGC CT
START CODON
Figure 4.7. Diagram of the synthetic oligonucleotides, showing the important features.
ENZYMATIC PHOSPHORYLATION OF THE NON-PHOSPHORYLATED LINKER 
Only phosphorylated molecules are substrates for bacteriophage T4 DNA ligase, so the 
non-phosphorylated linker required treatment with bacteriophage T4 polynucleotide 
kinase and ATP, before it could be joined to DNA. The following reaction mixture was set
The reaction mixture was incubated at 37°C for 90 minutes. The bacteriophage T4 
polynucleotide kinase was inactivated by incubating the reaction mixture at 65°C for 10 
minutes, then allowing the reaction mixture to cool at room temperature for 15 minutes 
(S. Pearson, Pharmacia - Personal Communication). The phosphorylated linker was now 
ready for attachment to the partial NlaTV digested PCR fragment.
up:-
Lin k e r D N A  (2.9|ig/|xl)
B u f f e r  (lOx c o n c e n t r a t e )
ATP (lOmM)
B a c ter io ph ag e  T4 P o l y n u c l e o t id e  Kin a se  ( 10U/p,l) 







LIGATION OF THE PHOSPHORYLATED LINKER TO THE BLUNT-ENDED 
FRAGMENT FROM THE PARTIAL NlalV DIGEST 
The following ligation mixture was set up :-
B l u n t -E n d e d  DNA (0.15pg/p,l) 2|xl
Ph o sph o r y l a t e d  Lin k er  (0.2p,g/p,l) 5.5pl
ATP (lOmM) ljil
B u ffe r  ( lOx c o n c e n t r a t e ) 2pl
These were all mixed at 0°C, then the following added at room temperature :-
PEG 8000 (40%w/v) 7.5pl
T4 DNA L ig a se  (8U/jx1) 2|il
The ligation mixture was incubated at 20°C for 8 hours. The ligase enzyme was then 
inactivated by incubating the reaction mixture at 65°C for 20 minutes, then allowing the 
reaction mixture to cool at room temperature for 30 minutes.
RESTRICTION ENZYME DIGESTION OF THE NEW DNA FRAGMENT 
The following reaction mixture was set up :-
Ligation M ixture 20j l l 1
B uffer  (1 Ox  concentrate) 20jxl
S t e r i le  DDDW 53jxl
EcoRI (25U /pl) 4jil
H ind lll (15U/jxl) 3|xl
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This was incubated at 37°C for 4 hours, then an extra 2 fil of EcoRI and l|xl of Hindin 
were added, and the reaction mixture incubated at 37°C for a further 60 minutes. After 
incubation, 2pl of 0.5M EDTA (pH 8.0) was added to the reaction mixture, mixed by 
vortexing, and spun down. 200jxl of phenol : chloroform : isoamyl alcohol (25 : 24 : 1) 
was added to the reaction mixture, mixed by vortexing, and centrifuged at full speed for 3 
minutes. The upper aqueous layer was carefully transferred to a fresh microcentrifuge 
tube. The restriction fragment was purified by spun-column chromatography, to remove 
smaller fragments of DNA which would interfere with the subsequent ligation reaction. A 
Sephacryl S-400 column (Ph arm acia) was prepared in accordance with the manufacturers 
instructions. 50pl of the reaction mixture was slowly pipetted onto the flat upper surface 
of the compacted bed of the column, and the column centrifuged for 2 minutes at 1500 
rpm. The eluted solution contained the purified DNA restriction fragment in 
approximately 50|il of TE (pH 8.0) buffer. The DNA was precipitated by addition of 10|il 
of 3M sodium acetate solution and 220|il of 96% ethanol (-20°C), then incubated at -20°C 
for 2 hours. The DNA was collected by centrifugation at full speed for 10 minutes. The 
supernatant was carefully removed, and the DNA rinsed with 200(il of 70% ethanol (room 
temperature), which was then carefully removed. The DNA was air-dried for 10 minutes, 
then redissolved in 8 |il of TE (pH 8.0). The DNA restriction fragment was now ready for 
ligation with pKK223-3.
PREPARATION OF VECTOR DNA
Plasmid pKK223-3 was isolated and purified as described in Section 2.2.2. The 
concentration of the purified plasmid DNA was calculated as described in Section 2.2.3. 
10|ig of pKK223-3 plasmid DNA was digested with an excess of restriction enzymes 
EcoRI and Hindlll for 2 hours at 37°C to ensure complete digestion. Half the sample was 
run on an agarose gel to confirm that digestion had taken place. The restriction enzymes
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were inactivated by incubating at 85°C for 30 minutes, then allowing the reaction mixture 
to cool at room temperature for 30 minutes.
The pKK223-3 /  EcoRI /  Hindlll restricted DNA was treated with Alkaline Phosphatase 
to dephosphorylate the sticky ends of the linear DNA, to prevent self-ligation, as described 
in Section 2.2.7. The Alkaline Phosphatase was inactivated by incubating at 85°C for 15 
minutes, then allowing the reaction mixture to cool at room temperature for 30 minutes.
LIGATION OF THE DNA FRAGMENT AND VECTOR DNA
The DNA fragment containing the phrA  gene was ligated to the vector DNA in the 
following ligation mixture
pKK223-3 /  EcoRI /  HindHI (= O.l^g/^il) l^il
F r a g m e n t  DNA /  EcoRI /  Hindlll (= 0.04[ig/|il) 6pl
This reaction mixture was incubated at 45°C for 5 minutes to melt any cohesive bonds that 
had formed, then cooled on ice for 5 minutes. Then the following were added
BUFFER (1 Ox CONCENTRATE) lp.1
ATP (lOmM) l^il
T4  DNA LIGASE (1 unit/^1) l[L\
This was mixed by vortexing, spun down and incubated at 16°C overnight (a minimum of 
6  hours).
Two separate ligation mixtures were set up, termed LIGATION A and LIGATION B.
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PRODUCTION OF COMPETENT JM105 CELLS
Fresh competent cells of JM105 were prepared as described in Section 2.2.9. These were 
stored at 4°C for 16 hours and then used for transformation.
TRANSFORMATION OF LIGATION MIXTURE INTO JM105 
Transformation of the competent JM105 cells with the ligation mixture was performed as 
described in Section 2.2.10. The 12 hour liquid culture was streaked out onto LB /  amp 
plates and incubated at 37°C for 48 hours. Growth was seen on plates from LIGATION A 
and LIGATION B.
CONTROLS
The following controls were performed alongside the proper ligation mixture :-
a) LIGATION M IX -N O  ENZYME
The T4  DNA ligase was omitted from the ligation mixture. No growth was seen after 
incubation in the LB /  amp broth after 12 hours at 37°C or after streaking onto LB /  amp 
plates after incubation for 48 hours at 37°C.
b) LIGATION M IX -N O  INSERT DNA
The EcoRI /  Hindlll digested DNA fragment was omitted from the ligation mixture. 
Growth was seen after incubation in the LB /  amp broth after 12 hours at 37°C and after 
streaking onto LB /  amp plates after incubation for 48 hours at 37°C. Restriction analysis 
showed the plasmid present to be the same as pKK223-3.
c) TRANSFORMATION MIX - NO LIGATION MIX
No ligation mixture was added to the competent cells of JM105, which then underwent 
the transformation procedure. No growth was seen after incubation in the LB /  amp broth
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after 12 hours at 37°C or after streaking onto LB /  amp plates after incubation for 48 
hours at 37°C.
d) COMPETENT CELLS - VIABILITY TEST
The competent cells of JM105 were streaked out on LB, LB /  amp and LB /  str plates and 
incubated at 37°C for 48 hours. No growth was seen on LB /  amp plates, while growth 
occurred on the LB and LB /  str plates.
4.3.6 ANALYSIS OF THE NEW PLASMID
Plasmid DNA was isolated from individual colonies in batches of twelve as described in 
Section 2.2.2. The plasmids were restricted with restriction enzyme EcoRI and then 
loaded onto an agarose gel and run for 90 minutes, using pKK223-3 /  EcoRI as a control. 
Plasmids which showed up on the gel to be heavier than pKK223-3 were then restricted 
with restriction enzymes EcoRI and Hindm to see if the insert DNA could be cut out of 
the plasmids. This proved to be the case for all plasmids tested. These plasmids were then 
restricted with restriction enzymes Sphl and Hindlll + EcoRV to test for the same insert 
as in pASOl - see Agarose Gel 4.3. This test was positive for all plasmids tested. This new 
plasmid was termed pND05 - see Figure 4.8.
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Agarose Gel 4.3. Restriction digests of plasmids pND05 and pKK223-3.
Lane 1, ADNA / Hindlll; Lane 2, pND05 /  EcoRI + Hindlll;
Lane 3, pKK223-3 /  EcoRI + HindHI; Lane 4; pND05 /  Sphl; Lane 5, pKK223-3 /  Sphl; 
Lane 6, pND05 /  Hindlll + EcoRV; Lane 7, pKK223-3 /  Hindlll + EcoRV.
4.3 .7  INDUCTIO N OF pN D 05
An overnight culture of JM105 /  pND05 was grown up in LB broth supplemented with 
100(ig/ml ampicillin and 50|ig/ml streptomycin. Induction cultures were prepared as 
described in Section 2.4.1. The cultures were grown over a 24 hour period and sampled at 
different time intervals as described in Section 2.4.1. The samples were treated as 
described in Section 2.4.2. A SDS polyacrylamide gel was prepared as described in 
Section 2.4.3 and 5|il of marker loaded onto the first lane of each gel. 5|il of each sample 
was then loaded onto the remaining lanes of the gels, and the gel run for approximately 60 
minutes, until the blue marker in the loading buffer had reached the bottom of the gel. The
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gel assembly was disassembled, the gel stained and destained as described in Section 2.4.4. 
The results are shown in SDS-PA Gel 4.9. Refer to SDS-PA Gels 4.7 and 4.8 for controls 








Figure 4.8. Diagram of pND05, showing the important features.
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SDS-PA Gel 4.9. JM105 /  pND05 induced with ImM IPTG over 24hrs.
Lane 1, Markers; Lane 2, 2hrs; Lane 3, 4hrs; Lane 4, 6hrs; Lane 5, 12hrs; Lane 6, 24hrs
As can be seen from comparing SDS-PA Gels 4.5 and 4.9, there seems to be no 
discernible difference between JM105 /  pND03 and JM105 /  pND05 under the 
experimental expression conditions used.
4 .3 .8  IN D U C TIO N  OF pA H 13
As stated at the beginning of Section 4.3, a positive control (JM83 /  pAH13, which 
contains the mdh gene inserted in the polycloning site of pUC19) was run alongside the 
test induction cultures, to show that the experimental expression conditions were 
conducive to over-producing a protein from a plasmid.
An overnight culture of JM83 /  pAH13 was grown up in LB broth supplemented with 100 
fig/ml ampicillin and 50p.g/ml streptomycin. An induction culture was prepared as 
described in Section 2.4.1. The culture was grown over a 24 hour period and sampled at
- • i Mi
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different time intervals as described in Section 2.4.1. The sample was treated as described 
in Section 2.4.2. A SDS polyacrylamide gel was prepared as described in Section 2.4.3 
and 5(il of marker loaded onto the first lane of each gel. 5|il of each sample was then 
loaded onto the remaining lanes of the gels, and the gel run for approximately 60 minutes, 
until the blue marker in the loading buffer had reached the bottom of the gel. The gel 
assembly was disassembled, the gel stained and destained as described in Section 2.4.4. 
The results are shown in SDS-PA Gel 4.10. Refer to SDS-PA Gels 4.3 and 4.4 for 
controls (JM83 /  pUC19 and JM83)








SDS-PA Gel 4.10. JM83 /  pAH13 induced with ImM IPTG over 24hrs.
Lane 1, Markers; Lane 2, 2hrs; Lane 3, 4hrs; Lane 4, 6hrs; Lane 5, 12hrs; Lane 6, 24hrs
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4.4 DISCUSSION
The attempt to over-express the putative ph rk  gene product from pNDOl involved the 
use of the promoter sequences and the ribosome-binding site identified 5' to the ATG start 
codon in Section 3.4. No protein band was identified in the region of the expected size of 
the putative ph rk  gene product, or in any other region, above the background protein 
bands of the two controls - see SDS-PA Gels 4 .1 ,4 .3  and 4.4. No protein band of any size 
was identified from the induction of pND02, above the background protein bands of the 
two controls - see SDS-PA Gels 4.2,4.3 and 4.4.
The attempt to over-express the putative ph rk  gene product from pND03 involved the 
use of the strong tac promoter on the pKK223-3 expression vector (Brosius and Holy, 
1984) and the ribosome-binding site identified 51 to the ATG start codon in Section 3.4. 
Again, no protein band was identified above the background protein bands of the two 
controls - see SDS-PA Gels 4.5, 4.7 and 4.8. No protein band of any size was identified 
from the induction of pND04, above the background protein bands of the two controls - 
see SDS-PA Gels 4.6, 4.7 and 4.8.
The attempt to over-express the putative ph rk  gene product from pND05 involved the 
use of the strong tac promoter and the ribosome-binding site on the pKK223-3 expression 
vector (Brosius and Holy, 1984). Again, no protein band was identified above the 
background protein bands of the two controls - see SDS-PA Gels 4.9, 4.7 and 4.8.
The predicted difficulties in over-expressing the putative phrk  gene product (see Section 
3.4) were thus encountered during this section of the study. In the three vector systems 
utilised to carry the putative phrk  gene (pNDOl, pND03 and pND05) there was no 
discernible expression o f the putative p h rk  gene product.
One possible explanation for this could be that the staining system used (Coomassie 
Brilliant Blue Stain) was not sensitive enough to pick up the low levels of the putative 
ph rk  gene product produced by the induction process. The smallest amount of protein
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that can be usually detected by staining with Coomassie Brilliant Blue is around 0.1 jig 
(Sambrook et al.y 1989). Staining with silver salts is approximately 100-1000 fold more 
sensitive than staining with Coomassie Brilliant Blue stain (Sambrook et al., 1989), and is 
capable of detecting as little as O.l-l.Ong of protein in a single band. This would have been 
the next step in the expression studies had time allowed. Also, running the samples on a 
larger gel using a larger gel apparatus, such as a P r o t e a n  II xi (bio-rad) dual slab cell for 
example, could show up lower levels of protein due to better separation of the gel bands. 
Another explanation could be that the inducing chemical (IPTG) was not functioning in 
the correct manner. The positive control experiments show that the IPTG used was 
functioning as an inducer under the experimental expression conditions used. IPTG, as 
well as having an inducing effect, can, at certain concentrations, act as an inhibitor of gene 
expression (S. Pearson, Pharmacia - Personal Communication). However, different 
concentrations of IPTG were tried for pND03 and pND05, between 0.1 - 5.0 mM IPTG in 
the final culture (results not shown). This produced no difference from the expression seen 
in SDS-PA Gels 4.5 and 4.9 at any of the concentrations tried. Therefore, this was 
unlikely to be the cause of the lack of expression of the putative phrk  gene product.
The results from the in vivo studies of pNDOl, pND03 and pND05 reported in Chapter 5 
cast an interesting light over the expression of the putative ph rk  gene product from these 
three vectors, suggesting that some increase in gene expression is taking place in these 
vectors. Therefore, the problems encountered in this section of the study, the likely causes 
and the possible remedies, will be discussed in more detail in Chapter 6 , during the final 
discussion of the work in this study.
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CHAPTER FIVE
U V-IRRADIATION AND 
PHOTOREACTIVATION STUDIES
5.1 INTRODUCTION
The initial aim of this part of the study was to try and reproduce the work of Smith (1987) 
(which showed photoreactivation of about 1 log cycle after UV-irradiation reduction of 4 
log cycles o f strain AS46 /  pASOl) with the plasmids produced in this study carrying the 
putative phrA  gene transformed into AS46, which is a phrA phrB mutant - see 
APPENDIX A. It has been proposed (Husain and Sancar, 1987a; Husain et al., 1988) that 
the photoreactivation seen in phrB mutants is due to Type III photoreactivation. This type 
of photoreactivation is characterised by a X max of 313nm with a narrow wavelength range 
(300nm to 360nm), and the absence of dose-rate and temperature effects - see Section 
1.3.5. Reference to Figure 2.4 shows the photoreactivating light used in this study would 
allow some Type m  photoreactivation to occur. Experiments to study the effects of 
changes in the temperature at which exposure to the photoreactivating light takes place, 
and changes in the fluence rate of the photoreactivating light, were carried out.
5.2 METHODS
The UV-irradiation, photoreactivation techniques and experimental conditions have 
already been described in Chapter 2.
Other relevant methods are described in detail in the following section.
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5.3 RESULTS
The first stage in this part of the study was to transform the plasmids produced in Chapter 
3 (pNDOl) and Chapter 4 (pND03) into the phrA phrB mutant, AS46. Plasmid pND05 
(Chapter 4) was not produced until much later on.
5.3.1 TRANSFORMATION OF AS46 WITH THE PLASMIDS 
PRODUCED IN THIS STUDY
For a valid comparison with the first results obtained for photoreactivation with the cloned 
putative phrA  gene (Smith, 1987; Smith and Moss, 1988), the phrA phrB mutant, AS46, 
was used as the host strain.
PREPARATION OF PLASMID DNA
Each plasmid was isolated and purified as described in Section 2.2.2. The concentration of 
the DNA was calculated as described in Section 2.2.3, and diluted with TE (pH 8.0) to 
give a final concentration of 0 .0 1 (ig/(il.
PRODUCTION OF COMPETENT AS46 CELLS
Fresh competent cells o f AS46 were prepared as described in Section 2.2.9. These were 
stored at 4°C for 16 hours and then used for transformation.
TRANSFORMATION OF PLASMIDS INTO AS46
Transformation of the competent AS46 cells with the plasmid DNA was performed as 
described in Section 2.2.10. The 12 hour liquid cultures were streaked out onto LB /  amp 
plates in duplicate, and incubated at 37°C for 48 hours. Growth was seen on all plates.
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ANALYSIS OF THE PLASMIDS
Plasmid DNA was isolated from individual colonies in batches of four as described in 
Section 2.2.2. The plasmids were restricted with restriction enzyme EcoRI and then 
loaded onto an agarose gel and run for 90 minutes, using the relevant stock plasmid, 
restricted with EcoRI, as a control. Plasmids which matched the size of the control 
plasmid were further analysed with relevant restriction enzymes to further confirm the 
validity of the plasmid in question.
5.3.2 INITIAL PHOTOREACTIVATION STUDIES
The initial photoreactivation studies were carried out at 25°C. Strains AS46 /  pNDOl and 
AS46 /  pND03 were studied using strains AS46 /  pUC19 and AS46 /  pKK223-3 as 
controls, respectively. It was hoped that AS46 /  pND03 would show a greater rate of 
photoreactivation than AS46 /  pNDOl, and maybe even a greater extent of recovery, due 
to better expression of the putative phrA  gene product in AS46 /  pND03. Although no 
discernible difference in the expression of the putative phrA gene product was detected 
during the expression studies (see Section 4.3), if the putative phrA  gene product was 
produced in only slighdy higher amounts in pND03 to pNDOl (even just two molecules 
per cell rather than one), a greater effect would be expected if the putative phrA  gene 
product is indeed photoactive.
SURVIVAL CURVES
Initial 254nm UV survival curves were produced for all organisms. 24 hour secondary 
cultures of each organism were grown up as described in Section 2.1.4, the cells harvested 
as described in Section 2.5.1, and irradiated to reduce the surviving fraction by 
approximately 4 log cycles in four doses as described in Section 2.5.2. The results are 
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Figure 5 3 . Survival Curve for UV-irradiated AS46/pND03 (■).
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Figure 5.4. Survival Curve for UV-irradiated AS46/pKK223-3 (■).
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PHOTOREACTIYATION
24 hour secondary cultures of both organisms were produced, harvested and irradiated as 
described above to reduce the surviving fraction to approximately 1 x 103 colony forming 
units per ml. The irradiated cells were incubated at 25°C for 20 minutes to allow any 
enzyme-substrate complexation to occur, then the cells were transferred to an illumination 
vessel which was placed in the temperature control unit. The irradiated cells were then 
exposed to photoreactivating light as described in Section 2.5.4 for a period of 120 
minutes at a constant temperature of 25°C, sampling at 30 minutes intervals. Unirradiated 
cells were also exposed to the photoreactivating light at the same time and samples taken 
at 30 minute intervals as well. A sample of irradiated cells were held in the dark at 25°C 
and samples taken at 30 minute intervals as well. The results are shown in Figures 5.5, 5.6, 
5.7 and 5.8. Throughout this work, all experiments were performed in triplicate, and one 
experiment presented in graphical form as a representative example.
The results show that all the strains studied showed a degree of recovery upon exposure 
to the photoreactivating light following UV irradiation, compared to the same UV- 
irradiated cells held in the dark. However, the strains carrying the phrA  gene (AS46 /  
pNDOl and AS46 /  pND03) showed a degree of recovery greater than that seen in the 
strains carrying the plasmid vector alone (AS46 /  pUC19 and AS46 /  pKK223-3). The 
data was analysed quantitatively by examining the mean increase in survival from the three 
sets of results for each experiment for each strain studied. This was calculated from the 
surviving fractions at T = 0 and T = 120, by measuring the logarithmic increase in S/So at 
T = 120 from T = 0 - see Table 5.1.
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STRAIN AND PHENOTYPE INCREASE IN SURVIVAL
A S46/ pNDOl (phrA+) 0.62 0 .0 2
AS46 /  pUC19 (phrA") 0.40 0.11
AS46 /  pND03 (phrA+) 0.84 0.07
AS46 /  pKK223-3 (phrA") 0.50 0.04
AS46 (phrA") 0.33 0.14
Table 5.1. Increase in mean survival after 120 minutes of photoreactivation at 25°C. 
These results suggested two important points
a) Strain AS46 is not totally photoreactivation-repair deficient as reported by Smith 
(1987), which is in keeping with the results published by Husain and Sancar (1987a), who 
suggested that no known E. coli strain was totally deficient in photoreactivation.
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Figure 5.5. Photoreactivation of UV-irradiated AS46/pND01 (■) at 25°C. The controls 
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Figure 5.6. Photoreactivation of UV-irradiated AS46/pUC19 (• )  at 25°C. The controls
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Figure 5.7. Photoreactivation of UV-irradiated AS46/pND03 (■) at 25°C. The controls 
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Figure 5.8. Photoreactivation of UV-irradiated AS46/pKK223-3 (•)  at 25°C. The
controls are UV-irradiated AS46/pKK223-3 (O) in the dark and unirradiated
AS46/pKK223-3 (A) in the photoreactivating light
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The same photoreactivation experiment as described above was performed with AS46, 
which also showed a degree of light-repair compared to dark-repair over a 120  minute 
period of exposure to photoreactivating light - see Figure 5.9 and Table 5.1. However, the 
degree of repair was no way near the level of 30% of the lethal damage reported by 
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Figure 5.9. Photoreactivation of UV-irradiated AS46 ( • )  at 25°C. The controls are UV- 
irradiated AS46 (O) in the dark and unirradiated AS46 (A) in the photoreactivating light
The rate and extent of repair in strain AS46 /  pND03 was higher over a 120 minute period 
of exposure to photoreactivating light than that seen in strain AS46 /  pNDOl - see Table 
5.1. Therefore in the following temperature and dose-rate studies, AS46 /  pND03 was 
used as the test strain and AS46 /  pKK223-3 used as the control strain.
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5.3.3 TEMPERATURE DEPENDENCE STUDIES
It has been claimed that the photoreactivation seen in phrB mutants is due to Type III 
photoreactivation (Husain and Sancar, 1987a). One of the features of Type III 
photoreactivation is the absence of the effect of temperature changes on the rate of 
recovery. Thus the photoreactivation experiments were performed at 37°C, 25°C and at 
10°C to see if temperature was a factor in the repair seen in strains AS46 /  pND03 and 
AS46 /  pKK223-3.
PHOTOREACTIVATION AT DIFFERENT TEMPERATURES
24 hour secondary cultures of both organisms were produced, harvested and irradiated as 
described above to reduce the surviving fraction to approximately 1 x 103 colony forming 
units per ml. The irradiated cells were incubated at 25°C for 20 minutes to allow any 
enzyme-substrate complexation to occur, then the cells were transferred to an illumination 
vessel which was placed in the temperature control unit and allowed to equilibrate to the 
experimental temperature for a further 5 minutes. The irradiated cells were then exposed 
to photoreactivating light as described in Section 2.5.4 for a period of 120 minutes, 
sampling at 30 minutes intervals. Unirradiated cells were also exposed to the 
photoreactivating light at the same time and samples taken at 30 minute intervals as well. 
A sample of irradiated cells were held in the dark at the experimental temperature and 
samples taken at 30 minute intervals as well. The results are shown in Figures 5.10, 5.7, 
5.11,5.12, 5.8 and 5.13.
The results showed that the temperature at which photoreactivation takes place had a 
dramatic effect on the rate and extent of repair of strain AS46 /  pND03 and very little 
effect on the rate and extent of repair of strain AS46 /pKK223-3 - see Table 5.2. This is 
discussed in Section 2.4.
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STRAIN AND PHENOTYPE INCREASE IN SURVIVAL
AS46 /  pND03 (phrA+) at 37°C 1.01 0.01
AS46 /  pND03 (phrA+) at 25°C 0.84 0.07
AS46 /  pND03 (phrA+) at 10°C 0.27 0.12
AS46 /  pKK223-3 (phrA-) at 37°C 0.50 0.12
AS46 /  pKK223-3 (phrA") at 25°C 0.50 0.04
AS46 /  pKK223-3 (phrA") at 10°C 0.26 0.19
Table 5.2. Increase in mean survival after 120 minutes of photoreactivation at different 
temperatures using a fluence-rate of 8.5Wnr2.
Using the increase in mean survival after 60 minutes instead of after 120 minutes, gives an 
indication of the increase in the rate of the photorecovery at 37°C compared to 25°C - see 
Table 5.3.
STRAIN AND PHENOTYPE INCREASE IN SURVIVAL
AS46 /  pND03 (phrA+) at 37°C 0.91 0.03
AS46 /  pND03 (phrA+) at 25°C 0.50 0.08
AS46 /  pKK223-3 (phrA') at 37°C 0.33 0.19
AS46 /  pKK223-3 (phrA") at 25°C 0.31 0.13
Table 5.3. Increase in mean survival after 60 minutes of photoreactivation at different 
temperatures using a fluence-rate of 8.5Wm-2
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Figure 5.10. Photoreactivation of UV-irradiated AS46/pND03 (■) at 37°C. The controls 
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Figure 5.11. Photoreactivation of UV-irradiated AS46/pND03 (■) at 10°C. The controls















Figure 5.12. Photoreactivation of UV-irradiated AS46/pKK223-3 ( • )  at 37°C. The 
controls are UV-irradiated AS46/pKK223-3 (O) in the dark and unirradiated 
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Figure 5.13. Photoreactivation of UV-irradiated AS46/pKK223-3 (•)  at 10°C. The
controls are UV-irradiated AS46/pKK223-3 (O) in the dark and unirradiated
AS46/pKK223-3 (A) in the photoreactivating light
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5.3.4 DOSE-RATE DEPENDENCE STUDIES
Another feature of Type III photoreactivation is the absence of dose-rate effects. Thus the 
photoreactivation of AS46 /  pND03 at 37°C and 25°C was performed using different 
fluences of photoreactivating light, using AS46 /  pKK223-3 as a control.
PHOTOREACTIVATION USING DIFFERENT FLUENCE RATES OF 
PHOTOREACTIVATING LIGHT
24 hour secondary cultures of both organisms were produced, harvested and irradiated as 
described above to reduce the surviving fraction to approximately 1 x 103 colony forming 
units per ml. The irradiated cells were incubated at 25°C for 20 minutes to allow any 
enzyme-substrate complexation to occur, then the cells were transferred to an illumination 
vessel which was placed in the temperature control unit and allowed to equilibrate to the 
experimental temperature for a further 5 minutes. The irradiated cells were then exposed 
to photoreactivating light for a period of 120 minutes, sampling at 30 minutes intervals. 
The comparative estimates of the fluence-rates were made using the calibrated thermopile 
as described in Section 2.5.4.
The fluence-rate of the photoreactivating light used in the Initial Photoreactivation Studies 
(see Section 5.3.2) was calculated as approximately 8.5Wnr2.
To decrease the fluence-rate of the photoreactivating light, the temperature control unit 
was moved further away from the light source, to give the approximate fluence-rates of 
5Wm2 and lWm"2.
To increase the fluence-rate of the photoreactivating light, the temperature control unit 
was moved closer to the light source, to give the approximate fluence-rate of 12Wnr2. 
Unirradiated cells were also exposed to the photoreactivating light at the same time and 
samples taken at 30 minute intervals as well. A sample of irradiated cells were held in the
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dark at the experimental temperature and samples taken at 30 minute intervals as well. The 
results are shown in Figures 5.14 to 5.21.
The results showed that at 37°C, reduction of the fluence-rate from approximately 
8.5Wnr2 to lWm-2 had very little effect on the rate or extent of repair of strain AS46 /  
pND03 or strain AS46 /pKK223-3 after 120 minutes of photoreactivation - see Figures 
5.14 and 5.15 and Table 5.4.
STRAIN AND PHENOTYPE INCREASE IN SURVIVAL
AS46 /  pND03 (phrA+) at 8.5Wnr2 1.01 0 .01
AS46 /  pND03 (phrA+) at lW nr2 0.96 0.02
AS46 /  pKK223-3 (phrA') at 8.5Wnr2 0.50 0.12
AS46 /  pKK223-3 (phrA") at lW nr2 0.45 0.09
Table 5.4. Increase in mean survival after 120 minutes of photoreactivation at different
fluence-rates at a temperature of 37°C.
However, using the increase in mean survival after 60 minutes instead of after 120 
minutes, shows there is a difference in the rate of the photorecovery at lWnr2 compared 
to 8.5Wnr2 - see Table 5.5.
STRAIN AND PHENOTYPE INCREASE IN SURVIVAL
AS46 /  pND03 (phrA+) at 8.5Wnr2 0.91 0.03
AS46 /  pND03 (phrA+) at 1 Wnr2 0.72 0.07
Table 5.5. Increase in mean survival after 60 minutes of photoreactivation at different
fluence-rates at a temperature of 37°C.
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At 25°C, reduction of the fluence-rate from approximately 8 .5Wnr2 to either lWnr2 or 
5Wnr2 had a dramatic effect on the rate and extent of repair of strain AS46 /  pND03 and 
very little effect on the rate and extent of repair of strain AS46 /  pKK223-3 - see Figures 
5.16 to 5.19. An increase of the fluence-rate from approximately 8 .5Wnr2 to 12Wnr2 
increased the rate and extent of repair of strain AS46 /  pND03, and had very little effect 
on the rate and extent of repair of strain AS46 /  pKK223-3 - see Figures 5.20 and 5.21. 
The changes in mean increase in survival are presented in Table 5.6.
STRAIN AND PHENOTYPE INCREASE IN SURVIVAL
AS46 /  pND03 (phrA+) at lW nr2 0.34 0.08
AS46 /  pND03 (phrA+) at 5Wnr2 0.51 0.17
AS46 /  pND03 (phrA+) at 8.5Wnr2 0.84 0.07
AS46 /  pND03 (phrA+) 12Wnr2 1.10  0.16
AS46 /  pKK223-3 (phrA') at lWnr2 0.45 0.18
AS46 /  pKK223-3 (phrA') at 5Wnr2 0.53 0.06
AS46 /  pKK223-3 (phrA') at 8.5Wnr2 0.50 0.04
AS46 /  pKK223-3 (phrA') at 12Wnr2 0.45 0.11
Table 5.6. Increase in mean survival after 120 minutes of photoreactivation at different
fluence-rates at a temperature of 25°C.
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Figure 5.14. Photoreactivation with a low fluence-rate (= lWnr2) of UV-irradiated 
AS46/pND03 (■) at 37°C. The controls are UV-irradiated AS46/pND03 (□ ) in the dark 
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Figure 5.15. Photoreactivation with a low fluence-rate (= lWnr2) of UV-irradiated 
AS46/pKK223-3 ( • )  at 37°C. The controls are UV-irradiated AS46/pKK223-3 (O) in the 
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Figure 5.16. Photoreactivation with a low fluence-rate (= lWm-2) of UV-irradiated 
AS46/pND03 (■) at 25°C. The controls are UV-irradiated AS46/pND03 (□) in the dark 
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Figure 5.17. Photoreactivation with a low fluence-rate (= lWm*2) o f UV-irradiated 
AS46/pKK223-3 ( • )  at 25°C. The controls are UV-irradiated AS46/pKK223-3 (O) in the 
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Figure 5.18. Photoreactivation with a low fluence-rate (= 5Wm-2) of UV-irradiated 
AS46/pND03 (■) at 25°C. The controls are UV-irradiated AS46/pND03 (□) in the dark 
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Figure 5.19. Photoreactivation with a low fluence-rate (= 5Wnr2) of UV-irradiated 
AS46/pKK223-3 ( • )  at 25°C. The controls are UV-iiTadiated AS46/pKK223-3 (O) in the 
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Figure 5.20. Photoreactivation with a high fluence-rate (= 12Wnr2) of UV-irradiated 
AS46/pND03 (■) at 25°C. The controls are UV-irradiated AS46/pND03 (□) in the dark 
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Figure 5.21. Photoreactivation with a high fluence-rate (= 12Wnr2) of UV-irradiated 
AS46/pKK223-3 ( • )  at 25°C. The controls are UV-irradiated AS46/pKK223-3 (O) in the 
dark and unirradiated AS46/pKK223-3 (A) in the photoreactivating light
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5.3.5 NEAR-UV SENSITIVITY STUDIES
Husain and Sancar (1987a) reported their observation that deletion of the gal-attX 
region in phrB mutants made the strains more sensitive to near-UV killing. Their 
explanation for this was that the increase in killing by near-UV light was due to 
sensitisation of the cells due to accumulation of coproporphyrin, which was in turn due to 
the deletion of the hemV gene, located within the gal-attX region (Bachmann, 1989) - 
see Section 1.5.3. The gene sequenced in this study is not the hetnF gene, and it was 
decided to investigate whether the presence of this gene decreased the sensitivity to near- 
UV light (photoreactivating light). This was accomplished by comparing the killing of 
AS46 /  pNDOl compared to AS46 /  pUC19, and AS46 /  pND03 compared to AS46 /  
pKK223-3, upon exposure of unirradiated cells to the photoreactivating light at 25 °C.
NEAR-UV SENSITIVITY OF phrA+ AND phrA- STRAINS IN A DARK REPAIR- 
DEFICIENT AND phrB- BACKGROUND
24 hour secondary cultures of each organism were produced and harvested to give 
approximately 1 x 107 colony forming units per ml as described above. After the 5 minutes 
incubation at 25°C, the cells were incubated at room temperature in the dark for 5 
minutes, to mimic the time and conditions allowed for while other cells would normally be 
irradiated. The cells were incubated at 25°C for 20 minutes to mimic the time allowed for 
any enzyme-substrate complexation to occur, then the cells were transferred to two 
separate illumination vessels which were placed in the temperature control unit. The cells 
were then exposed to photoreactivating light of approximate fluence-rate o f 8.5Wnr2 for a 
period of 120 minutes, sampling at 30 minutes intervals. The results are shown in Figures 
5.22 and 5.23.
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Figure 5.22. Near-UV sensitivity of AS46/pND01 (■) and AS46/pUC19 (□) when 
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Figure 5.23. Near-UV sensitivity of AS46/pND03 (■) and AS46/pKK223-3 (□) when 
unirradiated cells were exposed to photoreactivating light of a fluence-rate of 8.5Wm-2.
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The differences in the near-UV sensitivity between AS46 /  pNDOl and AS46 /  pUC19 
were not very pronounced - see Figure 5.22., while the differences between AS46 /  
pND03 and AS46 /  pKK223-3 were more noticeable, but not very dramatic. Therefore, 
using photoreactivating light of a fluence-rate of 8.5Wm'2 didn't really emphasise the 
observation made by Husain and Sancar (1987a). Therefore, the experiments were 
repeated with strains AS46 /  pND03 and AS46 /  pKK223-3 using photoreactivating light 
of a fluence-rate 12Wm'2. The results are shown in Figure 5.24.
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Figure 5.24. Near-UV sensitivity of AS46/pND03 (■) and AS46/pKK223-3 (□) when 
unirradiated cells were exposed to photoreactivating light of a fluence-rate of 12Wnr2.
The differences in near-UV sensitivity between AS46 /  pND03 and AS46 /  pKK223-3 
upon exposure to the higher fluence-rate of photoreactivating light were more 
pronounced.
These results are discussed in Section 5.4.
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5.3.6 FURTHER PHOTOREACTIVATION STUDIES
As stated at the beginning of Section 5.3, plasmid pND05 was not produced until much 
later on in this study. When pND05 was produced (see Section 4.3.5) it was transformed 
into strain AS46 as described in Section 5.3.1. It was hoped that though no over­
expression of the putative phrk  gene product was observed in Section 4.3.6, the in vivo 
activity would still be seen, as had been the case with pND03.
PHOTOREACTIVATION OF AS46 /  pND05
A 24 hour secondary culture of AS46 /  pND05 was produced, harvested and irradiated as 
described above to reduce the surviving fraction to approximately 1 x 103 colony forming 
units per ml. The irradiated cells were incubated at 25°C for 20 minutes to allow any 
enzyme-substrate complexation to occur, then the cells were transferred to an illumination 
vessel which was placed in the temperature control unit. The irradiated cells were then 
exposed to photoreactivating light of a fluence-rate of 8.5Wm-2 as described in Section 
2.5.4 for a period of 120 minutes at a constant temperature of 25°C, sampling at 30 
minutes intervals. Unirradiated cells were also exposed to the photoreactivating light at 
the same time and samples taken at 30 minute intervals as well. A sample of irradiated 
cells were held in the dark at 25°C and samples taken at 30 minute intervals as well. The 
results are shown in Figure 5.25.
The results showed that there was very litde difference in the rate and extent of 
photorepair between AS46 /  pND05 and AS46 /  pKK223-3 - see Table 5.7. The near-UV 
sensitivity of AS46 /  pND05 was closer to that seen in AS46 /  pKK223-3 than AS46 /  
pND03. This is discussed in Section 5.4.
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STRAIN AND PHENOTYPE INCREASE IN SURVIVAL
AS46 /  pND05 (phrA+) 0.36 0.10
AS46 /  pKK223-3 (phrA*) 0.50 0.04
Table 5.7. Increase in mean survival after 120 minutes of photoreactivation at 25°C using
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Figure 5.25. Photoreactivation of UV-irradiated AS46/pND05 (■ ) at 25°C. The controls 




The in vivo activity of the putative phrA  gene in the three vectors pNDOl, pND03 and 
pND05 was investigated in this section of the study. Smith (1987) and Smith and Moss 
(1988) have shown approximately 1 log cycle photorecovery after UV-irradiation 
reduction of 4 log cycles with strain AS46 /  pASOl, which carries the putative phrA  gene 
on plasmid pASOl.
The initial photoreactivation studies (see Sections 5.3.1 and 5.3.6) produced some 
interesting results. Both AS46 /  pNDOl and AS46 /  pND03 showed photorecovery above 
that of the controls, while AS46 /  pND05 did not. The photorecovery seen in AS46 /  
pND03 proceeded at a faster rate and to a greater extent than that seen in AS46 /  pNDOl. 
An attractive explanation for this observation from the point of view of this study, is that 
this is due to the presence of more molecules per cell of the putative phrA  gene product. 
The fact that AS46 /  pND05 did not photoreactivate above the rate or extent of the 
control, AS46 /  pKK223-3, would suggest that the putative phrA  gene is not functioning 
in this plasmid. This is supported by the near-UV sensitivity of AS46 /  pND05, which is 
closer to that observed in the phrA' phrB' background than in the phrA+ phrB' 
background.
Another interesting result was the level of photorecovery seen in the controls, AS46, 
AS46 /  pUC19 and AS46 /  pKK223-3. All these strains showed approximately half a log 
cycle photorecovery over a 120 minute period of exposure to photoreactivating light This 
is in contrast to the findings of Smith (1987), Smith et al. (1987) and Smith and Moss 
(1988), who found AS46 to be photoreactivation-deficient. A possible explanation for this 
is that the results presented in this study are corrected for near-UV induced killing, while 
those presented by Smith (1987), for example, are not. Smith et al. (1987) found that 
control experiments indicated that the surviving fraction of non-irradiated cells exposed to
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photoreactivating light did not fall below a surviving fraction of 0.9 over the time periods 
studied (180 minutes for AS46), which is why no correction was made for near-UV 
induced killing. Husain and Sancar (1987a) found that unirradiated cells exposed to 
photoreactivating light of a fluence-rate of 5Wnr2 were inactivated by near-UV killing to 
a much greater extent than that reported by Smith et al. (1987), and that strains with 
deletions of the region A(gal-uvrB) were more sensitive to near-UV killing. Because of 
this, the results in the work by Husain and Sancar (1987a) are corrected for near-UV 
killing. It has been suggested that the differences in photorecovery seen in phrA+ phrB~ 
and phrA' phrB' mutants can be explained entirely by the differences in near-UV killing. 
However, the results presented in Section 5.3, which have been corrected for near-UV 
killing, would contradict that statement
The temperature studies (see Section 5.3.3) showed that the photorecovery seen in AS46 /  
pND03 is dependent on the temperature the irradiated cells are held at during exposure to 
the photoreactivating light When this temperature is increased from 25°C to 37°C, the 
rate and extent of photorecovery observed is increased. When this temperature is 
decreased from 25°C to 10°C, the rate and extent of photorecovery observed is reduced 
to a level similar to that seen in the control, AS46 /  pKK223-3. At 37°C and 25°C there is 
very little difference in the rate and extent of photorecovery in AS46 /  pKK223-3.
These results would suggest that some part of the photorecovery seen in AS46 /  pND03 
was not due to Type III photoreactivation, and is possibly due to an unknown enzymatic 
action due to the putative phrA  gene product.
The dose-rate studies (see Section 5.4.4) showed that the photorecovery seen in AS46 /  
pND03 is dependent on the fluence-rate of the photoreactivating light At 37°C, even a 
low fluence-rate of lWnr2 didn't effect the rate or extent of photorecovery to any great 
extent. However, at 25°C, fluence-rates of lWm-2 and 5Wm-2 reduced the rate or extent
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of photorecovery seen in AS46 /  pND03 to a level approaching that of AS46 /  pKK223-3 
at those fluence-rates. At a higher fluence-rate of 12Wm-2, the rate and extent of 
photorecovery seen in AS46 /  pND03 was slightly increased, but remained unchanged in 
AS46 /  pKK223-3. Why is this fluence-rate dependence observed at 25°C, but not at the 
higher temperature of 37°C? One possibility is that at 37°C, the putative phrA  gene 
product is operating close to the optimum temperature for the enzyme-mediated reaction. 
Because of this, the enzyme kinetics of binding and catalysis will proceed at a faster rate, 
and the effects of a lower fluence-rate will be masked. Reference to Table 5.5 shows that 
at 60 minutes there is a decrease in the increase of mean survival of AS46 /  pND03 at 
lWnr2 compared to at 8.5Wnr2. Thus, if each enzyme-substrate complex requires a 
minimum fluence of photoreactivating light to initiate the catalysis reaction, at a lower 
fluence-rate at a lower temperature, where the kinetics of binding will be affected, the 
fluence-rate dependence will be more pronounced.
These results would also suggest that some part of the photorecovery seen in AS46 /  
pND03 was not due to Type III photoreactivation, and would support the hypothesis that 
it was due to an unknown photoactive protein, the putative phrA  gene product.
Another interesting aspect of this part of the photoreactivation studies, is that at a fluence- 
rate of 5Wnr2 the level of photorecovery seen in AS46 /  pND03 and AS46 /  pKK223-3 is 
virtually indistinguishable. This is the fluence-rate used by Husain and Sancar (1987a) 
when they found that deletion of the putative phrA  gene had no effect on the rate or 
extent of photoreactivation seen in either a phrB+ or phrB' mutant background. The 
results reported here would offer an explanation for the failure of Husain and Sancar 
(1987a) to detect any photoactivity due to the putative phrA  gene product.
The near-UV sensitivity results (see Section 5.3.5) agree with the observations made by 
Husain and Sancar (1987a) that cells with deletion of the gal-uvrB interval are more
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sensitive to near-UV light The results reported here would suggest that it is possibly due 
to deletion of the putative phrA gene that causes this increase in sensitivity to near-UV 
light, and not due to deletion of the hemV gene, as proposed by Husain and Sancar 
(1987a). However, that statement can not be concluded from this work, as the effect of 
the hemF gene is not accounted for, as it is deleted in all the strains used.
An interesting finding of the photoreactivation studies concerns the reproducibility of the 
results obtained in this study, and previously by other workers studying the effect of the 
putative phrA  gene. During the early experimental work when experiments were 
performed on a single exploratory basis, the fluence-rate of the 254nm UV light source 
was higher than later on in the study. This produced irradiated cell surviving fractions of 
less than 1 x 10-4 colony forming units per ml. Later on, when the fluence-rate of the 
254nm UV light source had decreased slightly, irradiated cell surviving fractions of greater 
than 1 x 1(H colony forming units per ml were produced. In the latter case the effect of 
the putative phrA  gene was often indistinguishable from the controls. Upon reducing the 
surviving fraction below 1 x 1CH colony forming units per ml, the effect of the putative 
phrA  gene was once again observed, while the rate and extent of photorecovery in the 
controls was unchanged irrespective of the initial irradiated cell surviving fraction.
This casts an interesting light over work performed by other workers in this field, and also 
over the possible mechanism by which the putative phrA  gene product functions. This will 
be expanded upon in the final discussion of the work in this study in Chapter 6 .
In conclusion, the results reported in this part of the study support previous work in our 





The work reported in this study is centred on the role of the putative phrA. gene in 
photoreactivation in Escherichia coii K-12. Sutherland and Hausrath (1979) originally 
proposed that there were two genes involved in photoenzymatic repair in E. coli, terming 
them phrA  and phrB respectively. Since then, the phrB gene and gene product have been 
cloned, sequenced and extensively characterised. It is now accepted that the phrB gene is 
the major photolyase gene in E. coli.
Husain and Sancar (1987a) studied the genetic control of photoreactivation in E. coli, and 
were unable to reproduce previous work which had supported a role for the phrA  gene in 
the genetic control of photoreactivation. They concluded that the phrA  gene played no 
significant physiological role in photoreactivation and should not be called phrA ; similarly 
the phrA  gene product should not be called a photolyase.
However, Smith et al. (1987) also studied the genetic control of photoreactivation in E. 
coli, and found, in contrast to the findings of Husain and Sancar (1987a), that a phrA+ 
phrB' strain did photoreactivate, while a phrA' phrB' strain was photoreactivation- 
deficient. Smith and Moss (1988) reported the cloning of a SphI restriction fragment from 
a Adgal transducing 'phage and demonstrated the appearance of a photoreactivable 
response in the photoreactivation-deficient phrA'phrB' strain.
The work in Chapter 3 involved the sequencing of this SphI restriction fragment from the 
plasmid pASOl, to investigate whether there was a gene present on this restriction 
fragment. At this point, it is worthwhile to correct a minor error in the work reported by 
Smith (1987) and Smith and Moss (1988). It is stated that the plasmid pASOl carries an
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approximately 8kbp insert from a partial SphI digest of the Xdgal transducing 'phage. 
Reference to Agarose Gel 3.1 shows that a complete SphI digest of pASOl produces two 
fragments, one the same size to the vector pBR322 into which the restriction fragment 
was cloned; and one of approximately 1.2kbp. Therefore, the insert sequenced in this 
study should not correspond to a 8kbp insert as reported previously, but to a 1 .2kbp 
insert. This was confirmed by the sequencing results. Also, the restriction fragment cloned 
into pBR322 to produce pASOl is a completely digested SphI fragment, not a partial 
digest
The insert sequenced was 1188bp in length, and upon analysis was discovered to contain 
an open reading frame of 340 amino acids commencing from an ATG start codon. The 
ORF coded for a protein of 37,894Da. Areas of similarity to consensus sequences for the 
transcriptional and translational signals in E. coli were identified - see Section 3.4. Upon 
searching for matches for the nucleotide and amino acid sequences on the EMBL and 
GenBank databases, no significant matches were found. The ORF was thus termed the 
putative phrA  gene, and the protein coded for by the putative phrA  gene termed the 
putative phrA  gene product.
Interestingly, the predicted amino acid composition of the putative phrA  gene product 
bears little resemblance to the amino acid composition presented by Snapka and 
Sutherland (1980) for the phrA  PRE isolated in their laboratory - see Section 3.4.
The work in Chapter 4 involved attempts to show over-expression of the putative phrA  
gene product. Three vectors containing the putative phrA  gene were studied. pNDOl 
utilised the transcriptional and translational signals already present 5' to the ATG start 
codon identified in Section 3.4 to initiate expression of the putative phrA  gene product. 
pND03 utilised the strong tac promoter on the expression vector pKK223-3 (Brosius and 
Holy, 1984) and the ribosome-binding site present 5' to the ATG start codon o f the 
putative phrA  gene. pND05 utilised the strong tac promoter and the ribosome-binding site
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on the expression vector pKK223-3, with the ATG start codon of the putative phrA  gene 
immediately 3' to the ribosome-binding site.
However, as predicted in Section 3.4, the over-expression of the putative phrA  gene 
product proved to be rather difficult. No discernible over-expression was observed on 
SDS-PA gels above that of the background protein bands of the controls - see Section 4.3. 
The results obtained in Chapter 5 cast an interesting light over those results obtained in 
Chapter 4.
The work in Chapter 5 involved studies of the in vivo photoreactivation produced by the 
putative phrA  gene. The results indicate that the putative phrA  gene confers two 
biological effects to a phrA phrB mutant. The first is a level of photorecovery above that 
observed in the phrA phrB mutant, and the second is an increase in resistance to near-UV 
induced killing. With this is mind, the results obtained for pNDOl, pND03 and pND05 
cast new light on the results obtained and the strategies used during the sub-cloning work 
performed in Section 4.3.
AS46 /  pNDOl showed a level of photorecovery above that of AS46 /  pUC19, and a slight 
increase in resistance to near-UV killing. However, the effect of the putative phrA  gene in 
AS46 /  pND03 was more pronounced. The rate and extent of photorecovery was above 
that observed in AS46 /  pKK223-3 and above that observed in AS46 /  pNDOl. The 
increase in resistance to near-UV killing was more pronounced as well. However, AS46 /  
pND05 did not exhibit a level of photorecovery above that of AS46 /  pKK223-3, and the 
sensitivity of AS46 /  pND05 to near-UV light was closer to that of AS46 /  pKK223-3 than 
AS46 /  pND03.
These results suggest that the putative phrA  gene is functioning in pNDOl, is over- 
expressed in relation to pNDOl in pND03, but not functioning in pND05. This suggests 
that the strategy to clone the putative phrA  gene downstream of a strong promoter was 
successful in increasing the expression of the putative phrA  gene product. However, when
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this strategy was expanded upon to include a strong ribosome-binding site, this resulted in 
the putative phrA  gene apparently not functioning.
One possible explanation for this is that the PCR generation of the putative phrA  gene 
used in Section 4.3.5 introduced an incorrect nucleotide, thus changing the reading frame 
and affecting the amino acid composition of the putative phrA  gene product, and thus its 
biological activity. This would explain the apparent lack of phrA  activity in AS46 /  
pND05. The sequence of an individual DNA molecule cloned from an amplified pool of 
PCR generated fragments is unreliable (Sambrook et al., 1989). A way to check this 
would be to sequence a number of independent recombinant clones to confirm the 
sequence of the putative phrA  gene. A quicker way would be to isolate a number of the 
plasmids from independent clones and after transforming the plasmid DNA into AS46, 
check the biological activity of the putative phrA  gene by photoreactivation experiments. 
However, the above does not explain why if a protein is been produced by the over- 
expression strategy used in the construction of pND05, this protein, though not 
biologically active, does not show up after induction by analysis by SDS-PAGE 
techniques. A possible reason for this has been proposed in Section 4.4, namely the 
staining system used is not sensitive enough to pick up the low levels of protein produced. 
Another possible reason is that the putative phrA  gene product has a low affinity for 
commonly used protein stains. Snapka and Sutherland (1980) reported similar problems 
with the enzyme they studied, making its localisation on gels difficult 
This, if it is the cause of the apparent lack of over-expression of the putative phrA  gene 
product, rather than the low numbers of molecules per cell, could be investigated by using 
radio-labelled amino acids, such as 35S Met, in the growth medium used in the induction 
cultures, and detecting the radio-labelled proteins after SDS-PAGE by autoradiography. 
Another possible cause of the lack of over-expression in pND05 is that the expression 
vectors ribosome-binding site is too far away from the ATG start codon of the putative 
phrA  gene. When the expression vector pKK223-3 was purchased from Ph a r m a c i a , the
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data sheet stated that to utilise the ribosome-binding site present on pKK223-3, the ATG 
start codon must be cloned within 10-15 bases 3' to the ribosome-binding site. However, 
the data sheet has now been revised, stating that the ATG start codon must be now within 
5-9 bases 3' to the ribosome-binding site. This is due to problems such as have been 
experienced with pND05 (S. Pearson, Pharmacia - Personal Communication).
The work performed in Chapter 4 has opened the way for many future experiments on the 
over-expression of the putative phrA  gene product These include
a) Running induced samples on a larger gel apparatus and staining with silver salts to
detect smaller amounts of protein.
b) Radio-labelling the proteins produced during induction and detecting these 
proteins by autoradiography after separation by SDS-PAGE.
c) Analysis of the biological activity of the gene present on the PCR generated 
fragments to check that the integrity of the putative phrA  gene has been 
maintained.
It is hoped that this area of the work, in particular, will be continued.
The work in Chapter 5, after showing a photoreactivable response associated with the 
putative phrA  gene above the photorecovery of the controls, centred on the statements 
made by Husain and Sancar (1987a) and Husain et al. (1988). They proposed that the 
photorecovery seen in phrB mutants was due to Type m  photoreactivation, and also 
observed that deletion of the gal-uvrB region increased the sensitivity of cells to near-UV 
induced killing.
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The results presented in Chapter 5 with the phrA phrB mutant AS46, carrying the plasmid 
pND03 which includes the putative phrA gene, suggest that part of the photorecovery 
observed in AS46 /  pND03 is not due to Type III photoreactivation, due to its dependence 
on :-
i) The temperature at which the irradiated cells are held during exposure to the
photoreactivating light
ii) The fluence-rate of the photoreactivating light
Additionally, the results with the phrA phrB mutant AS46, carrying the control plasmid 
pKK223-3, support the hypothesis that the photorecovery seen in phrA phrB mutants is 
due to Type III photoreactivation, due to this photorecovery being virtually independent 
of temperature and dose-rate effects - see Section 5.4. The near-UV sensitivity studies 
suggest that the putative phrA  gene does increase the resistance of cells to near-UV 
killing, which leads to the hypothesis that it is deletion of the putative phrA  gene which 
caused the effects reported by Husain and Sancar (1987a) and not deletion of the hemP 
gene as speculated by these workers. However, this can not be concluded from this work 
- see Section 5.4.
As well as the main conclusions drawn from the results obtained from Chapter 5, two 
explanations were reached to explain the failure of other workers to reproduce the activity 
of the putative phrA  gene product.
At fluence-rates of photoreactivating light below 8.5Wm-2, the photorecovery associated 
with the putative phrA  gene is virtually indistinguishable from that associated with Type 
HI photoreactivation seen in the control. This covers the fluence-rate (5Wm-2) used by 
Husain and Sancar (1987a) and would explain why they were unable to show any
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biological activity associated with the putative phrA gene, in contrast to the findings of 
workers in our laboratory, who used a fluence-rate of 17Wnr2 (for example, Smith et a l., 
1987).
When the irradiated cells initial surviving fraction was reduced below 1 x 1(H, the effect 
of the putative phrA  gene was clearly seen. However, when the irradiated cells initial 
surviving fraction was above 1 x 1(H, it was difficult to distinguish between the 
photorecovery associated with the putative phrA  gene and the photorecovery associated 
with Type III photoreactivation observed in the control. This again would explain why the 
effect of the putative phrA  gene has been overlooked in the past. No difference in the rate 
or extent of photorecovery seen in the control was observed when the irradiated cells 
initial surviving fraction was above or below 1 x Kk4. To observe a relatively small effect, 
the surviving fraction needs to be reduced to a level where it can be detected.
It is known that Type III photoreactivation is involved with the photoconversion of (6-4) 
photoproducts to their Dewar isomers - see Section 1.3.5. The Dewar isomer is thought to 
be less cytotoxic than the (6-4) photoproduct, but its effect on mutagenesis is as yet 
unclear. However, Husain and Sancar (1987a) reported a level of photorecovery in phrB 
mutants of 30% of the UV damage, despite their predictions that the (6-4) photoproducts 
would not constitute more than 15% of the total photoproducts induced by the UV  
fluences used in their experiments. This would imply that some of the pyrimidine dimers 
were repaired by exposure to the photoreactivating light.
The second of the two practical observations reported above would suggest that the 
putative phrA  gene product acts on a substrate other than pyrimidine dimers. Even with 
the fluence of 254nm UV-irradiation required to reduce the surviving fraction to 5 x 1(H, 
there would be more than enough pyrimidine dimers for the effect of the putative phrA  
gene product to be seen above that o f the control.
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An explanation would be that the higher fluence of 254nm UV-irradiation induces a higher 
number of the less important UV-induced photoproducts, to a level where they begin to 
become biologically significant Pyrimidine dimers other than the predominant T< >T 
dimers, such as C< >T dimers, could be formed in significant amounts. While considering 
the effect of repair of 254nm UV-induced damage, it is also worthwhile considering the 
effect the putative phrA gene has on near-UV sensitivity. Ellison and Childs (1981) 
showed that at low fluences of 300nm and 313nm light, C< >T dimers were formed more 
frequently than T< >T dimers, whereas the reverse was true at either longer or shorter 
wavelengths. This would suggest that any pyrimidine dimers produced in DNA by the 
photoreactivating light used in this study would be more likely to be T< >T dimers than 
C< >T dimers - see Figure 2.4 for the transmission properties of the photoreactivating 
light used in this study, which shows no transmission below 340nm. This reduces the 
likelihood of C< >T dimers been the substrate for the putative phrA  gene product.
After pyrimidine dimers, the next most important UV-induced photoproduct is the (6-4) 
photoproduct. This is the lesion converted to its Dewar isomer by Type III 
photoreactivation, and if it were the substrate for the putative phrA  gene product, it would 
help to explain why at low levels of UV-induced DNA damage it is difficult to distinguish 
between putative phrA  gene-mediated photorecovery and Type III photoreactivation, as 
both processes would be competing for the same lesion.
Husain and Sancar (1987a) showed that deletion of the gal-attk region increased the 
sensitivity of strains to near-UV killing, in both phrB+ and phrB- strains. Tyrrell et al. 
(1973) demonstrated the destruction of E. coli PRE by 365nm radiation. This would 
suggest that over long exposures to photoreactivating light the importance of the phrB 
gene product diminishes due to its inactivation, while the importance of the putative phrA  
gene product would increase. What remains unclear is whether the damage induced by the
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photoreactivating light is to DNA, DNA repair systems or membranes; and how and 
where the putative phrA  gene product acts.
With this in mind, another possibility is that the photorecovery is due to photoreactivating 
light-induced growth delay, allowing the putative phrA  gene product to act in a different 
manner than that of a photolyase.
Returning to the observation of Husain and Sancar (1987a) that the photorecovery in 
phrB mutants upon long exposures to photoreactivating light results in repair of 30% of 
the total UV damage, they proposed three possibilities to explain these findings
i) The existence of a second photolyase in E. coli.
ii) Dimer reversal is photosensitised by chromophoric metabolites.
iii) Pyrimidine dimers are directly reversed by photoreactivating light.
The third explanation was dismissed as it is unlikely that an inefficient photoreversal 
process would increase cell survival by use of light that introduces more dimers into DNA. 
In conclusion, they had no satisfactory explanation for the residual photoreactivation 
observed in phrB mutants. The work by Husain et a l  (1988) showed that in a phrA phrB 
mutant, pyrimidine dimer content remained unchanged after exposure to photoreactivating 
light This removes the second and third explanations for the residual photoreactivation in 
phrB mutants put forward by Husain and Sancar (1987a), which both involved the 
removal of pyrimidine dimers. A conclusion not drawn by Husain et al. (1988), even 
though they explained this residual photoreactivation observed in phrB mutants as been 
due to Type m  photoreactivation, is that the level of (6-4) photoproducts induced by the 
254nm UV-irradiation used in their studies is probably higher than the 15% they quoted,
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and closer to 30% of total UV-induced damage, which was the level of photorepair 
observed.
If this is the case, and the level of (6-4) photoproducts produced by the fluence of 254nm 
UV-irradiation is in the range of 20-30% in the experiments performed by Husain and 
Sancar (1987a) and in our laboratory in Bath, then the prospect that the putative phrA  
gene product repairs (6-4) photoproducts is very attractive.
In Section 1.5.4, three major possibilities for the role of phrA  in Escherichia coli K-12 
were proposed :-
i) No significant role in photoreactivation.
ii) Photoreactivation by repair of pyrimidine dimers at higher fluence-rates of 
photoreactivating light
iii) Photoreactivation by repair of (6-4) photoproducts.
The results obtained in Chapter 5 would suggest that the putative phrA  gene studied in
this work acts by photoreactivation of (6-4) photoproducts rather than pyrimidine dimers. 
Todo et al. (1993) showed that an extract from E. coli strain AB1157 bound UV- 
irradiated DNA depleted of pyrimidine dimers by prior treatment of with E. coli DNA 
photolyase. It would be interesting to repeat this experiment with extracts from AS46 and 
AS46 /  pND03 to see if a (6-4) photoproduct binding factor exists in AS46 /  pND03, but 
not in AS46. If this was the case, repeating the assay for photoreactivation-mediating 
activity would be the next step. If the results from this were positive, this would confirm 
the hypothesis that part of the photoreactivation seen in AS46 /  pND03 is due to repair of 
(6-4) photoproducts by the putative phrA  gene product.
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In conclusion, the work presented in this study supports the hypothesis that the putative 
phrA  gene studied in our laboratory in Bath does code for a photoactive protein and 
explanations are put forward for the contradicting results reported in the literature. A 
hypothesis is proposed that the putative phrA  gene product acts by repairing (6-4) 
photoproducts rather than pyrimidine dimers.
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APPENDIX A
Table A l. Bacterial Strains : Derivation and Sources.




A(gal-chlA) phr srlA300 :: TnlO recA56 
ara A(lac-proAB) rpsL(= strA) thi O80dlacZAMl5 
supE endA sbcB15 hspR4 rpsL thi A(lac-proAB) 














General vector - ampR + tetR 
pBR322 + phr A  gene - ampR 
General vector - ampR 
pUC19 + mdh gene - ampR 
Expression vector - ampR
Smith (1987) 
Smith (1987) 
P h a r m a c ia
A.H. Ahmed 







M gS04.7H20  lOg
DDDW to 1 litre
Made in batches of 500ml and sterilised at 121°C for 30 minutes. Stored at room
temperature in the dark.
M9B (12.5x CONCENTRATE)
KH2P 0 4 37.5g
Na2H P04.2H20  75g
NaCl 6.25g
DDDW to 1 litre
Made in batches of 500ml and sterilised at 121°C for 30 minutes. Stored at room 
temperature in the dark.
TRIS SOLUTIONS
The required amount of Tris base (mw 121.1) was dissolved in 400ml of DDDW and the 
pH adjusted to the desired value by adding concentrated hydrochloric acid (allowing the 
solution to cool to room temperature before making the final adjustments to pH). The 
volume was made up to 500ml with DDDW, the solution dispensed into 100ml volumes 
and sterilised at 121°C for 15 minutes. Stored at 4°C.
H
0.5M EDTA (pH 8.0)
186. lg  of EDTA . 2H20  was added to 800ml of DDDW and stirred vigorously with a 
magnetic stirrer. The pH was adjusted to 8.0 with 10M NaOH. The solution was made up 
to 1000ml with DDDW and dispensed into 100ml volumes and sterilised at 121°C for 15 
minutes. Stored at 4°C.
10% /  20% w/v SDS
lOg or 20g of SDS was dissolved in DDDW and heated to 6 8 °C to aid dissolution. The 
pH was adjusted to 7.2 by adding a few drops of concentrated hydrochloric acid. The 
volume was made up to 100ml and the solution dispensed into 20ml aliquots.
SOLUTION I 
50mM Glucose 
25mM Tris (pH 8.0) 
lOmM EDTA (pH 8.0)





Freshly prepared from 10M NaOH and 20% w/v SDS stock solutions.
SOLUTION m  
5M Potassium Acetate 






The resulting solution is 3M with respect to potassium and 5M with respect to acetate. 
Stored at 4°C for 1 month.
EQUILIBRATED PHENOL
Phenol was obtained from r a t h b u r n  chem icals l td , Sc o tla n d  and stored at -20°C. The 
volume for equilibration was allowed to warm to room temperature, then 
hydroxyquinolone added to a final concentration of 0.1% w/v. An equal volume of 0.5M 
Tris (pH 8.0) was added and mixed with a magnetic stirrer for 15 minutes. The aqueous 
and organic phases were allowed to partition, then the upper aqueous phase removed. An 
equal volume of 0.1M Tris (pH 8.0) was then added, mixed for 15 minutes as above, then 
the upper aqueous phase removed as above. This was repeated until the pH of the aqueous 
phase was = 8.0 as measured with pH paper. A 0.1 volume of 0.1M Tris (pH 8.0) 
containing 0 .2 % v/v p-mercaptoethanol was added, and the equilibrated phenol stored in a 
light-tight bottle at 4°C for 1 month.
CHLOROFORM : ISOAMYL ALCOHOL (24:1)
4ml of isoamyl alcohol was mixed with 70ml of chloroform and made up to 100ml with 
chloroform. Stored in a light-tight bottle at 4°C for 1 month.
PHENOL : CHLOROFORM : ISOAMYL ALCOHOL (25:24:1)
A mixture containing equal parts of equilibrated phenol and chloroform : isoamyl alcohol 
(24:1) was freshly prepared, and used immediately.
RN-ase (DN-ase f r e e ) 1 mg/ml
20mg of pancreatic RN-ase A (sig m a ) was dissolved in 20ml of lOmM Tris (pH 7.5) 
15mM NaCl. The solution was heated at 100°C for 15 minutes, then allowed to cool
IV
slowly to room temperature. The solution was sterilised by passage through a 25mm 
diameter 0.2pm membrane filter, and dispensed into 1ml aliquots and stored at -20°C.
TE (pH 8.0) CONTAINING 20pg/ml RN-ase 
lOmM Tris (pH 8.0)
ImMEDTA 
20pg/ml RN-ase
The solution was sterilised by passage through a 25mm diameter 0.2pm membrane filter, 
and dispensed into 1ml aliquots and stored at -20°C.
1M CaCl2
54g of CaCl2 . 6H20  was dissolved in DDDW and made up to 100ml. This solution was 
sterilised by passage through a 25mm diameter 0.2pm membrane filter. The sterile 
solution was dispensed into 1ml aliquots and stored at -20°C.
lOOmM IPTG
2.383g of IPTG was dissolved in DDDW and made up to 100ml. This solution was 
sterilised by passage through a 25mm diameter 0.2pm membrane filter. The sterile 
solution was dispensed into 1ml aliquots and stored at -20°C.
GEL LOADING BUFFER /  STOP MIX 
0.5% w/v SDS
0.025% w/v Bromophenol Blue 
50% v/v Glycerol
Stored at room temperature in glass containers.
V
XDNA /  Hindffl MARKER
XDNA pre-digested with HindHI was purchased from sigma as a 167|ig/ml solution. 20jxl 
of this solution was mixed with 200pl of sterile DDDW and 33|il o f gel-loading buffer, 
and stored at -20°C. 5pl of this solution was used as a marker for the size of DNA 
fragments on agarose gels. The XDNA /  HindHI digest contains eight fragments 
23,130bps, 9,416bps, 6,557bps, 4,316bps, 2,322bps, 2,027bps, 564bps, and 125bps.
p-MERCAPTOETHANOL
This was purchased as a 14.4M stock solution from sigma and stored in the dark at 4°C.
SDS- GEL LOADING BUFFER (2x CONCENTRATE) 
lOOmM Tris (pH 6 .8 )
4% w/v SDS
0.2% w/v Bromophenol Blue 
20% Glycerol
Stored at room temperature in glass containers. Before use, P-mercaptoethanol (14.4M) 
was added to a ratio of 1:19 and used immediately.
ETHIDIUM BROMIDE lOmg/ml
lg  of ethidium bromide (sigma) was dissolved in DDDW and made up to 100ml, and the 
solution stirred using a magnetic stirrer for several hours to ensure all the dye dissolved. 
The solution was transferred to a light-tight bottle, and stored at room temperature.
COOMASSIE BRILLIANT BLUE STAIN
1.25g of Coomassie Brilliant Blue R250 (bio-rad) was dissolved in 450ml of 
methanol:DDDW (1:1) and 50ml of glacial acetic acid. The solution was filtered through a
VI
Whatman No. 1 filter to remove any particulate matter, and stored in a brown glass 







This was stirred until all the solutes had dissolved, dispensed into 100ml volumes and 






This was stirred until all the solutes had dissolved, the pH adjusted to 7.0 with 5M NaOH, 
the media made up to 1000ml, dispensed into 100ml volumes and sterilised at 121°C for 




This was stirred until all the solutes had dissolved, dispensed into 100ml volumes and 






Agar Technical No 3 12g
DDDW 950ml
This was stirred until all the solutes had dissolved, the pH adjusted to 7.0 with 5M NaOH, 
the media made up to 1000ml, dispensed into 100ml volumes and sterilised at 121°C for 







The required pH of TE was prepared by diluting lOOmM Tris solution of the same pH. 
The solutions were sterilised at 121°C for 15 minutes. Stored at 4°C.
TAE BUFFER
A lOx concentrated stock solution was prepared
Tris Base 48.4g
Glacial acetic acid 11.4ml
0.5M EDTA (pH 8.0) 20ml
DDDW to 1000ml
A working concentration of buffer was prepared by diluting the stock solution 1:10 with 
DDDW.
TBE BUFFER
A 5x concentrated stock solution was prepared
Tris Base 54g
Boric Acid 27.5g
0.5M EDTA (pH 8.0) 20ml
DDDW to 1000ml






No. 1 (XI) First Forward (2.5hrs) First Forward (lhr)
No. 2 (XII) First Forward (8hrs) First Forward (4hrs)
No. 3 (Xni) Second Forward (4hrs) Second Forward (2hrs)
No. 4 (XIV) Second Forward (6hrs) Second Forward (9hrs)
No. 5 (XV) Third Forward (2hrs) Third Forward (6hrs)
No. 6  (XVI) Fourth Forward (6hrs) Fourth Forward (2hrs)
No. 7 (XVn) Third Reverse (5hrs) Third Reverse (2hrs)
No. 8 (Xm ) Second Reverse (5hrs) Fourth Reverse (5hrs) Fourth Reverse (2hrs)
No. 9 (XIX) Second Reverse (2hrs) First Reverse (5.5hrs)
Third Reverse (5.5hrs) Third Forward (5hrs)
No. 10 (XX) First Reverse (2hrs) Third Reverse (5hrs) First Reverse (4.5hrs)
XI
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Lane 1) 1st For (2.5hrs), Lane 2) 1st For (lhr).
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Lane 2) 1st For (8hrs), Lane 4) 1st For (4hrs).
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Lane 1) 3rd For (2hrs), Lane 2) 3rd For (6hrs).
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Lane 1) 4th For (6hrs), Lane 3) 4th For (2hrs). 
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Lane 1) 3rd Rev (5hrs), Lane 2) 3rd Rev (2hrs).
XVIII
■$&*<
Lane 2) 2nd Rev (5hrs), Lane 3) 4th Rev (5hrs), Lane 4) 4th Rev (2hrs).
XIX
Lane 1) 2nd Rev (2hrs), Lane 2) 1st Rev (5.5hrs), Lane 3) 3rd Rev (5.5hrs),
Lane 4) 1st Rev (4.5hrs).
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Lane 1) 1st Rev (2hrs), Lane 2) 3rd Rev (5hrs), Lane 4) 1st Rev (4.5hrs).
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APPENDIX D
UV-IRRADIATION AND PHOTOREACTIVATION DATA











la (3.16) 5.63 x 106 0.147 0.132 9.65 x 10-2
0.260 6.87 x 10-3
0.391 6.80 x 10^
0.508 5.68 x 10-5
lb  (3.32) 3.33 x 106 0.142 0.131 8.76 x 10-2
0.264 6.98 x 10-3
0.397 6.91 x 10^
0.524 6.82 x 10-5
lc  (3.04) 2.60 x 107 0.150 0.132 1.17 x 1 0 1
0.264 1.24 x 10-2
0.401 8.77 x 10-4
0.521 7.58 x 10-5
xxn
Table D .2. Survival Curve data for AS46/pUC19 irradiated at 254nm (Figure 5.2)










2a (3.22) 5.23 x 106 0.145 0.131 8.80 x 10-2
0.263 8.47 x lO'3
0.393 4.26 x 10^
0.524 4.65 x lO 5
2b (3.34) 6.57 x 106 0.145 0.135 8.71 x lO 2
0.268 6.92 x lO -3
0.403 6.81 x 10^
0.538 6.29 x lO 5
2c (4.18) 1.08 x 107 0.150 0.133 1.19 x lO -1
0.262 1.01 x lO 2
0.407 9.68 x 10^
0.524 8.98 x lO 5
xxni











3a (3.10) 4.60 x 106 0.150 0.136 1.06 x 1 0 1
0.271 5.65 x lO 3
0.404 5.07 x 10^
0.521 5.59 x lO 5
3b (3.24) 2 .2 0  x 106 0.145 0.128 1.33 x 1 0 1
0.255 1.18 x lO 2
0.382 1.35 x lO 3
0.498 1.05 x 10^
3c (3.40) 3.43 x 106 0.145 0.134 1.65 x 1 0 1
0.270 1.42 x lO 2
0.405 1.37 x lO 3
0.537 1.31 x lO*4
XXTV
Table D .4. Survival Curve data for AS46/pKK223-3 irradiated at 254nm (Figure 5.4)










4a (3.38) 5.23 x 106 0.145 0.125 1.71 x 1 0 1
0.252 1.56 x 10'2
0.378 1.51 x 10'3
0.499 1.49 x 10^
4b (3.42) 2.97 x 106 0.145 0.137 1.02  x 1 0 1
0.278 9.31 x 10'3
0.415 9.27 x 10A
0.546 9.09 x 10'5
4c (3.46) 3.60 x 107 0.142 0.132 5.32 x 10'2
0.271 4.78 x 10'3
0.404 4.72 x 10^
0.528 4.67 x 10'5
XXV
Table D .5. Photoreactivation data for AS46/pND01 at 25°C (Figure 5.5)
PHOTOREACTIYATION1TME (minutes)
Expt 5a (3.16) 0 30 60 90 120
UNIRRADIATED S/So 1.000 0.871 0.853 0.737 0.737
IRRADIATED S/So 5.28 x 10-5 5.56 x lO 5 1.00  x 10-4 1.29 x 10^ 1.67 x 10^
CORRECTED S/So 5.28 x 10-5 6.38 x lO'5 1.17 x 104 1.75 x 104 2.27 x 10-4
DARK IRRADIATED S/So 5.28 x lO 5 5.28 x lO*5 5.30 x lO 5 5.33 x lO 5 5.30 x 10*5
Expt 5b (3.07) 0 30 60 90 120
UNIRRADIATED S/So 1.000 0.867 0.847 0.746 0.691
IRRADIATED S/So 9.40 x lO 5 1.06 x lO*4 1.43 x 104 1.76 x KH 2.56 x 10-4
CORRECTED S/So 9.40 x lO 5 1.22  x 10^ 1.69 x 10-4 2.36 x 10^ 3.71 x 10-4
DARK IRRADIATED S/So 9.40 x lO 5 9.40 x lO 5 9.40 x lO 5 9.40 x lO 5 9.40 x lO 5
EXPT 5c (4.20) 0 30 60 90 120
UNIRRADIATED S/So 1.000 0.897 0.843 0.751 0.682
IRRADIATED S/So 6.48 x lO 5 6.72 x lO 5 1.06 x 10^ 1.38 x 10^ 1.89 x KH
CORRECTED S/So 6.48 x lO 5 7.49 x lO 5 1.26 x 10^ 1.84 x KH 2.77 x 10^
DARK IRRADIATED S/So 6.48 x lO 5 6.48 x lO 5 6.48 x lO 5 6.48 x lO 5 6.48 x lO 5
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Table D .6. Photoreactivation data for AS46/pUC19 at 25°C (Figure 5.6)
P]HOTOREACTIVATION11ME (minutes)
Expt 6a (3.22) 0 30 60 90 120
UNIRRADIATED S/So 1.000 0.893 0.702 0.727 0.713
IRRADIATED S/So 4.65 x 10-5 4.46 x 10'5 6.83 x lO 5 1.05 x 10"* 1.05 x 10"*
CORRECTED S/So 4.65 x lO 5 4.99 x lO 5 9.73 x 10-5 1.44 x 10"* 1.47 x 10"*
DARK IRRADIATED S/So 4.65 x lO 5 4.68 x lO 5 4.67 x lO 5 4.68 x 10'5 4.66 x lO 5
Expt 6b (3.34) 0 30 60 90 120
UNIRRADIATED S/So 1.000 0.890 0.724 0.701 0.678
IRRADIATED S/So 1.33 x 10"* 1.38 x 10"* 1.87 x 10"* 2.02 x 10"* 1.72 x 10"*
CORRECTED S/So 1.33 x 10"* 1.55 x 10"* 2.58 x 10"* 2.88 x 10"* 2.54 x 10"*
DARK IRRADIATED S/So 1.33 x 10"* 1.33 x 10"* 1.33 x 10"* 1.33 x 10"* 1.33 x 10"*
Expt 6c (4.18) 0 30 60 90 120
UNIRRADIATED S/So 1.000 0.930 0.749 0.679 0.532
IRRADIATED S/So 8.98 x lO 5 1.10 x 10"* 1.19x10"* 1.36 x 10"* 1.29 x 10"*
CORRECTED S/So 8.98 x 10 5 1.19 x 10"* 1.60 x 10"* 2.00 x 10-4 2.42 x 10"*
DARK IRRADIATED S/So 8.98 x lO 5 8.98 x lO 5 8.98 x lO 5 8.98 x lO 5 8.98 x lO 5
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Table D .7. Photoreactivation data for AS46/pND03 at 25°C (Figure 5.7)
PHOTORE ACTIVATION 1[TME (minutes)
Expt 7a (3.10) 0 30 60 90 120
UNIRRADIATED S/So 1.000 0.928 0.790 0.679 0.648
IRRADIATED S/So 4.72 x lO 5 5.80 x lO 5 1.42 x 10"* 2 .00  x 10"* 2.46 x 10"*
CORRECTED S/So 4.72 x lO 5 6.25 x lO 5 1.80 x 10"* 2.95 x 10"* 3.80x10"*
DARK IRRADIATED S/So 4.72 x lO 5 4.74 x lO 5 4.73 x lO 5 4.75 x 10*5 4.76 x lO*5
Expt 7b (4.16) 0 30 60 90 120
UNIRRADIATED S/So 1.000 0.918 0.838 0.654 0.636
IRRADIATED S/So 4.43 x 10'5 6 .68  x lO 5 1.15 x 10"* 1.55 x 10"* 1.62 x 10"*
CORRECTED S/So 4.43 x 10-5 7.28 x 10*5 1.37 x 10"* 2.36 x 10"* 2.55 x 10"*
DARK IRRADIATED S/So 4.43 x lO 5 4.43 x lO 5 4.43 x lO 5 4.43 x 10*5 4.43 x lO 5
Expt 7c (4.22) 0 30 60 90 120
UNIRRADIATED S/So 1 .000 0.915 0.817 0 .6 6 6 0.639
IRRADIATED S/So 5.78 x lO 5 7.57 x lO 5 1.26 x 10-4 2.04 x 10"* 2.63 x 10"*
CORRECTED S/So 5.78 x 10 s 8.27 x lO 5 1.54 x 10"* 3.06 x 10"* 4.12 x 10"*
DARK IRRADIATED S/So 5.78 x 10-5 5.78 x lO 5 5.78 x lO 5 5.78 x 10*5 5.78 x 10-5
xxvm
Table D .8. Photoreactivation data for AS46/pKK223-3 at 25°C (Figure 5.8)
PIHOTOREACIWATION1TME (minutes)
Expt 8 a (3.66) 0 30 60 90 120
UNIRRADIATED S/So 1.000 0.983 0.901 0.728 0.572
IRRADIATED S/So 2.28 X 10"* 2.49 x 10"* 3.21 x 10"* 3.90 x 10"* 3.77 x 10"*
CORRECTED S/So 2.28 X ICy4 2.53 x 10"* 3.57 x 10"* 5.36 x 10-4 6.59 x 10"*
DARK IRRADIATED S/So 2.28 x 10"* 2.28 x 10"* 2.28 x 10"* 2.28 x lO"1 2.28 x 10"*
Expt 8 b (4.14) 0 30 60 90 120
UNIRRADIATED S/So 1.000 0.924 0.660 0.592 0.548
IRRADIATED S/So 3.66 x lO 5 4.21 x 10-5 6.78 x IQ4 6.61 x 10"* 7 .1 0  x 10"*
CORRECTED S/So 3.66 x lO 5 4.55 x lO'5 1.03 x 10"* 1.12  x 10"* 1.29 x 10"*
DARK IRRADIATED S/So 3.66 x lO 5 3.66 x lO 5 3.66 x 10-5 3.66 x 10-5 3.66 x lO 5
Expt 8 c  (4.24) 0 30 60 90 120
UNIRRADIATED S/So 1.000 0.967 0.753 0.651 0.584
IRRADIATED S/So 6.71 x lO 5 7.89 x lO"5 9.56 x lO 5 1.00  x 10"* 1.21 x 10"*
CORRECTED S/So 6.71 x lO 5 8.16 x lO 5 1.27 x 10"* 1.54 x 10"* 2.07 x 10"*
DARK IRRADIATED S/So 6.71 x lO 5 6.71 x 1 0 5 6.71 x lO 5 6.71 x 10-5 6.71 x lO 5
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Table D .9. Photoreactivation data for AS46 at 25°C (Figure 5.9)
P]HOTOREACnVATION 11ME (minutes)
Expt 9a (3.18) 0 30 60 90 120
UNIRRADIATED S/So 1.000 0.890 0.890 0.812 0.807
IRRADIATED S/So 8.35 x lO 5 9.34 x lO*5 1.48 x 104 1.93 x 104 1.99 x 104
CORRECTED S/So 8.35 x lO 5 1.05 x 104 1.66  x 104 2.37 x 104 2.47 x 104
DARK IRRADIATED S/So 8.35 x lO 5 8.35 x lO 5 8.35 x lO 5 8.35 x lO 5 8.35 x lO 5
Expt 9b (3.30) 0 30 60 90 120
UNIRRADIATED S/So 1.000 0.792 0.777 0.652 0.744
IRRADIATED S/So 2.9 lx  104 3.43x 104 3.50 x 104 3.55 x 104 3.36 x 104
CORRECTED S/So 2.9 lx  104 4.33x 104 4.51 x 104 5.44 x 104 4.52 x 104
DARK IRRADIATED S/So 2.9 lx  104 2.9lx  104 2.91x 104 2.9 lx  104 2.9 lx  104
Expt 9c (3.02) 0 30 60 90 120
UNIRRADIATED S/So 1.000 0 .8 8 8 0.874 0.744 0.730
IRRADIATED S/So 4.7 lx  104 5.06x 104 6.30 x 104 7.46 x 104 7.46 x 104
CORRECTED S/So 4.7 lx  104 5.70x 104 7.20 x 104 1.00 x lO 3 1.02  x lO 3
DARK IRRADIATED S/So 4.7 lx  104 4.7 lx  104 4.7 lx  104 4.7 lx  104 4.7 lx  104
XXX
Table D .10. Photoreactivation data for AS46/pND03 at 37°C (Figure 5.10)
P]HOTOREACTIVATION TIME (minutes)
Expt 10a (3.24) 0 30 60 90 120
UNIRRADIATED S/So 1.000 0.952 0.709 0,692 0.639
IRRADIATED S/So 9.09 x lO 5 2.51 x 10-4 4.96 x 10^ 5.05 x lO4 5.77 x 10^
CORRECTED S/So 9.09 x lO 5 2.64 x 10-4 6.99 x 10^ 7.29 x 10^ 9.03 x 10-4
DARK IRRADIATED S/So 9.09 x lO 5 9.09 x lO 5 9.09 x lO 5 9.09 x lO 5 9.09 x lO 5
Expt 10b (3.36) * 0 30 60 90 120
UNIRRADIATED S/So 1.000 0.949 0.756 0.701 0.642
IRRADIATED S/So 2.53x 10^ 3.58x 10^ 5.58 x 10^ 5.11 x 10^ 5.47 x 10-4
CORRECTED S/So 2.53x 10^ 3.77x 10^ 7.38 x 10^ 7.29 x 10-4 8.52 x 10^
DARK IRRADIATED S/So 2.53x 10^ 2.53x 10^ 2.53x 10^ 2.53x 10^ 2.53x 10^
Expt 10c (4.26) 0 30 60 90 120
UNIRRADIATED S/So 1.000 0.962 0.748 0.689 0.641
IRRADIATED S/So 7.12 x 105 1.21 x 10-4 3.66 x 10^ 4.14 x KH 4.72 x 10^
CORRECTED S/So 7.12 x lO 5 1.26 x 10^ 4.89 x 10^ 6.01 x 10^ 7.36 x 10-4
DARK IRRADIATED S/So 7 .1 2 x l0 -5 7.12x10-5 7.12 x lO 5 7.12 x lO 5 7.12 x lO 5
* Data from Expt 10b was not included in the quantitative analysis o f the data for reasons 
explained in Section 5.4.
XXXI
Table D .11. Photoreactivation data for AS46/pND03 at 10°C (Figure 5.11)
P]HOTOREACITVATION TIME (minutes)
Expt 1 la  (4.02) 0 30 60 90 120
UNIRRADIATED S/So 1.000 0.904 0.824 0 .6 6 6 0.624
IRRADIATED S/So 8.70 x 10'5 9.54 x 10"5 9.54 x lO 5 9.54 x lO 5 1.21 x 10"*
CORRECTED S/So 8.70 x lO 5 1.06 x 10"* 1.16 x 10"* 1.37 x 10"* 1.93 x 10"*
DARK IRRADIATED S/So 8.70 x 10'5 8.70 x lO 5 8.70 x lO 5 8.70 x lO 5 8.70 x lO 5
Expt l ib  (3.48) 0 30 60 90 120
UNIRRADIATED S/So 1.000 0.988 0.673 0.590 0.612
IRRADIATED S/So 8.56 x lO 5 8.36 x lO 5 6.54 x lO*5 7.49 x lO 5 1.16x10"*
CORRECTED S/So 8.56 x lO 5 8.46 x lO 5 9.72 x lO 5 1.27 x 10"* 1.90x10"*
DARK IRRADIATED S/So 8.56 x lO 5 8 .5 6 x l0 5 8.56 x lO 5 8.56 x lO 5 8.56 x lO 5
Expt 1 lc  (4.28) 0 30 60 90 120
UNIRRADIATED S/So 1.000 0.965 0.754 0.632 0.601
IRRADIATED S/So 7.57 x lO'5 8.02 x lO 5 6.74 x lO 5 5.89 x lO 5 6.13 x lO 5
CORRECTED S/So 7.57 x lO 5 8.31 x lO 5 8.94 x lO 5 9.32 x lO 5 1.02  x 10"*
DARK IRRADIATED S/So 7.57 x lO 5 7.57 x lO 5 7.57 x lO 5 7.57 x lO 5 7.57 x lO 5
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Table D .12. Photoreactivation data for AS46/pKK223-3 at 37°C (Figure 5.12)
P]HOTOREACnVATION 1TME (minutes)
EXPT 12a (3.50) 0 30 60 90 120
UNIRRADIATED S/So 1.000 0.964 0.658 0.603 0.564
IRRADIATED S/So 1.48 x 10-4 2.30 x 10^ 3.28 x 10-4 3.26 x 10-4 3.10 x 10-4
CORRECTED S/So 1.48 x 10^ 2.38 x 10^ 4.98 x 10^ 5.41 x 10^ 5.48 x 10-4
DARK IRRADIATED S/So 1.48 x 10-4 1.48 x 10^ 1.48 x lO-4 1.48 x 10^ 1.48 x 10^
Expt 12b (4.30) 0 30 60 90 120
UNIRRADIATED S/So 1.000 0.932 0.701 0.612 0.554
IRRADIATED S/So 6.14 x lO 5 6.77 x lO 5 6.11 x lO*5 6.05 x lO 5 7.92 x lO 5
CORRECTED S/So 6.14 x 10'5 7.26 x lO 5 8.72 x lO 5 9.89 x lO 5 1.43 x 10-4
DARK IRRADIATED S/So 6.14 x lO 5 6.14 x lO 5 6.14 x 10 5 6.14 x 10-5 6.14 x lO 5
Expt 12c (4.32) 0 30 60 90 120
UNIRRADIATED S/So 1.000 0.941 0.687 0.621 0.571
IRRADIATED S/So 8.97 x lO 5 9.79 x lO 5 1.25 x 10-4 1.47 x 10^ 1.88 x 10-4
CORRECTED S/So 8.97 x lO 5 1.04 x 10-4 1.82 x 10^ 2.37 x 104 3.29 x 10^
DARK IRRADIATED S/So 8.97 x lO 5 8.97 x lO 5 8.97 x lO 5 8.97 x lO 5 8.97 x lO 5
x x x m
Table D .13. Photoreactivation data for AS46/pKK223-3 at 10°C (Figure 5.13)
PIHOTOREACTIVATION TIME (minutes)
Expt 13a (3.88) 0 30 60 90 120
UNIRRADIATED S/So 1.000 0.890 0.789 0.616 0.555
IRRADIATED S/So 1.05 X  104 1.20  x 104 1.19 x 104 1.21 x 104 1.36 x 104
CORRECTED S/So 1.05 X  104 1.35 x 104 1.50 x 104 1.96 x 104 2.45 x 104
DARK IRRADIATED S/So 1.05 x 104 1.05 x 104 1.05 x 104 1.05 x 104 1.05 x 104
Expt 13b (3.46) 0 30 60 90 120
UNIRRADIATED S/So 1.000 0.982 0.802 0.721 0.730
IRRADIATED S/So 4.67 x 104 4.17 x 104 3.58 x 104 3.86 x 104 3.69 x 104
CORRECTED S/So 4.67 x 104 4.24 x 104 4.47 x 104 5.35 x 104 5.06 x 104
DARK IRRADIATED S/So 4.67 x 104 4.67 x 104 4.67 x 104 4.67 x 104 4.67 x 104
Expt 13c (4.34) 0 30 60 90 120
UNIRRADIATED S/So 1.000 0.936 0.792 0.654 0.592
IRRADIATED S/So 5.47 x lO 5 6.37 x 10 3 6.27 x lO 5 6.42 x 10-5 7.76 x 10'5
CORRECTED S/So 5.47 x lO 5 6.81 x lO'5 7.92 x lO'5 9.82 x 10-5 1.31 x 104
DARK IRRADIATED S/So 5.47 x lO 5 5.47 x 10-5 5.47 x lO 5 5.47 x lO 3 5.47 x lO 3
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Table D .14. Photoreactivation data for AS46/pND03 at fluence rate of = lWnr2 at 37°C
(Figure 5.14)
P]HOTOREACnVATION TIME (minutes)
Expt 14a (3.52) 0 30 60 90 120
UNIRRADIATED S/So 1.000 0.993 0.750 0.727 0.721
IRRADIATED S/So 3.44 x lO'5 7.13 x 10*5 1.19 x KH 1.56 x 104 2 .1 2  x 10^
CORRECTED S/So 3.44 x lO 5 7.18 x lO 5 1.58 x 10^ 2.14 x KH 2.94 x 10*4
DARK IRRADIATED S/So 3.44 x lO 5 3.44 x lO 5 3.44 x lO 5 3.44 x lO 5 3.44 x lO 5
Expt 14b (4.36) 0 30 60 90 120
UNIRRADIATED S/So 1.000 0.987 0.797 0.751 0.719
IRRADIATED S/So 6.26 x lO 5 8.94 x 10'5 2.46 x 10^ 3.13 x 10^ 4.27 x 10^
CORRECTED S/So 6.26 x lO 5 9.06 x lO 5 3.09 x 10^ 4.17 x 10^ 5.94 x 10^
DARK IRRADIATED S/So 6.26 x lO 5 6.26 x lO 5 6.26 x lO 5 6.26 x lO 5 6.26 x lO 5
Expt 14c (4.38) 0 30 60 90 120
UNIRRADIATED S/So 1.000 0.971 0.782 0.734 0.727
IRRADIATED S/So 7.91 x lO 5 1.09 x lO -4 3.89 x 10^ 4.43 x 10^ 5.23 x 10-4
CORRECTED S/So 7.91 x lO 5 1.12  x 10-4 4.97 x 10-4 6.04 x 10^ 7.19 x KH
DARK IRRADIATED S/So 7.91 x lO 5 7.91 x lO 5 7.91 x lO 5 7.91 x lO 5 7.91 x lO 5
XXXY
Table D .15. Photoreactivation data for AS46/pKK223-3 at fluence rate of = lWnr2 at
37°C (Figure 5.15)
PHOTOREACTIVATION TIME (minutes)
Expt 15a (3.54) 0 30 60 90 120
UNIRRADIATED S/So 1.000 0.865 0.818 0.774 0.764
IRRADIATED S/So 1.49 x 10^ 1.49 x 104 2.02 x 10-4 3.05 x 10^ 3.49 x 10^
CORRECTED S/So 1.49 x 10-4 1.72 x KH 2.47 x 10-4 3.94 x 10^ 4.57 x 10^
DARK IRRADIATED S/So 1.49 x 10A 1.49 x 10^ 1.49 x 10^ 1.49 x 10^ 1.49 x 10-4
Expt 15b (4.40) 0 30 60 90 120
UNIRRADIATED S/So 1.000 0.896 0.808 0.764 0.734
IRRADIATED S/So 6.54 x 10*5 7.09 x lO 5 7.79 x lO 5 8.71 x lO 5 1.07 x 10^
CORRECTED S/So 6.54 x lO 5 7.91 x lO 5 9.64 x lO 5 1.14 x 1.46 x 10^
DARK IRRADIATED S/So 6.54 x lO 5 6.54 x lO 5 6.54 x lO 5 6.54 x lO 5 6.54 x lO 5
Expt 15c (4.42) 0 30 60 90 120
UNIRRADIATED S/So 1.000 0.901 0.821 0.784 0.746
IRRADIATED S/So 8.76 x lO 5 9.55 x lO 5 1.17 x 10^ 1.69 x 104 2.17 x 10^
CORRECTED S/So 8.76 x lO 5 1.06 x 10^ 1.43 x 10^ 2.16 x 104 2.91 x 10^
DARK IRRADIATED S/So 8.76 x lO 5 8.76 x lO 5 8.76 x lO 5 8.76 x lO 5 8.76 x lO 5
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Table D .16. Photoreactivation data for AS46/pND03 at fluence rate of = lWm-2 at 25°C
(Figure 5.16)
PHOTOREACTTVATION 1ME (minutes)
Expt 16a (3.56) 0 30 60 90 120
UNIRRADIATED S/So 1.000 0.977 0.977 0.967 0.920
IRRADIATED S/So 1.58 x 104 2.13 x 10-4 2.81 x 10-4 3.32 x 104 3.98 x 104
CORRECTED S/So 1.58 x 104 2.18 x 104 2 .88  x 104 3.43 x lO4 4.33 x 104
DARK IRRADIATED S/So 1.58 x 104 1.58 x 10-4 1.58 x lO"1 1.58 x 104 1.58 x 104
Expt 16b (4.44) 0 30 60 90 120
UNIRRADIATED S/So 1.000 0.934 0.797 0.751 0.724
IRRADIATED S/So 5.49 x lO 5 6.45 x lO'5 6.72 x lO 5 7.66 x lO'5 7.67 x 10-5
CORRECTEDS/So 5.49 x lO 5 6.91 x lO 5 8.43 x lO-5 1.02  x 104 1.06 x 104
DARK IRRADIATED S/So 5.49 x 10-5 5.49 x 10-5 5.49 x 10-5 5.49 x lO 5 5.49 x 10-5
E xpt  16c (4.46) 0 30 60 90 120
UNIRRADIATED S/So 1 .000 0.946 0.824 0.794 0.746
IRRADIATED S/So 5 .1 2 x l0 -5 6.36 x 10-5 6.77 x lO 5 7.81 x 10-5 7.76 x lO 5
CORRECTED S/So 5.12 x lO 5 6.72 x lO'5 8 .22  x lO 5 9.84 x lO 5 1.04 x 104
DARK IRRADIATED S/So 5.12 x lO 5 5.12x10-5 5.12 x lO 5 5.12 x 10-5 5.12 x lO-5
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Table D .17. Photoreactivation data for AS46/pKK223-3 at fluence rate of = lWnr2 at
25°C (Figure 5.17)
PHOTORE ACTIV ATION1TME (minutes)
Expt 17a (3.58) 0 30 60 90 120
UNIRRADIATED S/So 1.000 0.897 0.780 0.827 0.733
IRRADIATED S/So 1.31 x 10^ 1.41 x 10^ 2.09 x 10^ 2.61 x 10^ 3.12 x 10^
CORRECTED S/So 1.31 x 10^ 1.57 x 10^ 2.68 x 10^ 3.15 x KH 4.25 x 10^
DARK IRRADIATED S/So 1.31 x 10^ 1.31 x 10^ 1.31 x 10^ 1.31 x 10^ 1.31x HH
EXPT 17b (4.48) 0 30 60 90 120
UNIRRADIATED S/So 1.000 0.904 0.796 0.764 0.754
IRRADIATED S/So 8.46 x 10-5 9.01 x 10-5 1.05 x 10^ 1.53 x 10^ 2.46 x 10^
CORRECTED S/So 8.46 x 10-5 9.97 x 10-5 1.32 x 10^ 2.41 x 10^ 3.26 x 10^
DARK IRRADIATED S/So 8.46 x 10-5 8.46 x 10-5 8.46 x 10-5 8.46 x 10-5 8.46 x 10-5
Expt 17c (4.50) 0 30 60 90 120
UNIRRADIATED S/So 1.000 0.869 0.776 0.724 0.704
IRRADIATED S/So 5.69 x 10-5 5.59 x 10-5 5.93 x 10-5 6.52 x 10-5 6.95 x 10-5
CORRECTED S/So 5.69 x 10-5 6.43 x 10-5 7.64 x 10-5 9.01 x 10-5 9.87 x 10-5
DARK IRRADIATED S/So 5.69 x 10-5 5.69 x 10-5 5.69 x 10-5 5.69 x 10-5 5.69 x 10-5
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Table D .18. Photoreactivation data for AS46/pND03 at fluence rate of = 5Wnr2 at 25°C
(Figure 5.18)
PHOTORE ACnVATION 1ME (minutes)
Expt 18a (3.90) 0 30 60 90 120
UNIRRADIATED S/So 1.000 0.901 0.772 0.705 0.671
IRRADIATED S/So 6 .00  x 10-5 7.98 x 10'5 1.11 x lO 4 1.50 x 104 1.57 x 104
CORRECTED S/So 6 .00  x 10-5 8 .86  x 10'5 1.44 x 104 2.13 x 104 2.34 x 104
DARK IRRADIATED S/So 6 .00  x 10-5 6 .00  x 10'5 6.00x10-5 6.00 x lO 5 6.00 x lO 5
Expt 18b (3.72) 0 30 60 90 120
UNIRRADIATED S/So 1.000 0.869 0.759 0.700 0.678
IRRADIATED S/So 1.14x 104 1.45 x 104 2.08 x 10-4 3.25 x 104 3.25 x 104
CORRECTEDS/So 1.14x10'* 1.67 x 104 2.73 x 104 4.64 x lO 4 4.79 x 104
DARK IRRADIATED S/So 1.14 x 104 1.14 x 10"4 1.14 x 104 1.14 x 104 1.14 x 104
Expt  18c (4.52) 0 30 60 90 120
UNIRRADIATED S/So 1.000 0.894 0.763 0.712 0.674
IRRADIATED S/So 5.12 x 10-5 5.55 x lO'5 5.93 x lO4 6.71 x 10-5 7.15 x 10-5
CORRECTEDS/So 5.12 x 10-5 6.21  x 10-5 7.77 x lO'5 9.42 x lO 5 1.06 x 104
DARK IRRADIATED S/So 5.12 x 10-5 5.12 x 10'5 5.12x10-5 5.12x10-5 5.12 x 10-5
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Table D .19. Photoreactivation data for AS46/pKK223-3 at fluence rate of = 5Wm-2 at
25°C (Figure 5.19)
PHOTORE ACTIVATION 1TME (minutes)
Expt 19a (3.92) 0 30 60 90 120
UNIRRADIATED S/So 1.000 0.912 0.746 0.638 0.606
IRRADIATED S/So 6.35 x lO 5 8.08 x lO 5 1.23 x 10"* 1.24 x 10"* 1.46 x 10"*
CORRECTED S/So 6.35 x lO 5 8.86  x lO 5 1.65 x 10"* 1.95 x 10"* 2.40 x 10"*
DARK IRRADIATED S/So 6.35 x lO 5 6.35 x lO 5 6.35 x lO 5 6.35 x lO 5 6.35 x lO 5
Expt 19b (3.74) 0 30 60 90 120
UNIRRADIATED S/So 1.000 0.847 0.757 0.633 0.602
IRRADIATED S/So 1.66  x 10"* 1.99 x 10"* 2.52 x 10"* 3.30 x 10"* 3.52 x 10"*
CORRECTEDS/So 1.66  x 10"* 2.35 x 10-4 3.32 x 10"* 5.22 x 10"* 5.84 x 10"*
DARK IRRADIATED S/So 1.66  x 10"* 1.66  x 10"* 1.66  x 10-4 1.66  x 10"* 1.66  x 10"*
Expt 19c (4.54) 0 30 60 90 120
UNIRRADIATED S/So 1.000 0.864 0.767 0.649 0.617
IRRADIATED S/So 5.01 x lO 5 5.80 x lO 5 6.32 x lO 5 7.72 x lO 5 8.82 x lO 5
CORRECTED S/So 5.01 x lO 5 6.71 x lO'5 8.24 x lO 5 1.19 x 10"* 1.43 x 10"*
DARK IRRADIATED S/So 5.01 x lO 5 5.01 x lO 5 5.01 x lO 5 5.01 x 10-5 5.01 x lO 5
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Table D .20. Photoreactivation data for AS46/pND03 at fluence rate of = 12Wnr2 at 25°C
(Figure 5.20)
P]HOTOREACTIVATION1nME (minutes)
Expt 20a (4.58) 0 30 60 90 120
UNIRRADIATED S/So 1.000 0.815 0.712 0.593 0.543
IRRADIATED S/So 4.43 x 10-5 5.47 x 10*5 1.00  x 10^ 1.46 x HH 2.50 x 10^
CORRECTEDS/So 4.43 x lO 5 6.71 x lO 5 1.40 x 10^ 2.46 x 10^ 4.60 x 10^
DARK IRRADIATED S/So 4.43 x 10'5 4.43 x lO 5 4.43 x lO'5 4.43 x lO 5 4.43 x 10-5
Expt 20b (4.10) 0 30 60 90 120
UNIRRADIATED S/So 1.000 0.833 0.699 0.562 0.579
IRRADIATED S/So 2.38 x lO 5 4.19 x lO 5 8.81 x lO 5 1.27 x 10^ 1.43 x 10^
CORRECTEDS/So 2.38 x lO 5 5.03 x lO 5 1.26 x 10^ 2.26 x 10^ 2.46 x 10
DARK IRRADIATED S/So 2.38 x lO 5 2.38 x lO 5 2.38 x lO 5 2.38 x lO 5 2.38 x lO 5
Expt 20c (4.56) 0 30 60 90 120
UNIRRADIATED S/So 1.000 0.824 0.754 0.564 0.521
IRRADIATED S/So 6.71 x lO 5 8.15 x 10'5 1.86 x lO -4 2.83 x 10^ 3.39 x 10^
CORRECTEDS/So 6.71 x lO'5 9.89 x 10'5 2.47 x 10-4 5.02 x KH 6.51 x 10-4
DARK IRRADIATED S/So 6.71 x lO 5 6.71 x lO 5 6.71 x lO 5 6.71 x lO 5 6.71 x lO 5
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Table D .21. Photoreactivation data for AS46/pKK223-3 at fluence rate of = 12Wnr2 at
25°C (Figure 5.21)
P]HOTORE ACTIVATION 1TME (minutes)
Expt 21a (4.12) 0 30 60 90 120
UNIRRADIATED S/So 1.000 0.754 0.513 0.474 0.396
IRRADIATED S/So 4.50 x lO 5 5.31 x lO 5 5.98 x lO 5 6.35 x lO 5 5.50 x lO 5
CORRECTED S/So 4.50 x lO 5 7.04 x lO 5 1.17 x 10"* 1.34 x 10"* 1.39 x 10"*
DARK IRRADIATED S/So 4.50 x lO'5 4.50 x lO 5 4.50 x 10'5 4.50 x lO 5 4.50 x lO 5
EXPT 21b (3.84) 0 30 60 90 120
UNIRRADIATED S/So 1.000 0.722 0.509 0.460 0.400
IRRADIATED S/So 2.08 x 10^ 2.36 x 10"* 2.84 x 10"* 2.88  x 10"* 3.12 x 10-4
CORRECTED S/So 2.08 x 10-4 3.27 x 10-4 5.58 x 10"* 6.26 x 10-4 7.08 x 10-4
DARK IRRADIATED S/So 2.08 x 10^ 2.08 x 10-4 2.08 x 10"* 2.08 x 10"* 2.08 x 10"*
Expt 21c (4.60) 0 30 60 90 120
UNIRRADIATED S/So 1.000 0.764 0.521 0.469 0.410
IRRADIATED S/So 6.79 x lO 5 6 .20  x 10'5 5.15 x 10^ 5.35 x 10-4 5.99 x 10"*
CORRECTEDS/So 6.79 x lO 5 8.12 x lO 5 9.88 x lO 5 1.14 x lO -4 1.46 x 10"*
DARK IRRADIATED S/So 6.79 x lO 5 6.79 x lO 5 6.79 x lO 5 6.79 x lO*5 6.79 x lO 5
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Table D.221. Sensitivity of unirradiated AS46/pND01 to the photoreactivating light at
fluence rate of = 8Wnr2 at 25°C (Figure 5.22)
P]HOTOREACTTVATION TIME (minutes)
(4.4)
Expt 22ia 0 30 60 90 120
S/So 1.000 1.174 0.870 0.709 0.565
Expt 22ib 0 30 60 90 120
S/So 1 .000 0.863 0.493 0.619 0.604
AVERAGE S/So 1.000 0.948 0.668 0.660 0.588
Table D.22ii. Sensitivity of uninradiated AS46/pUC19 to the photoreactivating light at 
fluence rate of = 8Wnr2 at 25°C (Figure 5.22)
PHOTORE ACITV ATION 1TME (minutes)
(3.80)
E xp t 22iia 0 30 60 90 120
S/So 1.000 0.930 0.749 0.679 0.532
E x p t 22iib 0 30 60 90 120
S/So 1.000 0.935 0.691 0.634 0.586
AVERAGE S/So 1.000 0.932 0.717 0.656 0.561
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Table D.23i. Sensitivity of unirradiated AS46/pND03 to the photoreactivating light at
fluence rate of = 8Wm-2 at 25°C (Figure 5.23)
P]HOTOREACTTVATION TIME (minutes)
(3.60)
Expt 23ia 0 30 60 90 120
S/So 1.000 1.061 0.820 0.689 0.731
Expt 23ib 0 30 60 90 120
S/So 1 .000 0.812 0.763 0.670 0.575
AVERAGE S/So 1.000 0.928 0.790 0.679 0.648
Table D.23ii. Sensitivity of unirradiated AS46/pKK223-3 to the photoreactivating light at 
fluence rate of = 8Wm-2 at 25°C (Figure 5.23)
P]HOTOREACnVATION TIME (minutes)
(3.78)
E xpt 23iia 0 30 60 90 120
S/So 1.000 0.944 0.725 0.595 0.470
E xpt 23iib 0 30 60 90 120
S/So 1 .000 0.939 0.825 0.721 0.607
AVERAGE S/So 1 .000 0.942 0.773 0.656 0.537
XLIV
Table D .24i. Sensitivity of unirradiated AS46/pND03 to the photoreactivating light at
fluence rate of = 12Wnr2 at 25°C (Figure 5.24)
P]HOTOREACTIVATION TIME (minutes)
(4.6)
Expt 24ia 0 30 60 90 120
S/So 1.000 0.840 0.834 0.764 0.604
Expt 24ib 0 30 60 90 120
S/So 1.000 0.808 0.801 0.741 0.566
AVERAGE S/So 1.000 0.824 0.817 0.757 0.584
Table D.24ii. Sensitivity of unirradiated AS46/pKK223-3 to the photoreactivating light at 
fluence rate of = 12Wm-2 at 25°C (Figure 5.24)
P]HOTORE ACTTV ATION 1TME (minutes)
(4.8)
E xpt 24iia 0 30 60 90 120
S/So 1.000 0.745 0.529 0.471 0.418
E xpt 24iib 0 30 60 90 120
S/So 1.000 0.755 0.516 0.475 0.402
AVERAGE S/So 1.000 0.749 0.522 0.473 0.408
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Table D.25. Photoreactivation data for AS46/pND05 at 25°C (Figure 5.25)
PHOTOREACTIV ATION 1TME (minutes)
EXPT 25a (3.86) 0 30 60 90 120
UNIRRADIATED S/So 1.000 0.857 0.801 0.614 0.438
IRRADIATED S/So 1.29 x 10^ 1.21 x 10^ 1.39 x 10-4 1.48 x 10*4 1.51 x 10^
CORRECTED S/So 1.29 x 10^ 1.42 x 10A 1.74 x 10^ 2.40 x 10-4 3.45 x 10-4
DARK IRRADIATED S/So 1.29 x 10^ 1.29 x lO*4 1.29 x 10^ 1.29 x 10-4 1.29 x 10^
E xpt 25b (4.62) 0 30 60 90 120
UNIRRADIATED S/So 1.000 0.864 0.790 0.631 0.459
IRRADIATED S/So 7.26 x lO 5 7.31 x lO 5 7.75 x lO 5 7 . 1 9 x l 0 5 6.38 x lO 5
CORRECTEDS/So 7.26 x lO 5 8.46 x 10-5 9.81 x lO 5 1.14 x 10^ 1.39 x 10^
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Figure E .l. Calibration curve of the optical density at 510nm against the amount of
ferrous ions present in the solution.
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Figure E 2. Calibration curve of the viable count of a cell suspension of AS46 /  pND03 
against the optical density of the cell suspension mesured at 470nm.
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